<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Formation of Fibrin Clot (Clotting Cascade)" Data-Source="Reactome - http://www.reactome.org" Version="release 46" Author="D'Eustachio, P" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">The formation of a fibrin clot at the site of an injury to the wall of a normal blood vessel is an essential part of the process to stop blood loss after vascular injury.  The reactions that lead to fibrin clot formation are commonly described as a cascade, in which the product of each step is an enzyme or cofactor needed for following reactions to proceed efficiently.  The entire clotting cascade can be divided into three portions, the extrinsic pathway, the intrinsic pathway, and the common pathway.  The extrinsic pathway begins with the release of tissue factor at the site of vascular injury and leads to the activation of factor X.  The intrinsic pathway provides an alternative mechanism for activation of factor X, starting from the activation of factor XII.  The common pathway consists of the steps linking the activation of factor X to the formation of a multimeric, cross-linked fibrin clot.  Each of these pathways includes not only a cascade of events that generate the catalytic activities needed for clot formation, but also numerous positive and negative regulatory events.
&lt;a href=http://www.reactome.org/PathwayBrowser/#DB=gk_current&amp;FOCUS_SPECIES_ID=48887&amp;FOCUS_PATHWAY_ID=140877&gt;View original pathway at Reactome&lt;/a&gt; </Comment>
  <Graphics BoardWidth="5230.0" BoardHeight="1157.0" />
  <DataNode TextLabel="sequestered tissue factor" GraphId="n1318" Type="Protein">
    <Graphics CenterX="3266.0" CenterY="754.0" Width="114.0" Height="38.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P13726" />
  </DataNode>
  <DataNode TextLabel="PalmC-F3" GraphId="n1319" Type="Protein">
    <Graphics CenterX="3154.0" CenterY="755.0" Width="82.0" Height="28.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P13726" />
  </DataNode>
  <DataNode TextLabel="10xCbxE-F7" GraphId="n1321" Type="Protein">
    <BiopaxRef>d54</BiopaxRef>
    <BiopaxRef>f7b</BiopaxRef>
    <Graphics CenterX="3170.0" CenterY="404.5" Width="86.0" Height="41.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P08709" />
  </DataNode>
  <DataNode TextLabel="PalmC-F3 " Type="Protein" GroupRef="1407750.26866068013384425">
    <Graphics CenterX="100.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P13726" />
  </DataNode>
  <DataNode TextLabel="10xCbxE-F7" Type="Protein" GroupRef="1407750.26866068013384425">
    <BiopaxRef>d54</BiopaxRef>
    <BiopaxRef>f7b</BiopaxRef>
    <Graphics CenterX="100.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P08709" />
  </DataNode>
  <DataNode TextLabel="TF&#xA;F7" GraphId="n1322" Type="Complex">
    <Graphics CenterX="3056.0" CenterY="755.5" Width="48.0" Height="23.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4908" />
  </DataNode>
  <DataNode TextLabel="11xCbxE-3D-F10" Type="Protein" GroupRef="1407390.3575707758019925">
    <BiopaxRef>bb6</BiopaxRef>
    <BiopaxRef>c4a</BiopaxRef>
    <Graphics CenterX="210.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00742" />
  </DataNode>
  <DataNode TextLabel="factor X heavy chain " Type="Protein" GroupRef="1407390.3575707758019925">
    <BiopaxRef>da1</BiopaxRef>
    <Graphics CenterX="210.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00742" />
  </DataNode>
  <DataNode TextLabel="factor X" GraphId="n1324" Type="Complex">
    <BiopaxRef>da1</BiopaxRef>
    <Graphics CenterX="2710.0" CenterY="483.5" Width="54.0" Height="25.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_3749" />
  </DataNode>
  <DataNode TextLabel="11xCbxE-3D-F10" Type="Protein" GroupRef="1406890.20354281619170667">
    <BiopaxRef>bb6</BiopaxRef>
    <BiopaxRef>c4a</BiopaxRef>
    <Graphics CenterX="320.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00742" />
  </DataNode>
  <DataNode TextLabel="factor Xa heavy chain " Type="Protein" GroupRef="1406890.20354281619170667">
    <BiopaxRef>da1</BiopaxRef>
    <BiopaxRef>a14</BiopaxRef>
    <Graphics CenterX="320.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00742" />
  </DataNode>
  <DataNode TextLabel="Ca2+ " Type="Metabolite" GroupRef="1406890.20354281619170667">
    <Graphics CenterX="320.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="factor Xa" GraphId="n1325" Type="Complex">
    <BiopaxRef>da1</BiopaxRef>
    <BiopaxRef>e58</BiopaxRef>
    <Graphics CenterX="2936.0" CenterY="313.5" Width="56.0" Height="39.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_5349" />
  </DataNode>
  <DataNode TextLabel="factor X activation peptide" GraphId="n1326" Type="Protein">
    <BiopaxRef>a14</BiopaxRef>
    <Graphics CenterX="2966.0" CenterY="507.5" Width="86.0" Height="53.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00742" />
  </DataNode>
  <DataNode TextLabel="10xCbxE-F7" Type="Protein" GroupRef="1407510.0068594233077811095">
    <BiopaxRef>d54</BiopaxRef>
    <BiopaxRef>f7b</BiopaxRef>
    <Graphics CenterX="430.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P08709" />
  </DataNode>
  <DataNode TextLabel="factor VIIa heavy chain " Type="Protein" GroupRef="1407510.0068594233077811095">
    <BiopaxRef>d54</BiopaxRef>
    <BiopaxRef>f7b</BiopaxRef>
    <Graphics CenterX="430.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P08709" />
  </DataNode>
  <DataNode TextLabel="Ca2+ " Type="Metabolite" GroupRef="1407510.0068594233077811095">
    <Graphics CenterX="430.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="factor VIIa" GraphId="n1328" Type="Complex">
    <BiopaxRef>d54</BiopaxRef>
    <BiopaxRef>f7b</BiopaxRef>
    <Graphics CenterX="3080.0" CenterY="576.0" Width="56.0" Height="34.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_2419" />
  </DataNode>
  <DataNode TextLabel="PalmC-F3 " Type="Protein" GroupRef="1407340.2835253504744524">
    <Graphics CenterX="540.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P13726" />
  </DataNode>
  <DataNode TextLabel="10xCbxE-F7" Type="Protein" GroupRef="1407330.21393290239157847">
    <BiopaxRef>d54</BiopaxRef>
    <BiopaxRef>f7b</BiopaxRef>
    <Graphics CenterX="540.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P08709" />
  </DataNode>
  <DataNode TextLabel="factor VIIa heavy chain " Type="Protein" GroupRef="1407330.21393290239157847">
    <BiopaxRef>d54</BiopaxRef>
    <BiopaxRef>f7b</BiopaxRef>
    <Graphics CenterX="540.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P08709" />
  </DataNode>
  <DataNode TextLabel="Ca2+ " Type="Metabolite" GroupRef="1407330.21393290239157847">
    <Graphics CenterX="540.0" CenterY="1017.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="TF&#xA;F7a" GraphId="n1330" Type="Complex">
    <Graphics CenterX="2834.0" CenterY="758.0" Width="56.0" Height="24.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4532" />
  </DataNode>
  <DataNode TextLabel="Ca2+" GraphId="n1332" Type="Metabolite">
    <Graphics CenterX="2631.5" CenterY="595.5" Width="61.0" Height="31.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="11xCbxE-3D-F9" GraphId="n1374" Type="Protein">
    <BiopaxRef>e8a</BiopaxRef>
    <BiopaxRef>fe8</BiopaxRef>
    <Graphics CenterX="2395.5" CenterY="234.0" Width="79.0" Height="40.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00740" />
  </DataNode>
  <DataNode TextLabel="factor IX activation peptide" GraphId="n1375" Type="Protein">
    <BiopaxRef>e8a</BiopaxRef>
    <Graphics CenterX="2392.5" CenterY="323.0" Width="113.0" Height="38.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00740" />
  </DataNode>
  <DataNode TextLabel="factor IXa heavy chain " Type="Protein" GroupRef="1408960.5711435348782689">
    <BiopaxRef>e8a</BiopaxRef>
    <Graphics CenterX="650.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00740" />
  </DataNode>
  <DataNode TextLabel="12xCbxE-3D-F9" Type="Protein" GroupRef="1408960.5711435348782689">
    <BiopaxRef>e8a</BiopaxRef>
    <BiopaxRef>fe8</BiopaxRef>
    <Graphics CenterX="650.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00740" />
  </DataNode>
  <DataNode TextLabel="factor IXa" GraphId="n1376" Type="Complex">
    <BiopaxRef>e8a</BiopaxRef>
    <Graphics CenterX="2402.0" CenterY="446.0" Width="66.0" Height="26.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_3075" />
  </DataNode>
  <DataNode TextLabel="TFPI" GraphId="n1378" Type="Protein">
    <Graphics CenterX="2899.5" CenterY="610.5" Width="33.0" Height="23.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P10646" />
  </DataNode>
  <DataNode TextLabel="TFPI " Type="Protein" GroupRef="1408330.8390454022727077">
    <Graphics CenterX="760.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P10646" />
  </DataNode>
  <DataNode TextLabel="PalmC-F3 " Type="Protein" GroupRef="1407340.9848290460901136">
    <Graphics CenterX="760.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P13726" />
  </DataNode>
  <DataNode TextLabel="10xCbxE-F7" Type="Protein" GroupRef="1407330.33778460995024207">
    <BiopaxRef>d54</BiopaxRef>
    <BiopaxRef>f7b</BiopaxRef>
    <Graphics CenterX="760.0" CenterY="1017.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P08709" />
  </DataNode>
  <DataNode TextLabel="factor VIIa heavy chain " Type="Protein" GroupRef="1407330.33778460995024207">
    <BiopaxRef>d54</BiopaxRef>
    <BiopaxRef>f7b</BiopaxRef>
    <Graphics CenterX="760.0" CenterY="1037.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P08709" />
  </DataNode>
  <DataNode TextLabel="Ca2+ " Type="Metabolite" GroupRef="1407330.33778460995024207">
    <Graphics CenterX="760.0" CenterY="1057.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="11xCbxE-3D-F10" Type="Protein" GroupRef="1406490.22310516120981316">
    <BiopaxRef>bb6</BiopaxRef>
    <BiopaxRef>c4a</BiopaxRef>
    <Graphics CenterX="760.0" CenterY="1097.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00742" />
  </DataNode>
  <DataNode TextLabel="factor Xa heavy chain " Type="Protein" GroupRef="1406490.22310516120981316">
    <BiopaxRef>da1</BiopaxRef>
    <BiopaxRef>a14</BiopaxRef>
    <Graphics CenterX="760.0" CenterY="1117.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00742" />
  </DataNode>
  <DataNode TextLabel="TFPI&#xA;TF&#xA;F7a&#xA;factor Xa" GraphId="n1379" Type="Complex">
    <Graphics CenterX="2953.0" CenterY="762.0" Width="96.0" Height="38.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_2685" />
  </DataNode>
  <DataNode TextLabel="KNG1" GraphId="n1381" Type="Protein">
    <Graphics CenterX="2580.5" CenterY="681.5" Width="71.0" Height="23.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01042" />
  </DataNode>
  <DataNode TextLabel="C1QBP " Type="Protein" GroupRef="1583180.24682457041767225">
    <Graphics CenterX="870.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="Q07021" />
  </DataNode>
  <DataNode TextLabel="C1q binding protein tetramer" GraphId="n1382" Type="Complex">
    <Graphics CenterX="2605.0" CenterY="760.5" Width="116.0" Height="35.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_2937" />
  </DataNode>
  <DataNode TextLabel="KNG1" Type="Protein" GroupRef="1581720.4107935766207831">
    <Graphics CenterX="980.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01042" />
  </DataNode>
  <DataNode TextLabel="C1QBP " Type="Protein" GroupRef="1583180.4249271272321663">
    <Graphics CenterX="980.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="Q07021" />
  </DataNode>
  <DataNode TextLabel="KNG&#xA;C1q binding protein tetramer" GraphId="n1383" Type="Complex">
    <Graphics CenterX="2468.0" CenterY="760.0" Width="130.0" Height="38.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4804" />
  </DataNode>
  <DataNode TextLabel="Zn2+" GraphId="n1384" Type="Metabolite">
    <Graphics CenterX="2441.0" CenterY="675.5" Width="42.0" Height="31.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29105" />
  </DataNode>
  <DataNode TextLabel="KLKB1" GraphId="n1386" Type="Protein">
    <Graphics CenterX="2347.0" CenterY="760.5" Width="86.0" Height="33.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P03952" />
  </DataNode>
  <DataNode TextLabel="KLKB1" Type="Protein" GroupRef="1584040.8273408742960129">
    <Graphics CenterX="1090.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P03952" />
  </DataNode>
  <DataNode TextLabel="KNG1" Type="Protein" GroupRef="1581720.236107297834812">
    <Graphics CenterX="1090.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01042" />
  </DataNode>
  <DataNode TextLabel="C1QBP " Type="Protein" GroupRef="1583180.34489288549614994">
    <Graphics CenterX="1090.0" CenterY="1017.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="Q07021" />
  </DataNode>
  <DataNode TextLabel="prekallikrein&#xA;kininogen&#xA;C1q binding protein tetramer" GraphId="n1387" Type="Complex">
    <Graphics CenterX="929.0" CenterY="754.0" Width="132.0" Height="64.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_3461" />
  </DataNode>
  <DataNode TextLabel="KLKB1" Type="Protein" GroupRef="1582430.8599995046203145">
    <Graphics CenterX="1200.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P03952" />
  </DataNode>
  <DataNode TextLabel="KLKB1" Type="Protein" GroupRef="1582430.8599995046203145">
    <Graphics CenterX="1200.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P03952" />
  </DataNode>
  <DataNode TextLabel="KNG1" Type="Protein" GroupRef="1581720.3915810453391875">
    <Graphics CenterX="1200.0" CenterY="1017.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01042" />
  </DataNode>
  <DataNode TextLabel="C1QBP " Type="Protein" GroupRef="1583180.25192077050986084">
    <Graphics CenterX="1200.0" CenterY="1057.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="Q07021" />
  </DataNode>
  <DataNode TextLabel="kallikrein&#xA;kininogen&#xA;C1q binding protein tetramer" GraphId="n1389" Type="Complex">
    <Graphics CenterX="784.5" CenterY="755.5" Width="117.0" Height="63.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4714" />
  </DataNode>
  <DataNode TextLabel="PRCP " Type="Protein" GroupRef="1581760.75023621733358">
    <Graphics CenterX="1310.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P42785" />
  </DataNode>
  <DataNode TextLabel="prolylcarboxypeptidase dimer" GraphId="n1390" Type="Complex">
    <Graphics CenterX="646.5" CenterY="762.0" Width="127.0" Height="38.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_5699" />
  </DataNode>
  <DataNode TextLabel="KNG1" Type="Protein" GroupRef="1584000.6385055572847841">
    <Graphics CenterX="1420.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01042" />
  </DataNode>
  <DataNode TextLabel="KNG1" Type="Protein" GroupRef="1584000.6385055572847841">
    <Graphics CenterX="1420.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01042" />
  </DataNode>
  <DataNode TextLabel="C1QBP " Type="Protein" GroupRef="1583180.6493625737658735">
    <Graphics CenterX="1420.0" CenterY="1017.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="Q07021" />
  </DataNode>
  <DataNode TextLabel="activated kininogen&#xA;C1q binding protein tetramer" GraphId="n1392" Type="Complex">
    <Graphics CenterX="512.5" CenterY="758.5" Width="117.0" Height="53.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_3121" />
  </DataNode>
  <DataNode TextLabel="KLKB1" Type="Protein" GroupRef="1581400.86723657000276">
    <Graphics CenterX="1530.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P03952" />
  </DataNode>
  <DataNode TextLabel="KLKB1" Type="Protein" GroupRef="1581400.86723657000276">
    <Graphics CenterX="1530.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P03952" />
  </DataNode>
  <DataNode TextLabel="Plasma kallikrein" GraphId="n1393" Type="Complex">
    <Graphics CenterX="263.5" CenterY="515.5" Width="63.0" Height="23.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4124" />
  </DataNode>
  <DataNode TextLabel="Bradykinin" GraphId="n1394" Type="Protein">
    <Graphics CenterX="630.0" CenterY="595.5" Width="76.0" Height="23.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01042" />
  </DataNode>
  <DataNode TextLabel="factor XII" GraphId="n1396" Type="Protein">
    <Graphics CenterX="1128.5" CenterY="760.5" Width="61.0" Height="23.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00748" />
  </DataNode>
  <DataNode TextLabel="factor XIIa heavy chain " Type="Protein" GroupRef="1583060.03234454559252553">
    <Graphics CenterX="1640.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00748" />
  </DataNode>
  <DataNode TextLabel="factor XIIa light chain " Type="Protein" GroupRef="1583060.03234454559252553">
    <Graphics CenterX="1640.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00748" />
  </DataNode>
  <DataNode TextLabel="factor XIIa" GraphId="n1397" Type="Complex">
    <Graphics CenterX="1034.5" CenterY="478.0" Width="67.0" Height="24.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4236" />
  </DataNode>
  <DataNode TextLabel="KNG1" GraphId="n1398" Type="Protein">
    <Graphics CenterX="1047.5" CenterY="760.5" Width="71.0" Height="25.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01042" />
  </DataNode>
  <DataNode TextLabel="factor XI monomer " Type="Protein" GroupRef="1582340.06089759672804407">
    <Graphics CenterX="1750.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P03951" />
  </DataNode>
  <DataNode TextLabel="factor XI" GraphId="n1401" Type="Complex">
    <Graphics CenterX="2062.0" CenterY="668.5" Width="52.0" Height="31.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4915" />
  </DataNode>
  <DataNode TextLabel="factor XI monomer " Type="Protein" GroupRef="1581430.5992630800508533">
    <Graphics CenterX="1860.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P03951" />
  </DataNode>
  <DataNode TextLabel="GP1BA " Type="Protein" GroupRef="1146670.6838511503788506">
    <Graphics CenterX="1860.0" CenterY="1017.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P07359" />
  </DataNode>
  <DataNode TextLabel="GP1BB " Type="Protein" GroupRef="1146670.6838511503788506">
    <Graphics CenterX="1860.0" CenterY="1037.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P13224" />
  </DataNode>
  <DataNode TextLabel="GP9 " Type="Protein" GroupRef="1146670.6838511503788506">
    <Graphics CenterX="1860.0" CenterY="1057.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P14770" />
  </DataNode>
  <DataNode TextLabel="GP5 " Type="Protein" GroupRef="1146670.6838511503788506">
    <Graphics CenterX="1860.0" CenterY="1077.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P40197" />
  </DataNode>
  <DataNode TextLabel="factor XI&#xA;GPIb-IX-V complex" GraphId="n1402" Type="Complex">
    <Graphics CenterX="1963.0" CenterY="760.0" Width="118.0" Height="38.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_5726" />
  </DataNode>
  <DataNode TextLabel="factor XIa heavy chain " Type="Protein" GroupRef="1583900.6348549720288448">
    <Graphics CenterX="1970.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P03951" />
  </DataNode>
  <DataNode TextLabel="factor XIa light chain " Type="Protein" GroupRef="1583900.6348549720288448">
    <Graphics CenterX="1970.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P03951" />
  </DataNode>
  <DataNode TextLabel="GP1BA " Type="Protein" GroupRef="1146670.04277691965236419">
    <Graphics CenterX="1970.0" CenterY="1037.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P07359" />
  </DataNode>
  <DataNode TextLabel="GP1BB " Type="Protein" GroupRef="1146670.04277691965236419">
    <Graphics CenterX="1970.0" CenterY="1057.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P13224" />
  </DataNode>
  <DataNode TextLabel="GP9 " Type="Protein" GroupRef="1146670.04277691965236419">
    <Graphics CenterX="1970.0" CenterY="1077.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P14770" />
  </DataNode>
  <DataNode TextLabel="GP5 " Type="Protein" GroupRef="1146670.04277691965236419">
    <Graphics CenterX="1970.0" CenterY="1097.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P40197" />
  </DataNode>
  <DataNode TextLabel="factor XIa&#xA;GPIb&#xA;GPIX&#xA;GPV complex" GraphId="n1404" Type="Complex">
    <Graphics CenterX="1819.0" CenterY="760.0" Width="124.0" Height="38.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4765" />
  </DataNode>
  <DataNode TextLabel="thrombin heavy chain " Type="Protein" GroupRef="1567860.06592605786600314">
    <BiopaxRef>e5d</BiopaxRef>
    <BiopaxRef>d4a</BiopaxRef>
    <Graphics CenterX="2080.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00734" />
  </DataNode>
  <DataNode TextLabel="thrombin light chain " Type="Protein" GroupRef="1567860.06592605786600314">
    <BiopaxRef>e5d</BiopaxRef>
    <BiopaxRef>d4a</BiopaxRef>
    <Graphics CenterX="2080.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00734" />
  </DataNode>
  <DataNode TextLabel="Ca2+ " Type="Metabolite" GroupRef="1567860.06592605786600314">
    <Graphics CenterX="2080.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="Activated thrombin " GraphId="n1406" Type="Complex">
    <Graphics CenterX="1790.5" CenterY="154.0" Width="111.0" Height="46.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_3298" />
  </DataNode>
  <DataNode TextLabel="factor VIII light chain " Type="Protein" GroupRef="1583500.3291229080131778">
    <Graphics CenterX="2190.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00451" />
  </DataNode>
  <DataNode TextLabel="factor VIII heavy chain " Type="Protein" GroupRef="1583500.3291229080131778">
    <Graphics CenterX="2190.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00451" />
  </DataNode>
  <DataNode TextLabel="factor VIII" GraphId="n1409" Type="Complex">
    <Graphics CenterX="2088.5" CenterY="46.5" Width="69.0" Height="33.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4493" />
  </DataNode>
  <DataNode TextLabel="VWF" Type="Protein" GroupRef="1581360.7615224343200825">
    <Graphics CenterX="2300.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P04275" />
  </DataNode>
  <DataNode TextLabel="von Willibrand factor multimer" GraphId="n1410" Type="Complex">
    <Graphics CenterX="2087.0" CenterY="122.0" Width="122.0" Height="38.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_5706" />
  </DataNode>
  <DataNode TextLabel="factor VIII light chain " Type="Protein" GroupRef="1583500.1396785018251797">
    <Graphics CenterX="2410.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00451" />
  </DataNode>
  <DataNode TextLabel="factor VIII heavy chain " Type="Protein" GroupRef="1583500.1396785018251797">
    <Graphics CenterX="2410.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00451" />
  </DataNode>
  <DataNode TextLabel="VWF" Type="Protein" GroupRef="1583500.1396785018251797">
    <Graphics CenterX="2410.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P04275" />
  </DataNode>
  <DataNode TextLabel="factor VIII&#xA;von Willebrand factor multimer" GraphId="n1411" Type="Complex">
    <Graphics CenterX="1913.5" CenterY="87.5" Width="103.0" Height="53.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_3248" />
  </DataNode>
  <DataNode TextLabel="factor VIIIa A1 polypeptide " Type="Protein" GroupRef="1583070.07854737213047636">
    <Graphics CenterX="2520.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00451" />
  </DataNode>
  <DataNode TextLabel="factor VIIIa A2 polypeptide " Type="Protein" GroupRef="1583070.07854737213047636">
    <Graphics CenterX="2520.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00451" />
  </DataNode>
  <DataNode TextLabel="factor VIIIa A3 C1 C2 polypeptide " Type="Protein" GroupRef="1583070.07854737213047636">
    <Graphics CenterX="2520.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00451" />
  </DataNode>
  <DataNode TextLabel="factor VIIIa" GraphId="n1413" Type="Complex">
    <Graphics CenterX="1974.0" CenterY="263.5" Width="66.0" Height="37.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4190" />
  </DataNode>
  <DataNode TextLabel="factor VIIIa B A3 acidic polypeptide" GraphId="n1414" Type="Protein">
    <Graphics CenterX="2056.5" CenterY="214.0" Width="107.0" Height="38.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00451" />
  </DataNode>
  <DataNode TextLabel="factor VIIIa A1 polypeptide " Type="Protein" GroupRef="1583740.715774201970569">
    <Graphics CenterX="2630.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00451" />
  </DataNode>
  <DataNode TextLabel="factor VIIIa A2 polypeptide " Type="Protein" GroupRef="1583740.715774201970569">
    <Graphics CenterX="2630.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00451" />
  </DataNode>
  <DataNode TextLabel="factor VIIIa A3 C1 C2 polypeptide " Type="Protein" GroupRef="1583740.715774201970569">
    <Graphics CenterX="2630.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00451" />
  </DataNode>
  <DataNode TextLabel="factor IXa heavy chain " Type="Protein" GroupRef="1583670.9810203385058415">
    <Graphics CenterX="2630.0" CenterY="1037.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00740" />
  </DataNode>
  <DataNode TextLabel="12xCbxE-3D-F9" Type="Protein" GroupRef="1583670.9810203385058415">
    <BiopaxRef>e8a</BiopaxRef>
    <BiopaxRef>fe8</BiopaxRef>
    <Graphics CenterX="2630.0" CenterY="1057.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00740" />
  </DataNode>
  <DataNode TextLabel="factor VIIIa&#xA;factor IXa" GraphId="n1416" Type="Complex">
    <Graphics CenterX="2733.5" CenterY="759.0" Width="105.0" Height="34.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_3217" />
  </DataNode>
  <DataNode TextLabel="SERPING1" GraphId="n1459" Type="Protein">
    <Graphics CenterX="358.0" CenterY="517.5" Width="46.0" Height="23.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P05155" />
  </DataNode>
  <DataNode TextLabel="KLKB1" Type="Protein" GroupRef="1581400.5442506582005325">
    <Graphics CenterX="2740.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P03952" />
  </DataNode>
  <DataNode TextLabel="KLKB1" Type="Protein" GroupRef="1581400.5442506582005325">
    <Graphics CenterX="2740.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P03952" />
  </DataNode>
  <DataNode TextLabel="SERPING1 " Type="Protein" GroupRef="1581400.5442506582005325">
    <Graphics CenterX="2740.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P05155" />
  </DataNode>
  <DataNode TextLabel="kallikrein&#xA;C1Inh" GraphId="n1460" Type="Complex">
    <Graphics CenterX="301.5" CenterY="344.5" Width="99.0" Height="27.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_5874" />
  </DataNode>
  <DataNode TextLabel="A2M " Type="Protein" GroupRef="1582550.04777546856039361">
    <Graphics CenterX="2850.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01023" />
  </DataNode>
  <DataNode TextLabel="Alpha2-macroglobulin" GraphId="n1462" Type="Complex">
    <Graphics CenterX="154.5" CenterY="515.5" Width="119.0" Height="35.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_3449" />
  </DataNode>
  <DataNode TextLabel="KLKB1" Type="Protein" GroupRef="1581400.835786771930862">
    <Graphics CenterX="2960.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P03952" />
  </DataNode>
  <DataNode TextLabel="KLKB1" Type="Protein" GroupRef="1581400.835786771930862">
    <Graphics CenterX="2960.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P03952" />
  </DataNode>
  <DataNode TextLabel="A2M " Type="Protein" GroupRef="1582550.06040244502358183">
    <Graphics CenterX="2960.0" CenterY="1017.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01023" />
  </DataNode>
  <DataNode TextLabel="kallikrein&#xA;alpha2-macroglobulin" GraphId="n1463" Type="Complex">
    <Graphics CenterX="182.5" CenterY="380.5" Width="115.0" Height="47.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4115" />
  </DataNode>
  <DataNode TextLabel="factor XIIa heavy chain " Type="Protein" GroupRef="1583060.4284136010734807">
    <Graphics CenterX="3070.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00748" />
  </DataNode>
  <DataNode TextLabel="factor XIIa light chain " Type="Protein" GroupRef="1583060.4284136010734807">
    <Graphics CenterX="3070.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00748" />
  </DataNode>
  <DataNode TextLabel="SERPING1 " Type="Protein" GroupRef="1583060.4284136010734807">
    <Graphics CenterX="3070.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P05155" />
  </DataNode>
  <DataNode TextLabel="factor XIIa&#xA;C1Inh" GraphId="n1465" Type="Complex">
    <Graphics CenterX="392.0" CenterY="397.5" Width="100.0" Height="33.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_2283" />
  </DataNode>
  <DataNode TextLabel="10xCbxE-F2" GraphId="n1467" Type="Protein">
    <BiopaxRef>e0c</BiopaxRef>
    <BiopaxRef>e5d</BiopaxRef>
    <BiopaxRef>d4a</BiopaxRef>
    <Graphics CenterX="1796.5" CenterY="480.5" Width="123.0" Height="43.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00734" />
  </DataNode>
  <DataNode TextLabel="10xCbxE-F2" GraphId="n1468" Type="Protein">
    <BiopaxRef>e0c</BiopaxRef>
    <BiopaxRef>d4a</BiopaxRef>
    <Graphics CenterX="1791.0" CenterY="309.5" Width="84.0" Height="57.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00734" />
  </DataNode>
  <DataNode TextLabel="11xCbxE-3D-F10" Type="Protein" GroupRef="1406490.5860404343430662">
    <BiopaxRef>bb6</BiopaxRef>
    <BiopaxRef>c4a</BiopaxRef>
    <Graphics CenterX="3180.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00742" />
  </DataNode>
  <DataNode TextLabel="factor Xa heavy chain " Type="Protein" GroupRef="1406490.5860404343430662">
    <BiopaxRef>da1</BiopaxRef>
    <BiopaxRef>a14</BiopaxRef>
    <Graphics CenterX="3180.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00742" />
  </DataNode>
  <DataNode TextLabel="Ca2+ " Type="Metabolite" GroupRef="1406490.5860404343430662">
    <Graphics CenterX="3180.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="factor Xa" GraphId="n1469" Type="Complex">
    <BiopaxRef>da1</BiopaxRef>
    <BiopaxRef>e58</BiopaxRef>
    <Graphics CenterX="1704.0" CenterY="760.0" Width="60.0" Height="24.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_3099" />
  </DataNode>
  <DataNode TextLabel="factor V" GraphId="n1471" Type="Protein">
    <Graphics CenterX="1454.0" CenterY="358.0" Width="54.0" Height="32.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P12259" />
  </DataNode>
  <DataNode TextLabel="factor V activation peptide" GraphId="n1472" Type="Protein">
    <Graphics CenterX="1460.0" CenterY="524.5" Width="108.0" Height="51.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P12259" />
  </DataNode>
  <DataNode TextLabel="factor Va light chain " Type="Protein" GroupRef="1406920.385987081563939">
    <BiopaxRef>ed6</BiopaxRef>
    <BiopaxRef>b3d</BiopaxRef>
    <BiopaxRef>ed5</BiopaxRef>
    <Graphics CenterX="3290.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P12259" />
  </DataNode>
  <DataNode TextLabel="factor Va heavy chain " Type="Protein" GroupRef="1406920.385987081563939">
    <BiopaxRef>ed6</BiopaxRef>
    <BiopaxRef>b3d</BiopaxRef>
    <BiopaxRef>ed5</BiopaxRef>
    <Graphics CenterX="3290.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P12259" />
  </DataNode>
  <DataNode TextLabel="Ca2+ " Type="Metabolite" GroupRef="1406920.385987081563939">
    <Graphics CenterX="3290.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="factor Va" GraphId="n1473" Type="Complex">
    <Graphics CenterX="1556.0" CenterY="525.5" Width="56.0" Height="35.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_2497" />
  </DataNode>
  <DataNode TextLabel="11xCbxE-3D-F10" Type="Protein" GroupRef="1406490.6051977607708366">
    <BiopaxRef>bb6</BiopaxRef>
    <BiopaxRef>c4a</BiopaxRef>
    <Graphics CenterX="3400.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00742" />
  </DataNode>
  <DataNode TextLabel="factor Xa heavy chain " Type="Protein" GroupRef="1406490.6051977607708366">
    <BiopaxRef>da1</BiopaxRef>
    <BiopaxRef>a14</BiopaxRef>
    <Graphics CenterX="3400.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00742" />
  </DataNode>
  <DataNode TextLabel="Ca2+ " Type="Metabolite" GroupRef="1406490.6051977607708366">
    <Graphics CenterX="3400.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="factor Va heavy chain " Type="Protein" GroupRef="1406610.03397430695579051">
    <BiopaxRef>ed6</BiopaxRef>
    <BiopaxRef>b3d</BiopaxRef>
    <BiopaxRef>ed5</BiopaxRef>
    <Graphics CenterX="3400.0" CenterY="1037.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P12259" />
  </DataNode>
  <DataNode TextLabel="factor Va light chain " Type="Protein" GroupRef="1406610.03397430695579051">
    <BiopaxRef>ed6</BiopaxRef>
    <BiopaxRef>b3d</BiopaxRef>
    <BiopaxRef>ed5</BiopaxRef>
    <Graphics CenterX="3400.0" CenterY="1057.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P12259" />
  </DataNode>
  <DataNode TextLabel="Va&#xA;Xa complex " GraphId="n1475" Type="Complex">
    <BiopaxRef>e58</BiopaxRef>
    <Graphics CenterX="2230.0" CenterY="760.5" Width="110.0" Height="37.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_5441" />
  </DataNode>
  <DataNode TextLabel="FGA" Type="Protein" GroupRef="1146180.16323640758295732">
    <Graphics CenterX="3510.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P02671" />
  </DataNode>
  <DataNode TextLabel="FGB" Type="Protein" GroupRef="1146180.16323640758295732">
    <Graphics CenterX="3510.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P02675" />
  </DataNode>
  <DataNode TextLabel="FGG " Type="Protein" GroupRef="1146180.16323640758295732">
    <Graphics CenterX="3510.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P02679" />
  </DataNode>
  <DataNode TextLabel="Fibrinogen" GraphId="n1518" Type="Complex">
    <Comment Source="Reactome">Fibrinogen is a hexamer, containing two fibrinogen alpha chains, two fibrinogen beta chains, and two fibrinogen gamma chains, held together by disulfide bonds.</Comment>
    <Comment Source="Reactome">Fibrinogen is a hexamer, containing two fibrinogen alpha chains, two fibrinogen beta chains, and two fibrinogen gamma chains, held together by disulfide bonds.</Comment>
    <Graphics CenterX="676.0" CenterY="278.0" Width="74.0" Height="24.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4095" />
  </DataNode>
  <DataNode TextLabel="FGB" GraphId="n1519" Type="Protein">
    <Graphics CenterX="748.0" CenterY="142.5" Width="98.0" Height="23.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P02675" />
  </DataNode>
  <DataNode TextLabel="FGA" GraphId="n1520" Type="Protein">
    <Graphics CenterX="624.5" CenterY="144.5" Width="93.0" Height="23.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P02671" />
  </DataNode>
  <DataNode TextLabel="FGA " Type="Protein" GroupRef="1405860.8029475397924184">
    <Graphics CenterX="3620.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P02671" />
  </DataNode>
  <DataNode TextLabel="FGB " Type="Protein" GroupRef="1405860.8029475397924184">
    <Graphics CenterX="3620.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P02675" />
  </DataNode>
  <DataNode TextLabel="FGG " Type="Protein" GroupRef="1405860.8029475397924184">
    <Graphics CenterX="3620.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P02679" />
  </DataNode>
  <DataNode TextLabel="fibrin monomer" GraphId="n1521" Type="Complex">
    <Comment Source="Reactome">Fibrin is a hexamer of two fibrinogen alpha chains, two fibrinogen beta chains, and two fibrinogen gamma chains, held together by disulfide bonds.  It is formed in vivo by the thrombin-catalyzed removal of amino terminal fibinopeptides from the A alpha and B beta chains of fibrinogen.  This fibrin hexamer ("fibrin monomer") is the subunit that multimerizes to form a fibrin clot ("fibrin multimer").</Comment>
    <Comment Source="Reactome">Fibrin is a hexamer of two fibrinogen alpha chains, two fibrinogen beta chains, and two fibrinogen gamma chains, held together by disulfide bonds.  It is formed in vivo by the thrombin-catalyzed removal of amino terminal fibinopeptides from the A alpha and B beta chains of fibrinogen.  This fibrin hexamer ("fibrin monomer") is the subunit that multimerizes to form a fibrin clot ("fibrin multimer").</Comment>
    <Graphics CenterX="568.0" CenterY="217.0" Width="88.0" Height="34.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_5594" />
  </DataNode>
  <DataNode TextLabel="FGA " Type="Protein" GroupRef="1405860.6948354753994485">
    <Graphics CenterX="3730.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P02671" />
  </DataNode>
  <DataNode TextLabel="FGB " Type="Protein" GroupRef="1405860.6948354753994485">
    <Graphics CenterX="3730.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P02675" />
  </DataNode>
  <DataNode TextLabel="FGG " Type="Protein" GroupRef="1405860.6948354753994485">
    <Graphics CenterX="3730.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P02679" />
  </DataNode>
  <DataNode TextLabel="fibrin multimer" GraphId="n1523" Type="Complex">
    <Comment Source="Reactome">The fibrin "monomers" formed by the action of thrombin on fibrinogen associate spontaneously into multimers.  This association can follow several distinct pathways and may be able to form several types of higher-order structures.  All of these possibilities are represented in Reactome as a fibrin trimer.</Comment>
    <Comment Source="Reactome">The fibrin "monomers" formed by the action of thrombin on fibrinogen associate spontaneously into multimers.  This association can follow several distinct pathways and may be able to form several types of higher-order structures.  All of these possibilities are represented in Reactome as a fibrin trimer.</Comment>
    <Graphics CenterX="422.0" CenterY="218.5" Width="84.0" Height="35.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4444" />
  </DataNode>
  <DataNode TextLabel="factor XIII A chain " Type="Protein" GroupRef="1406080.016012592627640654">
    <BiopaxRef>b23</BiopaxRef>
    <Graphics CenterX="3840.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00488" />
  </DataNode>
  <DataNode TextLabel="F13B " Type="Protein" GroupRef="1406080.016012592627640654">
    <BiopaxRef>add</BiopaxRef>
    <Graphics CenterX="3840.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P05160" />
  </DataNode>
  <DataNode TextLabel="factor XIII" GraphId="n1525" Type="Complex">
    <Graphics CenterX="600.5" CenterY="339.5" Width="57.0" Height="33.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4285" />
  </DataNode>
  <DataNode TextLabel="factor XIII A chain activation peptide" GraphId="n1526" Type="Protein">
    <Graphics CenterX="800.5" CenterY="327.0" Width="107.0" Height="48.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00488" />
  </DataNode>
  <DataNode TextLabel="factor XIIIa A chain " Type="Protein" GroupRef="1407890.5725579502588494">
    <Graphics CenterX="3950.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00488" />
  </DataNode>
  <DataNode TextLabel="F13B " Type="Protein" GroupRef="1407890.5725579502588494">
    <BiopaxRef>add</BiopaxRef>
    <Graphics CenterX="3950.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P05160" />
  </DataNode>
  <DataNode TextLabel="factor XIII cleaved tetramer" GraphId="n1527" Type="Complex">
    <BiopaxRef>c93</BiopaxRef>
    <Graphics CenterX="873.5" CenterY="180.0" Width="109.0" Height="38.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_2648" />
  </DataNode>
  <DataNode TextLabel="F13B" GraphId="n1569" Type="Protein">
    <BiopaxRef>add</BiopaxRef>
    <Graphics CenterX="990.0" CenterY="34.5" Width="104.0" Height="23.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P05160" />
  </DataNode>
  <DataNode TextLabel="factor XIIIa A chain " Type="Protein" GroupRef="1408490.2042600944116444">
    <Graphics CenterX="4060.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00488" />
  </DataNode>
  <DataNode TextLabel="Ca2+ " Type="Metabolite" GroupRef="1408490.2042600944116444">
    <Graphics CenterX="4060.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="factor XIIIa" GraphId="n1570" Type="Complex">
    <BiopaxRef>c93</BiopaxRef>
    <Graphics CenterX="897.0" CenterY="29.0" Width="66.0" Height="34.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4387" />
  </DataNode>
  <DataNode TextLabel="fibrin multimer, crosslinked" GraphId="n1572">
    <Graphics CenterX="373.0" CenterY="89.0" Width="88.0" Height="48.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_2721" />
  </DataNode>
  <DataNode TextLabel="NH4+" GraphId="n1573" Type="Metabolite">
    <Graphics CenterX="468.5" CenterY="104.5" Width="45.0" Height="31.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:28938" />
  </DataNode>
  <DataNode TextLabel="SERPINC1" GraphId="n1615" Type="Protein">
    <BiopaxRef>c28</BiopaxRef>
    <Graphics CenterX="295.0" CenterY="658.5" Width="78.0" Height="33.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01008" />
  </DataNode>
  <DataNode TextLabel="Heparin" GraphId="n1616">
    <Graphics CenterX="296.0" CenterY="763.0" Width="54.0" Height="26.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4737" />
  </DataNode>
  <DataNode TextLabel="SERPINC1 " Type="Protein" GroupRef="1407990.44607989096756084">
    <BiopaxRef>c28</BiopaxRef>
    <Graphics CenterX="4170.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01008" />
  </DataNode>
  <DataNode TextLabel="antithrombin III&#xA;heparin" GraphId="n1617" Type="Complex">
    <Graphics CenterX="390.5" CenterY="762.0" Width="91.0" Height="38.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_2653" />
  </DataNode>
  <DataNode TextLabel="thrombin heavy chain " Type="Protein" GroupRef="1408110.8273497280641423">
    <Graphics CenterX="4280.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00734" />
  </DataNode>
  <DataNode TextLabel="thrombin light chain " Type="Protein" GroupRef="1408110.8273497280641423">
    <Graphics CenterX="4280.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00734" />
  </DataNode>
  <DataNode TextLabel="Ca2+ " Type="Metabolite" GroupRef="1408110.8273497280641423">
    <Graphics CenterX="4280.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="SERPINC1 " Type="Protein" GroupRef="1408110.8273497280641423">
    <BiopaxRef>c28</BiopaxRef>
    <Graphics CenterX="4280.0" CenterY="1017.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01008" />
  </DataNode>
  <DataNode TextLabel="thrombin&#xA;antithrombin III&#xA;heparin" GraphId="n1619" Type="Complex">
    <Graphics CenterX="196.5" CenterY="767.5" Width="103.0" Height="49.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_2423" />
  </DataNode>
  <DataNode TextLabel="thrombin heavy chain " Type="Protein" GroupRef="1408110.8008209055126884">
    <Graphics CenterX="4390.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00734" />
  </DataNode>
  <DataNode TextLabel="thrombin light chain " Type="Protein" GroupRef="1408110.8008209055126884">
    <Graphics CenterX="4390.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00734" />
  </DataNode>
  <DataNode TextLabel="Ca2+ " Type="Metabolite" GroupRef="1408110.8008209055126884">
    <Graphics CenterX="4390.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="SERPINC1" Type="Protein" GroupRef="1408220.037304361429414956">
    <Graphics CenterX="4390.0" CenterY="1037.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01008" />
  </DataNode>
  <DataNode TextLabel="SERPINC1" Type="Protein" GroupRef="1408220.037304361429414956">
    <Graphics CenterX="4390.0" CenterY="1057.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01008" />
  </DataNode>
  <DataNode TextLabel="thrombin&#xA;cleaved antithrombin III&#xA;heparin" GraphId="n1621" Type="Complex">
    <Graphics CenterX="75.0" CenterY="761.0" Width="104.0" Height="62.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_2621" />
  </DataNode>
  <DataNode TextLabel="thrombin heavy chain " Type="Protein" GroupRef="1567860.8941215948137226">
    <BiopaxRef>e5d</BiopaxRef>
    <BiopaxRef>d4a</BiopaxRef>
    <Graphics CenterX="4500.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00734" />
  </DataNode>
  <DataNode TextLabel="thrombin light chain " Type="Protein" GroupRef="1567860.8941215948137226">
    <BiopaxRef>e5d</BiopaxRef>
    <BiopaxRef>d4a</BiopaxRef>
    <Graphics CenterX="4500.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00734" />
  </DataNode>
  <DataNode TextLabel="Ca2+ " Type="Metabolite" GroupRef="1567860.8941215948137226">
    <Graphics CenterX="4500.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="SERPINC1" Type="Protein" GroupRef="1408210.5452695326602988">
    <Graphics CenterX="4500.0" CenterY="1037.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01008" />
  </DataNode>
  <DataNode TextLabel="SERPINC1" Type="Protein" GroupRef="1408210.5452695326602988">
    <Graphics CenterX="4500.0" CenterY="1057.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P01008" />
  </DataNode>
  <DataNode TextLabel="thrombin&#xA;cleaved antithrombin III" GraphId="n1623" Type="Complex">
    <Graphics CenterX="76.0" CenterY="594.5" Width="110.0" Height="43.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4175" />
  </DataNode>
  <DataNode TextLabel="THBD" GraphId="n1705" Type="Protein">
    <BiopaxRef>a42</BiopaxRef>
    <Graphics CenterX="1393.0" CenterY="761.5" Width="110.0" Height="23.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P07204" />
  </DataNode>
  <DataNode TextLabel="thrombin heavy chain " Type="Protein" GroupRef="1408110.5561401666924648">
    <Graphics CenterX="4610.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00734" />
  </DataNode>
  <DataNode TextLabel="thrombin light chain " Type="Protein" GroupRef="1408110.5561401666924648">
    <Graphics CenterX="4610.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P00734" />
  </DataNode>
  <DataNode TextLabel="Ca2+ " Type="Metabolite" GroupRef="1408110.5561401666924648">
    <Graphics CenterX="4610.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="THBD" Type="Protein" GroupRef="1408110.5561401666924648">
    <BiopaxRef>a42</BiopaxRef>
    <Graphics CenterX="4610.0" CenterY="1017.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P07204" />
  </DataNode>
  <DataNode TextLabel="activated thrombin&#xA;thrombomodulin" GraphId="n1706" Type="Complex">
    <BiopaxRef>da7</BiopaxRef>
    <Graphics CenterX="1235.5" CenterY="760.0" Width="111.0" Height="38.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_5904" />
  </DataNode>
  <DataNode TextLabel="8xCbxE-3D-PROC" Type="Protein" GroupRef="1410430.46307642254280024">
    <BiopaxRef>e35</BiopaxRef>
    <BiopaxRef>a11</BiopaxRef>
    <BiopaxRef>fe8</BiopaxRef>
    <Graphics CenterX="4720.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P04070" />
  </DataNode>
  <DataNode TextLabel="PROC" Type="Protein" GroupRef="1410430.46307642254280024">
    <BiopaxRef>a11</BiopaxRef>
    <BiopaxRef>e35</BiopaxRef>
    <Graphics CenterX="4720.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P04070" />
  </DataNode>
  <DataNode TextLabel="protein C" GraphId="n1708" Type="Complex">
    <BiopaxRef>a11</BiopaxRef>
    <BiopaxRef>e35</BiopaxRef>
    <Graphics CenterX="1153.0" CenterY="609.5" Width="64.0" Height="23.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4912" />
  </DataNode>
  <DataNode TextLabel="PROC" GraphId="n1709" Type="Protein">
    <BiopaxRef>a11</BiopaxRef>
    <BiopaxRef>e35</BiopaxRef>
    <BiopaxRef>f3b</BiopaxRef>
    <Graphics CenterX="1303.0" CenterY="565.0" Width="112.0" Height="48.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P04070" />
  </DataNode>
  <DataNode TextLabel="8xCbxE-3D-PROC" Type="Protein" GroupRef="1410500.1200796567509006">
    <BiopaxRef>e35</BiopaxRef>
    <BiopaxRef>a11</BiopaxRef>
    <BiopaxRef>fe8</BiopaxRef>
    <Graphics CenterX="4830.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P04070" />
  </DataNode>
  <DataNode TextLabel="PROC" Type="Protein" GroupRef="1410500.1200796567509006">
    <BiopaxRef>a11</BiopaxRef>
    <BiopaxRef>e35</BiopaxRef>
    <BiopaxRef>f3b</BiopaxRef>
    <Graphics CenterX="4830.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P04070" />
  </DataNode>
  <DataNode TextLabel="Ca2+ " Type="Metabolite" GroupRef="1410500.1200796567509006">
    <Graphics CenterX="4830.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="activated protein C" GraphId="n1710" Type="Complex">
    <BiopaxRef>a11</BiopaxRef>
    <BiopaxRef>e35</BiopaxRef>
    <BiopaxRef>f3b</BiopaxRef>
    <Graphics CenterX="1298.5" CenterY="643.0" Width="125.0" Height="22.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_2599" />
  </DataNode>
  <DataNode TextLabel="Platelet Factor 4" GraphId="n1711">
    <Graphics CenterX="1220.5" CenterY="514.0" Width="103.0" Height="24.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_12205" />
  </DataNode>
  <DataNode TextLabel="factor Va light chain " Type="Protein" GroupRef="1410550.5389102513198324">
    <BiopaxRef>ed6</BiopaxRef>
    <BiopaxRef>b3d</BiopaxRef>
    <BiopaxRef>ed5</BiopaxRef>
    <Graphics CenterX="4940.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P12259" />
  </DataNode>
  <DataNode TextLabel="factor Vi" GraphId="n1753" Type="Complex">
    <Graphics CenterX="1441.0" CenterY="642.5" Width="54.0" Height="43.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_4020" />
  </DataNode>
  <DataNode TextLabel="8xCbxE-3D-PROC" Type="Protein" GroupRef="1410240.20175381088475985">
    <BiopaxRef>e35</BiopaxRef>
    <BiopaxRef>a11</BiopaxRef>
    <BiopaxRef>fe8</BiopaxRef>
    <Graphics CenterX="5050.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P04070" />
  </DataNode>
  <DataNode TextLabel="PROC" Type="Protein" GroupRef="1410240.20175381088475985">
    <BiopaxRef>a11</BiopaxRef>
    <BiopaxRef>e35</BiopaxRef>
    <Graphics CenterX="5050.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P04070" />
  </DataNode>
  <DataNode TextLabel="Ca2+ " Type="Metabolite" GroupRef="1410240.20175381088475985">
    <Graphics CenterX="5050.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="activated protein C" GraphId="n1754" Type="Complex">
    <BiopaxRef>a11</BiopaxRef>
    <BiopaxRef>e35</BiopaxRef>
    <Graphics CenterX="1606.5" CenterY="756.0" Width="89.0" Height="38.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_5044" />
  </DataNode>
  <DataNode TextLabel="11xCbxE-PROS1" GraphId="n1755" Type="Protein">
    <BiopaxRef>d16</BiopaxRef>
    <Graphics CenterX="1508.5" CenterY="760.5" Width="65.0" Height="23.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P07225" />
  </DataNode>
  <DataNode TextLabel="Ca2+" GraphId="n1836" Type="Metabolite">
    <Graphics CenterX="1011.5" CenterY="171.5" Width="61.0" Height="31.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="Ca2+" GraphId="n1838" Type="Metabolite">
    <Graphics CenterX="2664.5" CenterY="326.5" Width="61.0" Height="31.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="Ca2+" GraphId="n1840" Type="Metabolite">
    <Graphics CenterX="2219.5" CenterY="298.5" Width="61.0" Height="31.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="GP1BA " Type="Protein" GroupRef="1146670.2749259321699087">
    <Graphics CenterX="5160.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P07359" />
  </DataNode>
  <DataNode TextLabel="GP1BB " Type="Protein" GroupRef="1146670.2749259321699087">
    <Graphics CenterX="5160.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P13224" />
  </DataNode>
  <DataNode TextLabel="GP9 " Type="Protein" GroupRef="1146670.2749259321699087">
    <Graphics CenterX="5160.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P14770" />
  </DataNode>
  <DataNode TextLabel="GP5 " Type="Protein" GroupRef="1146670.2749259321699087">
    <Graphics CenterX="5160.0" CenterY="1017.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-SwissProt" ID="P40197" />
  </DataNode>
  <DataNode TextLabel="GPIb-IX-V complex" GraphId="n1841" Type="Complex">
    <Graphics CenterX="2085.5" CenterY="760.0" Width="79.0" Height="36.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="REACT_3007" />
  </DataNode>
  <Interaction GraphId="e_1317">
    <Comment Source="Reactome">Tissue factor sequestered in the wall of a blood vessel is exposed to circulating blood when the endothelial lining of the vessel is injured.</Comment>
    <Comment Source="Reactome">Tissue factor sequestered in the wall of a blood vessel is exposed to circulating blood when the endothelial lining of the vessel is injured.</Comment>
    <BiopaxRef>ec8</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="3234.0" Y="732.0" GraphRef="n1318" RelX="-0.5614035087719298" RelY="-1.1578947368421053" />
      <Point X="3166.0" Y="738.0" GraphRef="n1319" RelX="0.2926829268292683" RelY="-1.2142857142857142" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1596" />
  </Interaction>
  <Interaction GraphId="e_1320">
    <Comment Source="Reactome">Tissue factor exposed at the endothelial cell surface forms a complex with factor VII from plasma.</Comment>
    <Comment Source="Reactome">Tissue factor exposed at the endothelial cell surface forms a complex with factor VII from plasma.</Comment>
    <BiopaxRef>a92</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="3142.0" Y="628.0" />
      <Point X="3063.0" Y="741.0" GraphRef="n1322" RelX="0.2916666666666667" RelY="-1.2608695652173914" ArrowHead="Arrow" />
      <Anchor Position="0.0" Shape="None" GraphId="e2b79" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1669" />
  </Interaction>
  <Interaction GraphId="e_1320_a_i0">
    <Comment Source="Reactome">Tissue factor exposed at the endothelial cell surface forms a complex with factor VII from plasma.</Comment>
    <Comment Source="Reactome">Tissue factor exposed at the endothelial cell surface forms a complex with factor VII from plasma.</Comment>
    <BiopaxRef>a92</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="3152.0" Y="738.0" GraphRef="n1319" RelX="-0.04878048780487805" RelY="-1.2142857142857142" />
      <Point X="3142.0" Y="628.0" GraphRef="e2b79" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1669" />
  </Interaction>
  <Interaction GraphId="e_1320_a_i1">
    <Comment Source="Reactome">Tissue factor exposed at the endothelial cell surface forms a complex with factor VII from plasma.</Comment>
    <Comment Source="Reactome">Tissue factor exposed at the endothelial cell surface forms a complex with factor VII from plasma.</Comment>
    <BiopaxRef>a92</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="3167.0" Y="428.0" GraphRef="n1321" RelX="-0.06976744186046512" RelY="1.146341463414634" />
      <Point X="3142.0" Y="628.0" GraphRef="e2b79" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1669" />
  </Interaction>
  <Interaction GraphId="e_1323">
    <Comment Source="Reactome">Factor VII, bound to tissue factor at the endothelial cell surface, catalyzes the activation of factor X from plasma with moderate efficiency.  The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released.  (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor VII, bound to tissue factor at the endothelial cell surface, catalyzes the activation of factor X from plasma with moderate efficiency.  The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released.  (This peptide has no known function.)</Comment>
    <BiopaxRef>d57</BiopaxRef>
    <BiopaxRef>a92</BiopaxRef>
    <BiopaxRef>cd2</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2740.0" Y="492.0" GraphRef="n1324" RelX="1.1111111111111112" RelY="0.68" />
      <Point X="3049.0" Y="466.0" />
      <Anchor Position="0.99" Shape="None" GraphId="a5207" />
      <Anchor Position="0.5" Shape="None" GraphId="a0213" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_493" />
  </Interaction>
  <Interaction GraphId="e_1323_o0">
    <Comment Source="Reactome">Factor VII, bound to tissue factor at the endothelial cell surface, catalyzes the activation of factor X from plasma with moderate efficiency.  The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released.  (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor VII, bound to tissue factor at the endothelial cell surface, catalyzes the activation of factor X from plasma with moderate efficiency.  The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released.  (This peptide has no known function.)</Comment>
    <BiopaxRef>d57</BiopaxRef>
    <BiopaxRef>a92</BiopaxRef>
    <BiopaxRef>cd2</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="3049.0" Y="466.0" GraphRef="a5207" RelX="3.0900000000001455" RelY="-0.2599999999999909" />
      <Point X="2950.0" Y="336.0" GraphRef="n1325" RelX="0.5" RelY="1.1538461538461537" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_493" />
  </Interaction>
  <Interaction GraphId="e_1323_o1">
    <Comment Source="Reactome">Factor VII, bound to tissue factor at the endothelial cell surface, catalyzes the activation of factor X from plasma with moderate efficiency.  The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released.  (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor VII, bound to tissue factor at the endothelial cell surface, catalyzes the activation of factor X from plasma with moderate efficiency.  The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released.  (This peptide has no known function.)</Comment>
    <BiopaxRef>d57</BiopaxRef>
    <BiopaxRef>a92</BiopaxRef>
    <BiopaxRef>cd2</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="3049.0" Y="466.0" GraphRef="a5207" RelX="3.0900000000001455" RelY="-0.2599999999999909" />
      <Point X="3012.0" Y="485.0" GraphRef="n1326" RelX="1.069767441860465" RelY="-0.8490566037735849" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_493" />
  </Interaction>
  <Interaction GraphId="e_1323_c_0">
    <Comment Source="Reactome">Factor VII, bound to tissue factor at the endothelial cell surface, catalyzes the activation of factor X from plasma with moderate efficiency.  The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released.  (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor VII, bound to tissue factor at the endothelial cell surface, catalyzes the activation of factor X from plasma with moderate efficiency.  The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released.  (This peptide has no known function.)</Comment>
    <BiopaxRef>d57</BiopaxRef>
    <BiopaxRef>a92</BiopaxRef>
    <BiopaxRef>cd2</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="3052.0" Y="741.0" GraphRef="n1322" RelX="-0.16666666666666666" RelY="-1.2608695652173914" />
      <Point X="3007.0" Y="585.0" GraphRef="a0213" RelX="112.5" RelY="106.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_493" />
  </Interaction>
  <Interaction GraphId="e_1327">
    <Comment Source="Reactome">Factor Xa catalyzes the activation of factor VII from plasma.</Comment>
    <Comment Source="Reactome">Factor Xa catalyzes the activation of factor VII from plasma.</Comment>
    <BiopaxRef>df0</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="3142.0" Y="428.0" GraphRef="n1321" RelX="-0.6511627906976745" RelY="1.146341463414634" />
      <Point X="3083.0" Y="556.0" GraphRef="n1328" RelX="0.10714285714285714" RelY="-1.1764705882352942" ArrowHead="Arrow" />
      <Anchor Position="0.5" Shape="None" GraphId="e9205" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_9" />
  </Interaction>
  <Interaction GraphId="e_1327_c_0">
    <Comment Source="Reactome">Factor Xa catalyzes the activation of factor VII from plasma.</Comment>
    <Comment Source="Reactome">Factor Xa catalyzes the activation of factor VII from plasma.</Comment>
    <BiopaxRef>df0</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2959.0" Y="336.0" GraphRef="n1325" RelX="0.8214285714285714" RelY="1.1538461538461537" />
      <Point X="3104.0" Y="454.0" GraphRef="e9205" RelX="-8.5" RelY="-38.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_9" />
  </Interaction>
  <Interaction GraphId="e_1329">
    <Comment Source="Reactome">Tissue factor exposed at the endothelial cell surface forms a complex with F7a (activated factor VII) from the plasma</Comment>
    <Comment Source="Reactome">Tissue factor exposed at the endothelial cell surface forms a complex with F7a (activated factor VII) from the plasma</Comment>
    <BiopaxRef>ed3</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="3002.0" Y="691.0" />
      <Point X="2856.0" Y="743.0" GraphRef="n1330" RelX="0.7857142857142857" RelY="-1.25" ArrowHead="Arrow" />
      <Anchor Position="0.0" Shape="None" GraphId="b94d2" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_137" />
  </Interaction>
  <Interaction GraphId="e_1329_a_i0">
    <Comment Source="Reactome">Tissue factor exposed at the endothelial cell surface forms a complex with F7a (activated factor VII) from the plasma</Comment>
    <Comment Source="Reactome">Tissue factor exposed at the endothelial cell surface forms a complex with F7a (activated factor VII) from the plasma</Comment>
    <BiopaxRef>ed3</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="3068.0" Y="596.0" GraphRef="n1328" RelX="-0.42857142857142855" RelY="1.1764705882352942" />
      <Point X="3002.0" Y="691.0" GraphRef="b94d2" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_137" />
  </Interaction>
  <Interaction GraphId="e_1329_a_i1">
    <Comment Source="Reactome">Tissue factor exposed at the endothelial cell surface forms a complex with F7a (activated factor VII) from the plasma</Comment>
    <Comment Source="Reactome">Tissue factor exposed at the endothelial cell surface forms a complex with F7a (activated factor VII) from the plasma</Comment>
    <BiopaxRef>ed3</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="3120.0" Y="738.0" GraphRef="n1319" RelX="-0.8292682926829268" RelY="-1.2142857142857142" />
      <Point X="3002.0" Y="691.0" GraphRef="b94d2" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_137" />
  </Interaction>
  <Interaction GraphId="e_1331">
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface (the "extrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface (the "extrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <BiopaxRef>baa</BiopaxRef>
    <BiopaxRef>d57</BiopaxRef>
    <BiopaxRef>d46</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2769.0" Y="395.0" />
      <Point X="2851.0" Y="395.0" />
      <Anchor Position="0.0" Shape="None" GraphId="c0b77" />
      <Anchor Position="0.99" Shape="None" GraphId="f577b" />
      <Anchor Position="0.5" Shape="None" GraphId="ce11f" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_245" />
  </Interaction>
  <Interaction GraphId="e_1331_a_i0">
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface (the "extrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface (the "extrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <BiopaxRef>baa</BiopaxRef>
    <BiopaxRef>d57</BiopaxRef>
    <BiopaxRef>d46</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2718.0" Y="468.0" GraphRef="n1324" RelX="0.2962962962962963" RelY="-1.24" />
      <Point X="2769.0" Y="395.0" GraphRef="c0b77" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_245" />
  </Interaction>
  <Interaction GraphId="e_1331_a_i1">
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface (the "extrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface (the "extrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <BiopaxRef>baa</BiopaxRef>
    <BiopaxRef>d57</BiopaxRef>
    <BiopaxRef>d46</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2687.0" Y="345.0" GraphRef="n1838" RelX="0.7377049180327869" RelY="1.1935483870967742" />
      <Point X="2769.0" Y="395.0" GraphRef="c0b77" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_245" />
  </Interaction>
  <Interaction GraphId="e_1331_o0">
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface (the "extrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface (the "extrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <BiopaxRef>baa</BiopaxRef>
    <BiopaxRef>d57</BiopaxRef>
    <BiopaxRef>d46</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2851.0" Y="395.0" GraphRef="f577b" RelX="0.8200000000001637" RelY="0.0" />
      <Point X="2915.0" Y="336.0" GraphRef="n1325" RelX="-0.75" RelY="1.1538461538461537" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_245" />
  </Interaction>
  <Interaction GraphId="e_1331_o1">
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface (the "extrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface (the "extrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <BiopaxRef>baa</BiopaxRef>
    <BiopaxRef>d57</BiopaxRef>
    <BiopaxRef>d46</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2851.0" Y="395.0" GraphRef="f577b" RelX="0.8200000000001637" RelY="0.0" />
      <Point X="2938.0" Y="478.0" GraphRef="n1326" RelX="-0.6511627906976745" RelY="-1.1132075471698113" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_245" />
  </Interaction>
  <Interaction GraphId="e_1331_c_0">
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface (the "extrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface (the "extrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <BiopaxRef>baa</BiopaxRef>
    <BiopaxRef>d57</BiopaxRef>
    <BiopaxRef>d46</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2833.0" Y="743.0" GraphRef="n1330" RelX="-0.03571428571428571" RelY="-1.25" />
      <Point X="2817.0" Y="395.0" GraphRef="ce11f" RelX="7.0" RelY="0.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_245" />
  </Interaction>
  <Interaction GraphId="e_1373">
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface, catalyzes the formation of activated factor IX with high efficiency.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface, catalyzes the formation of activated factor IX with high efficiency.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <BiopaxRef>ed4</BiopaxRef>
    <BiopaxRef>baa</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2413.0" Y="257.0" GraphRef="n1374" RelX="0.4430379746835443" RelY="1.15" />
      <Point X="2459.0" Y="390.0" />
      <Anchor Position="0.99" Shape="None" GraphId="d9921" />
      <Anchor Position="0.5" Shape="None" GraphId="b81d7" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_158" />
  </Interaction>
  <Interaction GraphId="e_1373_o0">
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface, catalyzes the formation of activated factor IX with high efficiency.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface, catalyzes the formation of activated factor IX with high efficiency.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <BiopaxRef>ed4</BiopaxRef>
    <BiopaxRef>baa</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2459.0" Y="390.0" GraphRef="d9921" RelX="0.4600000000000364" RelY="1.329999999999984" />
      <Point X="2411.0" Y="345.0" GraphRef="n1375" RelX="0.3274336283185841" RelY="1.1578947368421053" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_158" />
  </Interaction>
  <Interaction GraphId="e_1373_o1">
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface, catalyzes the formation of activated factor IX with high efficiency.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface, catalyzes the formation of activated factor IX with high efficiency.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <BiopaxRef>ed4</BiopaxRef>
    <BiopaxRef>baa</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2459.0" Y="390.0" GraphRef="d9921" RelX="0.4600000000000364" RelY="1.329999999999984" />
      <Point X="2415.0" Y="430.0" GraphRef="n1376" RelX="0.3939393939393939" RelY="-1.2307692307692308" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_158" />
  </Interaction>
  <Interaction GraphId="e_1373_c_0">
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface, catalyzes the formation of activated factor IX with high efficiency.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor VIIa, bound to tissue factor at the endothelial cell surface, catalyzes the formation of activated factor IX with high efficiency.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <BiopaxRef>ed4</BiopaxRef>
    <BiopaxRef>baa</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2824.0" Y="743.0" GraphRef="n1330" RelX="-0.35714285714285715" RelY="-1.25" />
      <Point X="2503.0" Y="348.0" GraphRef="b81d7" RelX="67.0" RelY="24.5" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_158" />
  </Interaction>
  <Interaction GraphId="e_1377">
    <Comment Source="Reactome">TFPI binds to the factor VIIa:TF complex and to factor Xa at the endothelial surface, forming a stable heterotetrameric complex in which factor VIIa is catalytically inactive.</Comment>
    <Comment Source="Reactome">TFPI binds to the factor VIIa:TF complex and to factor Xa at the endothelial surface, forming a stable heterotetrameric complex in which factor VIIa is catalytically inactive.</Comment>
    <BiopaxRef>e5a</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2853.0" Y="547.0" />
      <Point X="2945.0" Y="740.0" GraphRef="n1379" RelX="-0.16666666666666666" RelY="-1.1578947368421053" ArrowHead="Arrow" />
      <Anchor Position="0.0" Shape="None" GraphId="a152a" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_654" />
  </Interaction>
  <Interaction GraphId="e_1377_a_i0">
    <Comment Source="Reactome">TFPI binds to the factor VIIa:TF complex and to factor Xa at the endothelial surface, forming a stable heterotetrameric complex in which factor VIIa is catalytically inactive.</Comment>
    <Comment Source="Reactome">TFPI binds to the factor VIIa:TF complex and to factor Xa at the endothelial surface, forming a stable heterotetrameric complex in which factor VIIa is catalytically inactive.</Comment>
    <BiopaxRef>e5a</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2929.0" Y="336.0" GraphRef="n1325" RelX="-0.25" RelY="1.1538461538461537" />
      <Point X="2853.0" Y="547.0" GraphRef="a152a" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_654" />
  </Interaction>
  <Interaction GraphId="e_1377_a_i1">
    <Comment Source="Reactome">TFPI binds to the factor VIIa:TF complex and to factor Xa at the endothelial surface, forming a stable heterotetrameric complex in which factor VIIa is catalytically inactive.</Comment>
    <Comment Source="Reactome">TFPI binds to the factor VIIa:TF complex and to factor Xa at the endothelial surface, forming a stable heterotetrameric complex in which factor VIIa is catalytically inactive.</Comment>
    <BiopaxRef>e5a</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2835.0" Y="743.0" GraphRef="n1330" RelX="0.03571428571428571" RelY="-1.25" />
      <Point X="2853.0" Y="547.0" GraphRef="a152a" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_654" />
  </Interaction>
  <Interaction GraphId="e_1377_a_i2">
    <Comment Source="Reactome">TFPI binds to the factor VIIa:TF complex and to factor Xa at the endothelial surface, forming a stable heterotetrameric complex in which factor VIIa is catalytically inactive.</Comment>
    <Comment Source="Reactome">TFPI binds to the factor VIIa:TF complex and to factor Xa at the endothelial surface, forming a stable heterotetrameric complex in which factor VIIa is catalytically inactive.</Comment>
    <BiopaxRef>e5a</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2890.0" Y="596.0" GraphRef="n1378" RelX="-0.5757575757575758" RelY="-1.2608695652173914" />
      <Point X="2853.0" Y="547.0" GraphRef="a152a" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_654" />
  </Interaction>
  <Interaction GraphId="e_1380">
    <Comment Source="Reactome">Kininogen (high molecular weight kininogen; HK) associates with C1q binding protein on the cell surface in a reaction dependent on Zn++ (Joseph et al. 1996). In the body, the Zn++  needed to drive this reaction may be provided locally by Zn++ release from activated platelets (Mahdi et al. 2002). The C1q binding protein is inferred to form tetramers based on the properties of purified recombinant protein in vitro (Ghebrehiwet et al. 1994); the stoichiometry of the cell surface complex has not been determined directly.</Comment>
    <Comment Source="Reactome">Kininogen (high molecular weight kininogen; HK) associates with C1q binding protein on the cell surface in a reaction dependent on Zn++ (Joseph et al. 1996). In the body, the Zn++  needed to drive this reaction may be provided locally by Zn++ release from activated platelets (Mahdi et al. 2002). The C1q binding protein is inferred to form tetramers based on the properties of purified recombinant protein in vitro (Ghebrehiwet et al. 1994); the stoichiometry of the cell surface complex has not been determined directly.</Comment>
    <BiopaxRef>cd9</BiopaxRef>
    <BiopaxRef>a1e</BiopaxRef>
    <BiopaxRef>dab</BiopaxRef>
    <BiopaxRef>f42</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2545.0" Y="716.0" />
      <Point X="2485.0" Y="738.0" GraphRef="n1383" RelX="0.26153846153846155" RelY="-1.1578947368421053" ArrowHead="Arrow" />
      <Anchor Position="0.0" Shape="None" GraphId="b0df6" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_2239" />
  </Interaction>
  <Interaction GraphId="e_1380_a_i0">
    <Comment Source="Reactome">Kininogen (high molecular weight kininogen; HK) associates with C1q binding protein on the cell surface in a reaction dependent on Zn++ (Joseph et al. 1996). In the body, the Zn++  needed to drive this reaction may be provided locally by Zn++ release from activated platelets (Mahdi et al. 2002). The C1q binding protein is inferred to form tetramers based on the properties of purified recombinant protein in vitro (Ghebrehiwet et al. 1994); the stoichiometry of the cell surface complex has not been determined directly.</Comment>
    <Comment Source="Reactome">Kininogen (high molecular weight kininogen; HK) associates with C1q binding protein on the cell surface in a reaction dependent on Zn++ (Joseph et al. 1996). In the body, the Zn++  needed to drive this reaction may be provided locally by Zn++ release from activated platelets (Mahdi et al. 2002). The C1q binding protein is inferred to form tetramers based on the properties of purified recombinant protein in vitro (Ghebrehiwet et al. 1994); the stoichiometry of the cell surface complex has not been determined directly.</Comment>
    <BiopaxRef>cd9</BiopaxRef>
    <BiopaxRef>a1e</BiopaxRef>
    <BiopaxRef>dab</BiopaxRef>
    <BiopaxRef>f42</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2568.0" Y="696.0" GraphRef="n1381" RelX="-0.352112676056338" RelY="1.2608695652173914" />
      <Point X="2545.0" Y="716.0" GraphRef="b0df6" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_2239" />
  </Interaction>
  <Interaction GraphId="e_1380_a_i1">
    <Comment Source="Reactome">Kininogen (high molecular weight kininogen; HK) associates with C1q binding protein on the cell surface in a reaction dependent on Zn++ (Joseph et al. 1996). In the body, the Zn++  needed to drive this reaction may be provided locally by Zn++ release from activated platelets (Mahdi et al. 2002). The C1q binding protein is inferred to form tetramers based on the properties of purified recombinant protein in vitro (Ghebrehiwet et al. 1994); the stoichiometry of the cell surface complex has not been determined directly.</Comment>
    <Comment Source="Reactome">Kininogen (high molecular weight kininogen; HK) associates with C1q binding protein on the cell surface in a reaction dependent on Zn++ (Joseph et al. 1996). In the body, the Zn++  needed to drive this reaction may be provided locally by Zn++ release from activated platelets (Mahdi et al. 2002). The C1q binding protein is inferred to form tetramers based on the properties of purified recombinant protein in vitro (Ghebrehiwet et al. 1994); the stoichiometry of the cell surface complex has not been determined directly.</Comment>
    <BiopaxRef>cd9</BiopaxRef>
    <BiopaxRef>a1e</BiopaxRef>
    <BiopaxRef>dab</BiopaxRef>
    <BiopaxRef>f42</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2581.0" Y="740.0" GraphRef="n1382" RelX="-0.41379310344827586" RelY="-1.1714285714285715" />
      <Point X="2545.0" Y="716.0" GraphRef="b0df6" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_2239" />
  </Interaction>
  <Interaction GraphId="e_1380_a_0">
    <Comment Source="Reactome">Kininogen (high molecular weight kininogen; HK) associates with C1q binding protein on the cell surface in a reaction dependent on Zn++ (Joseph et al. 1996). In the body, the Zn++  needed to drive this reaction may be provided locally by Zn++ release from activated platelets (Mahdi et al. 2002). The C1q binding protein is inferred to form tetramers based on the properties of purified recombinant protein in vitro (Ghebrehiwet et al. 1994); the stoichiometry of the cell surface complex has not been determined directly.</Comment>
    <Comment Source="Reactome">Kininogen (high molecular weight kininogen; HK) associates with C1q binding protein on the cell surface in a reaction dependent on Zn++ (Joseph et al. 1996). In the body, the Zn++  needed to drive this reaction may be provided locally by Zn++ release from activated platelets (Mahdi et al. 2002). The C1q binding protein is inferred to form tetramers based on the properties of purified recombinant protein in vitro (Ghebrehiwet et al. 1994); the stoichiometry of the cell surface complex has not been determined directly.</Comment>
    <BiopaxRef>cd9</BiopaxRef>
    <BiopaxRef>a1e</BiopaxRef>
    <BiopaxRef>dab</BiopaxRef>
    <BiopaxRef>f42</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2465.0" Y="687.0" GraphRef="n1384" RelX="1.1428571428571428" RelY="0.7419354838709677" />
      <Point X="2509.0" Y="716.0" GraphRef="b81d7" RelX="73.0" RelY="392.5" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_2239" />
  </Interaction>
  <Interaction GraphId="e_1385">
    <Comment Source="Reactome">Prekallikrein (PK) associates specifically with kininogen (HK) on cell surfaces. In vivo, this reaction may occur primarily on the surfaces of endothelial cells in response to platelet activation (Lin et al. 1997; Motta et al. 1998; Mahdi et al. 2003).</Comment>
    <Comment Source="Reactome">Prekallikrein (PK) associates specifically with kininogen (HK) on cell surfaces. In vivo, this reaction may occur primarily on the surfaces of endothelial cells in response to platelet activation (Lin et al. 1997; Motta et al. 1998; Mahdi et al. 2003).</Comment>
    <BiopaxRef>aa7</BiopaxRef>
    <BiopaxRef>f84</BiopaxRef>
    <BiopaxRef>a08</BiopaxRef>
    <BiopaxRef>ae0</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2359.0" Y="811.0" />
      <Point X="994.0" Y="789.0" GraphRef="n1387" RelX="0.9848484848484849" RelY="1.09375" ArrowHead="Arrow" />
      <Anchor Position="0.0" Shape="None" GraphId="f7df9" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1335" />
  </Interaction>
  <Interaction GraphId="e_1385_a_i0">
    <Comment Source="Reactome">Prekallikrein (PK) associates specifically with kininogen (HK) on cell surfaces. In vivo, this reaction may occur primarily on the surfaces of endothelial cells in response to platelet activation (Lin et al. 1997; Motta et al. 1998; Mahdi et al. 2003).</Comment>
    <Comment Source="Reactome">Prekallikrein (PK) associates specifically with kininogen (HK) on cell surfaces. In vivo, this reaction may occur primarily on the surfaces of endothelial cells in response to platelet activation (Lin et al. 1997; Motta et al. 1998; Mahdi et al. 2003).</Comment>
    <BiopaxRef>aa7</BiopaxRef>
    <BiopaxRef>f84</BiopaxRef>
    <BiopaxRef>a08</BiopaxRef>
    <BiopaxRef>ae0</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2350.0" Y="780.0" GraphRef="n1386" RelX="0.06976744186046512" RelY="1.1818181818181819" />
      <Point X="2359.0" Y="811.0" GraphRef="f7df9" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1335" />
  </Interaction>
  <Interaction GraphId="e_1385_a_i1">
    <Comment Source="Reactome">Prekallikrein (PK) associates specifically with kininogen (HK) on cell surfaces. In vivo, this reaction may occur primarily on the surfaces of endothelial cells in response to platelet activation (Lin et al. 1997; Motta et al. 1998; Mahdi et al. 2003).</Comment>
    <Comment Source="Reactome">Prekallikrein (PK) associates specifically with kininogen (HK) on cell surfaces. In vivo, this reaction may occur primarily on the surfaces of endothelial cells in response to platelet activation (Lin et al. 1997; Motta et al. 1998; Mahdi et al. 2003).</Comment>
    <BiopaxRef>aa7</BiopaxRef>
    <BiopaxRef>f84</BiopaxRef>
    <BiopaxRef>a08</BiopaxRef>
    <BiopaxRef>ae0</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2427.0" Y="782.0" GraphRef="n1383" RelX="-0.6307692307692307" RelY="1.1578947368421053" />
      <Point X="2359.0" Y="811.0" GraphRef="f7df9" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1335" />
  </Interaction>
  <Interaction GraphId="e_1388">
    <Comment Source="Reactome">Prekallikrein in a complex with kininogen and C1q binding protein on the plasma membrane is cleaved to generate active kallikrein, which remains bound to the complex. In the body, this reaction appears to occur on the surfaces of endothelial cells and may require the presence of activated platelets. Recent work indicates that the protease that cleaves prekallikrein under these conditions is prolylcarboxypeptidase. Although this enzyme was originally isolated from lysosomes (Odya et al. 1978; Tan et al. 1993), it is associated with plasma membranes of cultured human endothelial cells in vitro (Moreira et al. 2002; Shariat-Madar et al. 2002), and the purified recombinant enzyme efficiently cleaves prekallikrein (Shariat-Madar et al. 2004). In contrast factor XII, despite its activity on prekallikrein in vitro, appears not to be responsible for prekallikrein activation on the cell surface (Rojkjaer et al. 1998).</Comment>
    <Comment Source="Reactome">Prekallikrein in a complex with kininogen and C1q binding protein on the plasma membrane is cleaved to generate active kallikrein, which remains bound to the complex. In the body, this reaction appears to occur on the surfaces of endothelial cells and may require the presence of activated platelets. Recent work indicates that the protease that cleaves prekallikrein under these conditions is prolylcarboxypeptidase. Although this enzyme was originally isolated from lysosomes (Odya et al. 1978; Tan et al. 1993), it is associated with plasma membranes of cultured human endothelial cells in vitro (Moreira et al. 2002; Shariat-Madar et al. 2002), and the purified recombinant enzyme efficiently cleaves prekallikrein (Shariat-Madar et al. 2004). In contrast factor XII, despite its activity on prekallikrein in vitro, appears not to be responsible for prekallikrein activation on the cell surface (Rojkjaer et al. 1998).</Comment>
    <BiopaxRef>eb9</BiopaxRef>
    <BiopaxRef>b66</BiopaxRef>
    <BiopaxRef>ffe</BiopaxRef>
    <BiopaxRef>e60</BiopaxRef>
    <BiopaxRef>a1a</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="895.0" Y="789.0" GraphRef="n1387" RelX="-0.5151515151515151" RelY="1.09375" />
      <Point X="820.0" Y="790.0" GraphRef="n1389" RelX="0.6068376068376068" RelY="1.0952380952380953" ArrowHead="Arrow" />
      <Anchor Position="0.5" Shape="None" GraphId="d1148" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_6" />
  </Interaction>
  <Interaction GraphId="e_1388_c_0">
    <Comment Source="Reactome">Prekallikrein in a complex with kininogen and C1q binding protein on the plasma membrane is cleaved to generate active kallikrein, which remains bound to the complex. In the body, this reaction appears to occur on the surfaces of endothelial cells and may require the presence of activated platelets. Recent work indicates that the protease that cleaves prekallikrein under these conditions is prolylcarboxypeptidase. Although this enzyme was originally isolated from lysosomes (Odya et al. 1978; Tan et al. 1993), it is associated with plasma membranes of cultured human endothelial cells in vitro (Moreira et al. 2002; Shariat-Madar et al. 2002), and the purified recombinant enzyme efficiently cleaves prekallikrein (Shariat-Madar et al. 2004). In contrast factor XII, despite its activity on prekallikrein in vitro, appears not to be responsible for prekallikrein activation on the cell surface (Rojkjaer et al. 1998).</Comment>
    <Comment Source="Reactome">Prekallikrein in a complex with kininogen and C1q binding protein on the plasma membrane is cleaved to generate active kallikrein, which remains bound to the complex. In the body, this reaction appears to occur on the surfaces of endothelial cells and may require the presence of activated platelets. Recent work indicates that the protease that cleaves prekallikrein under these conditions is prolylcarboxypeptidase. Although this enzyme was originally isolated from lysosomes (Odya et al. 1978; Tan et al. 1993), it is associated with plasma membranes of cultured human endothelial cells in vitro (Moreira et al. 2002; Shariat-Madar et al. 2002), and the purified recombinant enzyme efficiently cleaves prekallikrein (Shariat-Madar et al. 2004). In contrast factor XII, despite its activity on prekallikrein in vitro, appears not to be responsible for prekallikrein activation on the cell surface (Rojkjaer et al. 1998).</Comment>
    <BiopaxRef>eb9</BiopaxRef>
    <BiopaxRef>b66</BiopaxRef>
    <BiopaxRef>ffe</BiopaxRef>
    <BiopaxRef>e60</BiopaxRef>
    <BiopaxRef>a1a</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="695.0" Y="784.0" GraphRef="n1390" RelX="0.7637795275590551" RelY="1.1578947368421053" />
      <Point X="859.0" Y="820.0" GraphRef="d1148" RelX="1.5" RelY="30.5" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_6" />
  </Interaction>
  <Interaction GraphId="e_1391">
    <Comment Source="Reactome">The cleavage of kininogen (HK, high molecular weight kininogen) yields activated kininogen and the vasoactive peptide bradykinin (Kerbirou and Griffin 1979; Lottspeich et al. 1985; Kellerman et al. 1986). In vivo, this reaction is catalyzed by activated kallikrein, takes places within the kallikrein:kininogen:C1q binding protein tetramer complex on the endothelial cell surface, and results in the release of kallikrein and bradykinin (Motta et al. 1998). The hormonal functions of bradykinin will be annotated in a future version of Reactome.</Comment>
    <Comment Source="Reactome">The cleavage of kininogen (HK, high molecular weight kininogen) yields activated kininogen and the vasoactive peptide bradykinin (Kerbirou and Griffin 1979; Lottspeich et al. 1985; Kellerman et al. 1986). In vivo, this reaction is catalyzed by activated kallikrein, takes places within the kallikrein:kininogen:C1q binding protein tetramer complex on the endothelial cell surface, and results in the release of kallikrein and bradykinin (Motta et al. 1998). The hormonal functions of bradykinin will be annotated in a future version of Reactome.</Comment>
    <BiopaxRef>f42</BiopaxRef>
    <BiopaxRef>b5c</BiopaxRef>
    <BiopaxRef>d07</BiopaxRef>
    <BiopaxRef>a08</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="723.0" Y="736.0" GraphRef="n1389" RelX="-1.0512820512820513" RelY="-0.6190476190476191" />
      <Point X="511.0" Y="643.0" />
      <Anchor Position="0.99" Shape="None" GraphId="dd568" />
      <Anchor Position="0.5" Shape="None" GraphId="f014d" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_2004" />
  </Interaction>
  <Interaction GraphId="e_1391_o0">
    <Comment Source="Reactome">The cleavage of kininogen (HK, high molecular weight kininogen) yields activated kininogen and the vasoactive peptide bradykinin (Kerbirou and Griffin 1979; Lottspeich et al. 1985; Kellerman et al. 1986). In vivo, this reaction is catalyzed by activated kallikrein, takes places within the kallikrein:kininogen:C1q binding protein tetramer complex on the endothelial cell surface, and results in the release of kallikrein and bradykinin (Motta et al. 1998). The hormonal functions of bradykinin will be annotated in a future version of Reactome.</Comment>
    <Comment Source="Reactome">The cleavage of kininogen (HK, high molecular weight kininogen) yields activated kininogen and the vasoactive peptide bradykinin (Kerbirou and Griffin 1979; Lottspeich et al. 1985; Kellerman et al. 1986). In vivo, this reaction is catalyzed by activated kallikrein, takes places within the kallikrein:kininogen:C1q binding protein tetramer complex on the endothelial cell surface, and results in the release of kallikrein and bradykinin (Motta et al. 1998). The hormonal functions of bradykinin will be annotated in a future version of Reactome.</Comment>
    <BiopaxRef>f42</BiopaxRef>
    <BiopaxRef>b5c</BiopaxRef>
    <BiopaxRef>d07</BiopaxRef>
    <BiopaxRef>a08</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="511.0" Y="643.0" GraphRef="dd568" RelX="-2.1200000000000045" RelY="-0.9300000000000637" />
      <Point X="511.0" Y="729.0" GraphRef="n1392" RelX="-0.02564102564102564" RelY="-1.1132075471698113" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_2004" />
  </Interaction>
  <Interaction GraphId="e_1391_o1">
    <Comment Source="Reactome">The cleavage of kininogen (HK, high molecular weight kininogen) yields activated kininogen and the vasoactive peptide bradykinin (Kerbirou and Griffin 1979; Lottspeich et al. 1985; Kellerman et al. 1986). In vivo, this reaction is catalyzed by activated kallikrein, takes places within the kallikrein:kininogen:C1q binding protein tetramer complex on the endothelial cell surface, and results in the release of kallikrein and bradykinin (Motta et al. 1998). The hormonal functions of bradykinin will be annotated in a future version of Reactome.</Comment>
    <Comment Source="Reactome">The cleavage of kininogen (HK, high molecular weight kininogen) yields activated kininogen and the vasoactive peptide bradykinin (Kerbirou and Griffin 1979; Lottspeich et al. 1985; Kellerman et al. 1986). In vivo, this reaction is catalyzed by activated kallikrein, takes places within the kallikrein:kininogen:C1q binding protein tetramer complex on the endothelial cell surface, and results in the release of kallikrein and bradykinin (Motta et al. 1998). The hormonal functions of bradykinin will be annotated in a future version of Reactome.</Comment>
    <BiopaxRef>f42</BiopaxRef>
    <BiopaxRef>b5c</BiopaxRef>
    <BiopaxRef>d07</BiopaxRef>
    <BiopaxRef>a08</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="511.0" Y="643.0" GraphRef="dd568" RelX="-2.1200000000000045" RelY="-0.9300000000000637" />
      <Point X="285.0" Y="530.0" GraphRef="n1393" RelX="0.6825396825396826" RelY="1.2608695652173914" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_2004" />
  </Interaction>
  <Interaction GraphId="e_1391_o2">
    <Comment Source="Reactome">The cleavage of kininogen (HK, high molecular weight kininogen) yields activated kininogen and the vasoactive peptide bradykinin (Kerbirou and Griffin 1979; Lottspeich et al. 1985; Kellerman et al. 1986). In vivo, this reaction is catalyzed by activated kallikrein, takes places within the kallikrein:kininogen:C1q binding protein tetramer complex on the endothelial cell surface, and results in the release of kallikrein and bradykinin (Motta et al. 1998). The hormonal functions of bradykinin will be annotated in a future version of Reactome.</Comment>
    <Comment Source="Reactome">The cleavage of kininogen (HK, high molecular weight kininogen) yields activated kininogen and the vasoactive peptide bradykinin (Kerbirou and Griffin 1979; Lottspeich et al. 1985; Kellerman et al. 1986). In vivo, this reaction is catalyzed by activated kallikrein, takes places within the kallikrein:kininogen:C1q binding protein tetramer complex on the endothelial cell surface, and results in the release of kallikrein and bradykinin (Motta et al. 1998). The hormonal functions of bradykinin will be annotated in a future version of Reactome.</Comment>
    <BiopaxRef>f42</BiopaxRef>
    <BiopaxRef>b5c</BiopaxRef>
    <BiopaxRef>d07</BiopaxRef>
    <BiopaxRef>a08</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="511.0" Y="643.0" GraphRef="dd568" RelX="-2.1200000000000045" RelY="-0.9300000000000637" />
      <Point X="601.0" Y="610.0" GraphRef="n1394" RelX="-0.7631578947368421" RelY="1.2608695652173914" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_2004" />
  </Interaction>
  <Interaction GraphId="e_1391_c_0">
    <Comment Source="Reactome">The cleavage of kininogen (HK, high molecular weight kininogen) yields activated kininogen and the vasoactive peptide bradykinin (Kerbirou and Griffin 1979; Lottspeich et al. 1985; Kellerman et al. 1986). In vivo, this reaction is catalyzed by activated kallikrein, takes places within the kallikrein:kininogen:C1q binding protein tetramer complex on the endothelial cell surface, and results in the release of kallikrein and bradykinin (Motta et al. 1998). The hormonal functions of bradykinin will be annotated in a future version of Reactome.</Comment>
    <Comment Source="Reactome">The cleavage of kininogen (HK, high molecular weight kininogen) yields activated kininogen and the vasoactive peptide bradykinin (Kerbirou and Griffin 1979; Lottspeich et al. 1985; Kellerman et al. 1986). In vivo, this reaction is catalyzed by activated kallikrein, takes places within the kallikrein:kininogen:C1q binding protein tetramer complex on the endothelial cell surface, and results in the release of kallikrein and bradykinin (Motta et al. 1998). The hormonal functions of bradykinin will be annotated in a future version of Reactome.</Comment>
    <BiopaxRef>f42</BiopaxRef>
    <BiopaxRef>b5c</BiopaxRef>
    <BiopaxRef>d07</BiopaxRef>
    <BiopaxRef>a08</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="737.0" Y="721.0" GraphRef="n1389" RelX="-0.811965811965812" RelY="-1.0952380952380953" />
      <Point X="628.0" Y="698.0" GraphRef="f014d" RelX="11.0" RelY="8.5" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_2004" />
  </Interaction>
  <Interaction GraphId="e_1395">
    <Comment Source="Reactome">Cleavage of a single peptide bond converts factor XII to activated factor XII (factor XIIa) (Fujikawa and McMullen 1983; McMullen and Fujikawa 1985). Identification of the catalytic activity or activities responsible for this cleavage has not been straightforward. Studies in vitro have demonstrated the autoactivation of factor XII as well as activation by kallikrein. Both reactions require the presence of negatively charged surfaces and are accelerated in the presence of kininogen (high molecular weight kininogen, HK) (Griffin and Cochrane 1976; Meier et al. 1977; Silverberg et al. 1980). Recent work suggests that factor XII activation in vivo may occur primarily on endothelial cell surfaces and that, as in vitro, association with kininogen may accelerate the reaction (Mahdi et al. 2002; Schmaier 2004), although alternative pathways and alternative mechanisms for associating factor XII with the cell surface have not been excluded (Joseph et al. 2001).</Comment>
    <Comment Source="Reactome">Cleavage of a single peptide bond converts factor XII to activated factor XII (factor XIIa) (Fujikawa and McMullen 1983; McMullen and Fujikawa 1985). Identification of the catalytic activity or activities responsible for this cleavage has not been straightforward. Studies in vitro have demonstrated the autoactivation of factor XII as well as activation by kallikrein. Both reactions require the presence of negatively charged surfaces and are accelerated in the presence of kininogen (high molecular weight kininogen, HK) (Griffin and Cochrane 1976; Meier et al. 1977; Silverberg et al. 1980). Recent work suggests that factor XII activation in vivo may occur primarily on endothelial cell surfaces and that, as in vitro, association with kininogen may accelerate the reaction (Mahdi et al. 2002; Schmaier 2004), although alternative pathways and alternative mechanisms for associating factor XII with the cell surface have not been excluded (Joseph et al. 2001).</Comment>
    <BiopaxRef>ca9</BiopaxRef>
    <BiopaxRef>cef</BiopaxRef>
    <BiopaxRef>b18</BiopaxRef>
    <BiopaxRef>f54</BiopaxRef>
    <BiopaxRef>fb9</BiopaxRef>
    <BiopaxRef>fec</BiopaxRef>
    <BiopaxRef>dab</BiopaxRef>
    <BiopaxRef>c7a</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1121.0" Y="746.0" GraphRef="n1396" RelX="-0.2459016393442623" RelY="-1.2608695652173914" />
      <Point X="1033.0" Y="493.0" GraphRef="n1397" RelX="-0.04477611940298507" RelY="1.25" ArrowHead="Arrow" />
      <Anchor Position="0.5" Shape="None" GraphId="b4a15" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1455" />
  </Interaction>
  <Interaction GraphId="e_1395_c_0">
    <Comment Source="Reactome">Cleavage of a single peptide bond converts factor XII to activated factor XII (factor XIIa) (Fujikawa and McMullen 1983; McMullen and Fujikawa 1985). Identification of the catalytic activity or activities responsible for this cleavage has not been straightforward. Studies in vitro have demonstrated the autoactivation of factor XII as well as activation by kallikrein. Both reactions require the presence of negatively charged surfaces and are accelerated in the presence of kininogen (high molecular weight kininogen, HK) (Griffin and Cochrane 1976; Meier et al. 1977; Silverberg et al. 1980). Recent work suggests that factor XII activation in vivo may occur primarily on endothelial cell surfaces and that, as in vitro, association with kininogen may accelerate the reaction (Mahdi et al. 2002; Schmaier 2004), although alternative pathways and alternative mechanisms for associating factor XII with the cell surface have not been excluded (Joseph et al. 2001).</Comment>
    <Comment Source="Reactome">Cleavage of a single peptide bond converts factor XII to activated factor XII (factor XIIa) (Fujikawa and McMullen 1983; McMullen and Fujikawa 1985). Identification of the catalytic activity or activities responsible for this cleavage has not been straightforward. Studies in vitro have demonstrated the autoactivation of factor XII as well as activation by kallikrein. Both reactions require the presence of negatively charged surfaces and are accelerated in the presence of kininogen (high molecular weight kininogen, HK) (Griffin and Cochrane 1976; Meier et al. 1977; Silverberg et al. 1980). Recent work suggests that factor XII activation in vivo may occur primarily on endothelial cell surfaces and that, as in vitro, association with kininogen may accelerate the reaction (Mahdi et al. 2002; Schmaier 2004), although alternative pathways and alternative mechanisms for associating factor XII with the cell surface have not been excluded (Joseph et al. 2001).</Comment>
    <BiopaxRef>ca9</BiopaxRef>
    <BiopaxRef>cef</BiopaxRef>
    <BiopaxRef>b18</BiopaxRef>
    <BiopaxRef>f54</BiopaxRef>
    <BiopaxRef>fb9</BiopaxRef>
    <BiopaxRef>fec</BiopaxRef>
    <BiopaxRef>dab</BiopaxRef>
    <BiopaxRef>c7a</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="828.0" Y="721.0" GraphRef="n1389" RelX="0.7435897435897436" RelY="-1.0952380952380953" />
      <Point X="1033.0" Y="578.0" GraphRef="b4a15" RelX="-44.0" RelY="-41.5" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1455" />
  </Interaction>
  <Interaction GraphId="e_1395_a_0">
    <Comment Source="Reactome">Cleavage of a single peptide bond converts factor XII to activated factor XII (factor XIIa) (Fujikawa and McMullen 1983; McMullen and Fujikawa 1985). Identification of the catalytic activity or activities responsible for this cleavage has not been straightforward. Studies in vitro have demonstrated the autoactivation of factor XII as well as activation by kallikrein. Both reactions require the presence of negatively charged surfaces and are accelerated in the presence of kininogen (high molecular weight kininogen, HK) (Griffin and Cochrane 1976; Meier et al. 1977; Silverberg et al. 1980). Recent work suggests that factor XII activation in vivo may occur primarily on endothelial cell surfaces and that, as in vitro, association with kininogen may accelerate the reaction (Mahdi et al. 2002; Schmaier 2004), although alternative pathways and alternative mechanisms for associating factor XII with the cell surface have not been excluded (Joseph et al. 2001).</Comment>
    <Comment Source="Reactome">Cleavage of a single peptide bond converts factor XII to activated factor XII (factor XIIa) (Fujikawa and McMullen 1983; McMullen and Fujikawa 1985). Identification of the catalytic activity or activities responsible for this cleavage has not been straightforward. Studies in vitro have demonstrated the autoactivation of factor XII as well as activation by kallikrein. Both reactions require the presence of negatively charged surfaces and are accelerated in the presence of kininogen (high molecular weight kininogen, HK) (Griffin and Cochrane 1976; Meier et al. 1977; Silverberg et al. 1980). Recent work suggests that factor XII activation in vivo may occur primarily on endothelial cell surfaces and that, as in vitro, association with kininogen may accelerate the reaction (Mahdi et al. 2002; Schmaier 2004), although alternative pathways and alternative mechanisms for associating factor XII with the cell surface have not been excluded (Joseph et al. 2001).</Comment>
    <BiopaxRef>ca9</BiopaxRef>
    <BiopaxRef>cef</BiopaxRef>
    <BiopaxRef>b18</BiopaxRef>
    <BiopaxRef>f54</BiopaxRef>
    <BiopaxRef>fb9</BiopaxRef>
    <BiopaxRef>fec</BiopaxRef>
    <BiopaxRef>dab</BiopaxRef>
    <BiopaxRef>c7a</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1046.0" Y="745.0" GraphRef="n1398" RelX="-0.04225352112676056" RelY="-1.24" />
      <Point X="1033.0" Y="578.0" GraphRef="b4a15" RelX="-44.0" RelY="-41.5" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1455" />
  </Interaction>
  <Interaction GraphId="e_1399">
    <Comment Source="Reactome">Plasma factor XI binds to the platelet glycoprotein Ib:IX:V complex (Baglia et al. 2002; Greengard et al. 1986). In the body, this reaction occurs specifically on the surfaces of activated platelets, but not on endothelial cells (Baird and Walsh 2002). The stoichiometry of the platelet glycoprotein Ib:IX:V complex has not been established directly, but is inferred from the relative abundances of its components in platelet membranes (Modderman et al. 1992; Shrimpton et al. 2002).</Comment>
    <Comment Source="Reactome">Plasma factor XI binds to the platelet glycoprotein Ib:IX:V complex (Baglia et al. 2002; Greengard et al. 1986). In the body, this reaction occurs specifically on the surfaces of activated platelets, but not on endothelial cells (Baird and Walsh 2002). The stoichiometry of the platelet glycoprotein Ib:IX:V complex has not been established directly, but is inferred from the relative abundances of its components in platelet membranes (Modderman et al. 1992; Shrimpton et al. 2002).</Comment>
    <BiopaxRef>cee</BiopaxRef>
    <BiopaxRef>d24</BiopaxRef>
    <BiopaxRef>d64</BiopaxRef>
    <BiopaxRef>c89</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2026.0" Y="703.0" />
      <Point X="1982.0" Y="738.0" GraphRef="n1402" RelX="0.3220338983050847" RelY="-1.1578947368421053" ArrowHead="Arrow" />
      <Anchor Position="0.0" Shape="None" GraphId="ba321" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_177" />
  </Interaction>
  <Interaction GraphId="e_1399_a_i0">
    <Comment Source="Reactome">Plasma factor XI binds to the platelet glycoprotein Ib:IX:V complex (Baglia et al. 2002; Greengard et al. 1986). In the body, this reaction occurs specifically on the surfaces of activated platelets, but not on endothelial cells (Baird and Walsh 2002). The stoichiometry of the platelet glycoprotein Ib:IX:V complex has not been established directly, but is inferred from the relative abundances of its components in platelet membranes (Modderman et al. 1992; Shrimpton et al. 2002).</Comment>
    <Comment Source="Reactome">Plasma factor XI binds to the platelet glycoprotein Ib:IX:V complex (Baglia et al. 2002; Greengard et al. 1986). In the body, this reaction occurs specifically on the surfaces of activated platelets, but not on endothelial cells (Baird and Walsh 2002). The stoichiometry of the platelet glycoprotein Ib:IX:V complex has not been established directly, but is inferred from the relative abundances of its components in platelet membranes (Modderman et al. 1992; Shrimpton et al. 2002).</Comment>
    <BiopaxRef>cee</BiopaxRef>
    <BiopaxRef>d24</BiopaxRef>
    <BiopaxRef>d64</BiopaxRef>
    <BiopaxRef>c89</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2046.0" Y="687.0" GraphRef="n1401" RelX="-0.6153846153846154" RelY="1.1935483870967742" />
      <Point X="2026.0" Y="703.0" GraphRef="ba321" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_177" />
  </Interaction>
  <Interaction GraphId="e_1399_a_i1">
    <Comment Source="Reactome">Plasma factor XI binds to the platelet glycoprotein Ib:IX:V complex (Baglia et al. 2002; Greengard et al. 1986). In the body, this reaction occurs specifically on the surfaces of activated platelets, but not on endothelial cells (Baird and Walsh 2002). The stoichiometry of the platelet glycoprotein Ib:IX:V complex has not been established directly, but is inferred from the relative abundances of its components in platelet membranes (Modderman et al. 1992; Shrimpton et al. 2002).</Comment>
    <Comment Source="Reactome">Plasma factor XI binds to the platelet glycoprotein Ib:IX:V complex (Baglia et al. 2002; Greengard et al. 1986). In the body, this reaction occurs specifically on the surfaces of activated platelets, but not on endothelial cells (Baird and Walsh 2002). The stoichiometry of the platelet glycoprotein Ib:IX:V complex has not been established directly, but is inferred from the relative abundances of its components in platelet membranes (Modderman et al. 1992; Shrimpton et al. 2002).</Comment>
    <BiopaxRef>cee</BiopaxRef>
    <BiopaxRef>d24</BiopaxRef>
    <BiopaxRef>d64</BiopaxRef>
    <BiopaxRef>c89</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2066.0" Y="739.0" GraphRef="n1841" RelX="-0.4936708860759494" RelY="-1.1666666666666667" />
      <Point X="2026.0" Y="703.0" GraphRef="ba321" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_177" />
  </Interaction>
  <Interaction GraphId="e_1403">
    <Comment Source="Reactome">Factor XI, bound to the cell surface, is converted to activated factor XI (factor XIa). Chemically, this reaction involves the cleavage of a single peptide bond in each subunit of the factor XI homodimer; intra- and inter-chain disulfide bonds hold the resulting four polypeptides together  (Bouma and Griffin 1977; Kurachi and Davie 1977; McMullen et al. 1991). In the body, this reaction occurs on the surfaces of activated platelets (Greengard et al. 1986; Baglia et al. 2002; Baird and Walsh 2002); when this reaction occurs as a step in the intrinsic ("contact") pathway of blood coagulation, it is catalyzed by activated factor XIIa (Kurachi and Davie 1977, Baglia and Walsh 2000) which in turn is generated through the interactions of factor XII, kallikrein, and kininogen on endothelial cell surfaces (Schmaier 2004).</Comment>
    <Comment Source="Reactome">Factor XI, bound to the cell surface, is converted to activated factor XI (factor XIa). Chemically, this reaction involves the cleavage of a single peptide bond in each subunit of the factor XI homodimer; intra- and inter-chain disulfide bonds hold the resulting four polypeptides together  (Bouma and Griffin 1977; Kurachi and Davie 1977; McMullen et al. 1991). In the body, this reaction occurs on the surfaces of activated platelets (Greengard et al. 1986; Baglia et al. 2002; Baird and Walsh 2002); when this reaction occurs as a step in the intrinsic ("contact") pathway of blood coagulation, it is catalyzed by activated factor XIIa (Kurachi and Davie 1977, Baglia and Walsh 2000) which in turn is generated through the interactions of factor XII, kallikrein, and kininogen on endothelial cell surfaces (Schmaier 2004).</Comment>
    <BiopaxRef>b7a</BiopaxRef>
    <BiopaxRef>bee</BiopaxRef>
    <BiopaxRef>d85</BiopaxRef>
    <BiopaxRef>b17</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1944.0" Y="738.0" GraphRef="n1402" RelX="-0.3220338983050847" RelY="-1.1578947368421053" />
      <Point X="1820.0" Y="738.0" GraphRef="n1404" RelX="0.016129032258064516" RelY="-1.1578947368421053" ArrowHead="Arrow" />
      <Anchor Position="0.5" Shape="None" GraphId="aac22" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_905" />
  </Interaction>
  <Interaction GraphId="e_1403_c_0">
    <Comment Source="Reactome">Factor XI, bound to the cell surface, is converted to activated factor XI (factor XIa). Chemically, this reaction involves the cleavage of a single peptide bond in each subunit of the factor XI homodimer; intra- and inter-chain disulfide bonds hold the resulting four polypeptides together  (Bouma and Griffin 1977; Kurachi and Davie 1977; McMullen et al. 1991). In the body, this reaction occurs on the surfaces of activated platelets (Greengard et al. 1986; Baglia et al. 2002; Baird and Walsh 2002); when this reaction occurs as a step in the intrinsic ("contact") pathway of blood coagulation, it is catalyzed by activated factor XIIa (Kurachi and Davie 1977, Baglia and Walsh 2000) which in turn is generated through the interactions of factor XII, kallikrein, and kininogen on endothelial cell surfaces (Schmaier 2004).</Comment>
    <Comment Source="Reactome">Factor XI, bound to the cell surface, is converted to activated factor XI (factor XIa). Chemically, this reaction involves the cleavage of a single peptide bond in each subunit of the factor XI homodimer; intra- and inter-chain disulfide bonds hold the resulting four polypeptides together  (Bouma and Griffin 1977; Kurachi and Davie 1977; McMullen et al. 1991). In the body, this reaction occurs on the surfaces of activated platelets (Greengard et al. 1986; Baglia et al. 2002; Baird and Walsh 2002); when this reaction occurs as a step in the intrinsic ("contact") pathway of blood coagulation, it is catalyzed by activated factor XIIa (Kurachi and Davie 1977, Baglia and Walsh 2000) which in turn is generated through the interactions of factor XII, kallikrein, and kininogen on endothelial cell surfaces (Schmaier 2004).</Comment>
    <BiopaxRef>b7a</BiopaxRef>
    <BiopaxRef>bee</BiopaxRef>
    <BiopaxRef>d85</BiopaxRef>
    <BiopaxRef>b17</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1071.0" Y="477.0" GraphRef="n1397" RelX="1.0895522388059702" RelY="-0.08333333333333333" />
      <Point X="1827.0" Y="624.0" GraphRef="aac22" RelX="-55.0" RelY="-114.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_905" />
  </Interaction>
  <Interaction GraphId="e_1405">
    <Comment Source="Reactome">Factor XI, bound to the cell surface, is converted to activated factor XI (factor XIa). In the body, this reaction occurs on the surfaces of activated platelets (Baglia et al. 2002). Small quantities of factor XI can be activated in a reaction catalyzed by factor XIIa, to initiate formation of a fibrin clot. However, the efficient activation of larger quantities of factor XI, needed to propagate the blood clotting process, appears to be mediated by thrombin (Baglia and Walsh 2000; Gailani and Broze 1993; Naito and Fujikawa 1991; Oliver et al. 1999; Monroe et al. 2002).</Comment>
    <Comment Source="Reactome">Factor XI, bound to the cell surface, is converted to activated factor XI (factor XIa). In the body, this reaction occurs on the surfaces of activated platelets (Baglia et al. 2002). Small quantities of factor XI can be activated in a reaction catalyzed by factor XIIa, to initiate formation of a fibrin clot. However, the efficient activation of larger quantities of factor XI, needed to propagate the blood clotting process, appears to be mediated by thrombin (Baglia and Walsh 2000; Gailani and Broze 1993; Naito and Fujikawa 1991; Oliver et al. 1999; Monroe et al. 2002).</Comment>
    <BiopaxRef>b7a</BiopaxRef>
    <BiopaxRef>c3f</BiopaxRef>
    <BiopaxRef>f30</BiopaxRef>
    <BiopaxRef>d32</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1956.0" Y="738.0" GraphRef="n1402" RelX="-0.11864406779661017" RelY="-1.1578947368421053" />
      <Point X="1832.0" Y="738.0" GraphRef="n1404" RelX="0.20967741935483872" RelY="-1.1578947368421053" ArrowHead="Arrow" />
      <Anchor Position="0.5" Shape="None" GraphId="a790c" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1581" />
  </Interaction>
  <Interaction GraphId="e_1405_c_0">
    <Comment Source="Reactome">Factor XI, bound to the cell surface, is converted to activated factor XI (factor XIa). In the body, this reaction occurs on the surfaces of activated platelets (Baglia et al. 2002). Small quantities of factor XI can be activated in a reaction catalyzed by factor XIIa, to initiate formation of a fibrin clot. However, the efficient activation of larger quantities of factor XI, needed to propagate the blood clotting process, appears to be mediated by thrombin (Baglia and Walsh 2000; Gailani and Broze 1993; Naito and Fujikawa 1991; Oliver et al. 1999; Monroe et al. 2002).</Comment>
    <Comment Source="Reactome">Factor XI, bound to the cell surface, is converted to activated factor XI (factor XIa). In the body, this reaction occurs on the surfaces of activated platelets (Baglia et al. 2002). Small quantities of factor XI can be activated in a reaction catalyzed by factor XIIa, to initiate formation of a fibrin clot. However, the efficient activation of larger quantities of factor XI, needed to propagate the blood clotting process, appears to be mediated by thrombin (Baglia and Walsh 2000; Gailani and Broze 1993; Naito and Fujikawa 1991; Oliver et al. 1999; Monroe et al. 2002).</Comment>
    <BiopaxRef>b7a</BiopaxRef>
    <BiopaxRef>c3f</BiopaxRef>
    <BiopaxRef>f30</BiopaxRef>
    <BiopaxRef>d32</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1804.0" Y="180.0" GraphRef="n1406" RelX="0.24324324324324326" RelY="1.1304347826086956" />
      <Point X="1916.0" Y="623.0" GraphRef="a790c" RelX="22.0" RelY="-115.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1581" />
  </Interaction>
  <Interaction GraphId="e_1407">
    <Comment Source="Reactome">Factor XIa, bound to platelet glycoprotein (GP) Ib:IX:V on the platelet cell surface, catalyzes the formation of activated factor IX with high efficiency in a reaction that requires Ca++.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor XIa, bound to platelet glycoprotein (GP) Ib:IX:V on the platelet cell surface, catalyzes the formation of activated factor IX with high efficiency in a reaction that requires Ca++.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <BiopaxRef>e03</BiopaxRef>
    <BiopaxRef>d59</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2373.0" Y="257.0" GraphRef="n1374" RelX="-0.569620253164557" RelY="1.15" />
      <Point X="2316.0" Y="395.0" />
      <Anchor Position="0.99" Shape="None" GraphId="d1ef5" />
      <Anchor Position="0.5" Shape="None" GraphId="fad13" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_2073" />
  </Interaction>
  <Interaction GraphId="e_1407_o0">
    <Comment Source="Reactome">Factor XIa, bound to platelet glycoprotein (GP) Ib:IX:V on the platelet cell surface, catalyzes the formation of activated factor IX with high efficiency in a reaction that requires Ca++.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor XIa, bound to platelet glycoprotein (GP) Ib:IX:V on the platelet cell surface, catalyzes the formation of activated factor IX with high efficiency in a reaction that requires Ca++.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <BiopaxRef>e03</BiopaxRef>
    <BiopaxRef>d59</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2316.0" Y="395.0" GraphRef="d1ef5" RelX="-0.5700000000001637" RelY="1.3799999999999955" />
      <Point X="2371.0" Y="345.0" GraphRef="n1375" RelX="-0.3805309734513274" RelY="1.1578947368421053" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_2073" />
  </Interaction>
  <Interaction GraphId="e_1407_o1">
    <Comment Source="Reactome">Factor XIa, bound to platelet glycoprotein (GP) Ib:IX:V on the platelet cell surface, catalyzes the formation of activated factor IX with high efficiency in a reaction that requires Ca++.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor XIa, bound to platelet glycoprotein (GP) Ib:IX:V on the platelet cell surface, catalyzes the formation of activated factor IX with high efficiency in a reaction that requires Ca++.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <BiopaxRef>e03</BiopaxRef>
    <BiopaxRef>d59</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2316.0" Y="395.0" GraphRef="d1ef5" RelX="-0.5700000000001637" RelY="1.3799999999999955" />
      <Point X="2380.0" Y="430.0" GraphRef="n1376" RelX="-0.6666666666666666" RelY="-1.2307692307692308" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_2073" />
  </Interaction>
  <Interaction GraphId="e_1407_c_0">
    <Comment Source="Reactome">Factor XIa, bound to platelet glycoprotein (GP) Ib:IX:V on the platelet cell surface, catalyzes the formation of activated factor IX with high efficiency in a reaction that requires Ca++.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor XIa, bound to platelet glycoprotein (GP) Ib:IX:V on the platelet cell surface, catalyzes the formation of activated factor IX with high efficiency in a reaction that requires Ca++.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <BiopaxRef>e03</BiopaxRef>
    <BiopaxRef>d59</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1839.0" Y="738.0" GraphRef="n1404" RelX="0.3225806451612903" RelY="-1.1578947368421053" />
      <Point X="2270.0" Y="348.0" GraphRef="fad13" RelX="-74.5" RelY="22.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_2073" />
  </Interaction>
  <Interaction GraphId="e_1407_a_0">
    <Comment Source="Reactome">Factor XIa, bound to platelet glycoprotein (GP) Ib:IX:V on the platelet cell surface, catalyzes the formation of activated factor IX with high efficiency in a reaction that requires Ca++.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor XIa, bound to platelet glycoprotein (GP) Ib:IX:V on the platelet cell surface, catalyzes the formation of activated factor IX with high efficiency in a reaction that requires Ca++.  The amino terminal part of the heavy chain of factor IX, the factor IX activation peptide, is released.  (This peptide has no known function.)</Comment>
    <BiopaxRef>e03</BiopaxRef>
    <BiopaxRef>d59</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2234.0" Y="317.0" GraphRef="n1840" RelX="0.47540983606557374" RelY="1.1935483870967742" />
      <Point X="2270.0" Y="348.0" GraphRef="fad13" RelX="-74.5" RelY="22.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_2073" />
  </Interaction>
  <Interaction GraphId="e_1408">
    <Comment Source="Reactome">Factor VIII binds to von Willebrand factor to form a complex. This complex stabilizes factor VIII, which otherwise has a very short half-life in the blood.&lt;P&gt;Factor VIII (Vehar et al. 1984) is a heterodimer containing a heavy and a light polypeptide chain, generated by the proteolytic cleavage of a single large precursor polypeptide. Several forms of the heavy chain are found in vivo, all functionally the same but differing in the amount of the B domain removed by proteolysis. The single form annotated here is the shortest one (Eaton et al. 1986; Hill-Eubanks et al. 1989).&lt;P&gt;In vitro, von Willebrand factor (Titani et al. 1986) can form complexes with factor VIII with a 1:1 stoichiometry. The complexes that form in vivo, however, involve large multimers of von Willebrand factor and varied, but always low, proportions of factor VIII (Vlot et al. 1995). A stoichiometry of one molecule of factor VIII associated with 50 of von Willebrand factor is typical in vivo, and is used here to annotate the factor VIII:von Willebrand factor complex.</Comment>
    <Comment Source="Reactome">Factor VIII binds to von Willebrand factor to form a complex. This complex stabilizes factor VIII, which otherwise has a very short half-life in the blood.&lt;P&gt;Factor VIII (Vehar et al. 1984) is a heterodimer containing a heavy and a light polypeptide chain, generated by the proteolytic cleavage of a single large precursor polypeptide. Several forms of the heavy chain are found in vivo, all functionally the same but differing in the amount of the B domain removed by proteolysis. The single form annotated here is the shortest one (Eaton et al. 1986; Hill-Eubanks et al. 1989).&lt;P&gt;In vitro, von Willebrand factor (Titani et al. 1986) can form complexes with factor VIII with a 1:1 stoichiometry. The complexes that form in vivo, however, involve large multimers of von Willebrand factor and varied, but always low, proportions of factor VIII (Vlot et al. 1995). A stoichiometry of one molecule of factor VIII associated with 50 of von Willebrand factor is typical in vivo, and is used here to annotate the factor VIII:von Willebrand factor complex.</Comment>
    <BiopaxRef>b26</BiopaxRef>
    <BiopaxRef>a34</BiopaxRef>
    <BiopaxRef>aea</BiopaxRef>
    <BiopaxRef>b4d</BiopaxRef>
    <BiopaxRef>c95</BiopaxRef>
    <BiopaxRef>cf8</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2029.0" Y="81.0" />
      <Point X="1968.0" Y="82.0" GraphRef="n1411" RelX="1.058252427184466" RelY="-0.20754716981132076" ArrowHead="Arrow" />
      <Anchor Position="0.0" Shape="None" GraphId="bf641" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_531" />
  </Interaction>
  <Interaction GraphId="e_1408_a_i0">
    <Comment Source="Reactome">Factor VIII binds to von Willebrand factor to form a complex. This complex stabilizes factor VIII, which otherwise has a very short half-life in the blood.&lt;P&gt;Factor VIII (Vehar et al. 1984) is a heterodimer containing a heavy and a light polypeptide chain, generated by the proteolytic cleavage of a single large precursor polypeptide. Several forms of the heavy chain are found in vivo, all functionally the same but differing in the amount of the B domain removed by proteolysis. The single form annotated here is the shortest one (Eaton et al. 1986; Hill-Eubanks et al. 1989).&lt;P&gt;In vitro, von Willebrand factor (Titani et al. 1986) can form complexes with factor VIII with a 1:1 stoichiometry. The complexes that form in vivo, however, involve large multimers of von Willebrand factor and varied, but always low, proportions of factor VIII (Vlot et al. 1995). A stoichiometry of one molecule of factor VIII associated with 50 of von Willebrand factor is typical in vivo, and is used here to annotate the factor VIII:von Willebrand factor complex.</Comment>
    <Comment Source="Reactome">Factor VIII binds to von Willebrand factor to form a complex. This complex stabilizes factor VIII, which otherwise has a very short half-life in the blood.&lt;P&gt;Factor VIII (Vehar et al. 1984) is a heterodimer containing a heavy and a light polypeptide chain, generated by the proteolytic cleavage of a single large precursor polypeptide. Several forms of the heavy chain are found in vivo, all functionally the same but differing in the amount of the B domain removed by proteolysis. The single form annotated here is the shortest one (Eaton et al. 1986; Hill-Eubanks et al. 1989).&lt;P&gt;In vitro, von Willebrand factor (Titani et al. 1986) can form complexes with factor VIII with a 1:1 stoichiometry. The complexes that form in vivo, however, involve large multimers of von Willebrand factor and varied, but always low, proportions of factor VIII (Vlot et al. 1995). A stoichiometry of one molecule of factor VIII associated with 50 of von Willebrand factor is typical in vivo, and is used here to annotate the factor VIII:von Willebrand factor complex.</Comment>
    <BiopaxRef>b26</BiopaxRef>
    <BiopaxRef>a34</BiopaxRef>
    <BiopaxRef>aea</BiopaxRef>
    <BiopaxRef>b4d</BiopaxRef>
    <BiopaxRef>c95</BiopaxRef>
    <BiopaxRef>cf8</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2060.0" Y="66.0" GraphRef="n1409" RelX="-0.8260869565217391" RelY="1.1818181818181819" />
      <Point X="2029.0" Y="81.0" GraphRef="bf641" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_531" />
  </Interaction>
  <Interaction GraphId="e_1408_a_i1">
    <Comment Source="Reactome">Factor VIII binds to von Willebrand factor to form a complex. This complex stabilizes factor VIII, which otherwise has a very short half-life in the blood.&lt;P&gt;Factor VIII (Vehar et al. 1984) is a heterodimer containing a heavy and a light polypeptide chain, generated by the proteolytic cleavage of a single large precursor polypeptide. Several forms of the heavy chain are found in vivo, all functionally the same but differing in the amount of the B domain removed by proteolysis. The single form annotated here is the shortest one (Eaton et al. 1986; Hill-Eubanks et al. 1989).&lt;P&gt;In vitro, von Willebrand factor (Titani et al. 1986) can form complexes with factor VIII with a 1:1 stoichiometry. The complexes that form in vivo, however, involve large multimers of von Willebrand factor and varied, but always low, proportions of factor VIII (Vlot et al. 1995). A stoichiometry of one molecule of factor VIII associated with 50 of von Willebrand factor is typical in vivo, and is used here to annotate the factor VIII:von Willebrand factor complex.</Comment>
    <Comment Source="Reactome">Factor VIII binds to von Willebrand factor to form a complex. This complex stabilizes factor VIII, which otherwise has a very short half-life in the blood.&lt;P&gt;Factor VIII (Vehar et al. 1984) is a heterodimer containing a heavy and a light polypeptide chain, generated by the proteolytic cleavage of a single large precursor polypeptide. Several forms of the heavy chain are found in vivo, all functionally the same but differing in the amount of the B domain removed by proteolysis. The single form annotated here is the shortest one (Eaton et al. 1986; Hill-Eubanks et al. 1989).&lt;P&gt;In vitro, von Willebrand factor (Titani et al. 1986) can form complexes with factor VIII with a 1:1 stoichiometry. The complexes that form in vivo, however, involve large multimers of von Willebrand factor and varied, but always low, proportions of factor VIII (Vlot et al. 1995). A stoichiometry of one molecule of factor VIII associated with 50 of von Willebrand factor is typical in vivo, and is used here to annotate the factor VIII:von Willebrand factor complex.</Comment>
    <BiopaxRef>b26</BiopaxRef>
    <BiopaxRef>a34</BiopaxRef>
    <BiopaxRef>aea</BiopaxRef>
    <BiopaxRef>b4d</BiopaxRef>
    <BiopaxRef>c95</BiopaxRef>
    <BiopaxRef>cf8</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2060.0" Y="100.0" GraphRef="n1410" RelX="-0.4426229508196721" RelY="-1.1578947368421053" />
      <Point X="2029.0" Y="81.0" GraphRef="bf641" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_531" />
  </Interaction>
  <Interaction GraphId="e_1412">
    <Comment Source="Reactome">Factor VIII complexed to von Willibrand factor in the blood is cleaved into several smaller polypeptides that remain associated. The acidic polypeptide on the aminoterminal side of the A3 domain of the light chain is released, however, and as this polypeptide mediates the association of factor VIII with von Willibrand factor, the activated factor VIII is released. While several proteases are capable of catalyzing these cleavages in vitro, only thrombin is active on factor VIII:von Willibrand factor complexes under physiological conditions (Eaton et al. 1986; Hill-Eubanks et al. 1989; Lollar et al. 1988; Pieters et al. 1989)</Comment>
    <Comment Source="Reactome">Factor VIII complexed to von Willibrand factor in the blood is cleaved into several smaller polypeptides that remain associated. The acidic polypeptide on the aminoterminal side of the A3 domain of the light chain is released, however, and as this polypeptide mediates the association of factor VIII with von Willibrand factor, the activated factor VIII is released. While several proteases are capable of catalyzing these cleavages in vitro, only thrombin is active on factor VIII:von Willibrand factor complexes under physiological conditions (Eaton et al. 1986; Hill-Eubanks et al. 1989; Lollar et al. 1988; Pieters et al. 1989)</Comment>
    <BiopaxRef>b26</BiopaxRef>
    <BiopaxRef>a34</BiopaxRef>
    <BiopaxRef>c95</BiopaxRef>
    <BiopaxRef>f70</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1913.0" Y="117.0" GraphRef="n1411" RelX="-0.009708737864077669" RelY="1.1132075471698113" />
      <Point X="1947.0" Y="170.0" />
      <Anchor Position="0.99" Shape="None" GraphId="a5159" />
      <Anchor Position="0.5" Shape="None" GraphId="f51e7" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_217" />
  </Interaction>
  <Interaction GraphId="e_1412_o0">
    <Comment Source="Reactome">Factor VIII complexed to von Willibrand factor in the blood is cleaved into several smaller polypeptides that remain associated. The acidic polypeptide on the aminoterminal side of the A3 domain of the light chain is released, however, and as this polypeptide mediates the association of factor VIII with von Willibrand factor, the activated factor VIII is released. While several proteases are capable of catalyzing these cleavages in vitro, only thrombin is active on factor VIII:von Willibrand factor complexes under physiological conditions (Eaton et al. 1986; Hill-Eubanks et al. 1989; Lollar et al. 1988; Pieters et al. 1989)</Comment>
    <Comment Source="Reactome">Factor VIII complexed to von Willibrand factor in the blood is cleaved into several smaller polypeptides that remain associated. The acidic polypeptide on the aminoterminal side of the A3 domain of the light chain is released, however, and as this polypeptide mediates the association of factor VIII with von Willibrand factor, the activated factor VIII is released. While several proteases are capable of catalyzing these cleavages in vitro, only thrombin is active on factor VIII:von Willibrand factor complexes under physiological conditions (Eaton et al. 1986; Hill-Eubanks et al. 1989; Lollar et al. 1988; Pieters et al. 1989)</Comment>
    <BiopaxRef>b26</BiopaxRef>
    <BiopaxRef>a34</BiopaxRef>
    <BiopaxRef>c95</BiopaxRef>
    <BiopaxRef>f70</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1947.0" Y="170.0" GraphRef="a5159" RelX="0.33999999999991815" RelY="0.5300000000000011" />
      <Point X="1968.0" Y="242.0" GraphRef="n1413" RelX="-0.18181818181818182" RelY="-1.162162162162162" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_217" />
  </Interaction>
  <Interaction GraphId="e_1412_o1">
    <Comment Source="Reactome">Factor VIII complexed to von Willibrand factor in the blood is cleaved into several smaller polypeptides that remain associated. The acidic polypeptide on the aminoterminal side of the A3 domain of the light chain is released, however, and as this polypeptide mediates the association of factor VIII with von Willibrand factor, the activated factor VIII is released. While several proteases are capable of catalyzing these cleavages in vitro, only thrombin is active on factor VIII:von Willibrand factor complexes under physiological conditions (Eaton et al. 1986; Hill-Eubanks et al. 1989; Lollar et al. 1988; Pieters et al. 1989)</Comment>
    <Comment Source="Reactome">Factor VIII complexed to von Willibrand factor in the blood is cleaved into several smaller polypeptides that remain associated. The acidic polypeptide on the aminoterminal side of the A3 domain of the light chain is released, however, and as this polypeptide mediates the association of factor VIII with von Willibrand factor, the activated factor VIII is released. While several proteases are capable of catalyzing these cleavages in vitro, only thrombin is active on factor VIII:von Willibrand factor complexes under physiological conditions (Eaton et al. 1986; Hill-Eubanks et al. 1989; Lollar et al. 1988; Pieters et al. 1989)</Comment>
    <BiopaxRef>b26</BiopaxRef>
    <BiopaxRef>a34</BiopaxRef>
    <BiopaxRef>c95</BiopaxRef>
    <BiopaxRef>f70</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1947.0" Y="170.0" GraphRef="a5159" RelX="0.33999999999991815" RelY="0.5300000000000011" />
      <Point X="2008.0" Y="192.0" GraphRef="n1414" RelX="-0.9065420560747663" RelY="-1.1578947368421053" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_217" />
  </Interaction>
  <Interaction GraphId="e_1412_o2">
    <Comment Source="Reactome">Factor VIII complexed to von Willibrand factor in the blood is cleaved into several smaller polypeptides that remain associated. The acidic polypeptide on the aminoterminal side of the A3 domain of the light chain is released, however, and as this polypeptide mediates the association of factor VIII with von Willibrand factor, the activated factor VIII is released. While several proteases are capable of catalyzing these cleavages in vitro, only thrombin is active on factor VIII:von Willibrand factor complexes under physiological conditions (Eaton et al. 1986; Hill-Eubanks et al. 1989; Lollar et al. 1988; Pieters et al. 1989)</Comment>
    <Comment Source="Reactome">Factor VIII complexed to von Willibrand factor in the blood is cleaved into several smaller polypeptides that remain associated. The acidic polypeptide on the aminoterminal side of the A3 domain of the light chain is released, however, and as this polypeptide mediates the association of factor VIII with von Willibrand factor, the activated factor VIII is released. While several proteases are capable of catalyzing these cleavages in vitro, only thrombin is active on factor VIII:von Willibrand factor complexes under physiological conditions (Eaton et al. 1986; Hill-Eubanks et al. 1989; Lollar et al. 1988; Pieters et al. 1989)</Comment>
    <BiopaxRef>b26</BiopaxRef>
    <BiopaxRef>a34</BiopaxRef>
    <BiopaxRef>c95</BiopaxRef>
    <BiopaxRef>f70</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1947.0" Y="170.0" GraphRef="a5159" RelX="0.33999999999991815" RelY="0.5300000000000011" />
      <Point X="2031.0" Y="144.0" GraphRef="n1410" RelX="-0.9180327868852459" RelY="1.1578947368421053" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_217" />
  </Interaction>
  <Interaction GraphId="e_1412_c_0">
    <Comment Source="Reactome">Factor VIII complexed to von Willibrand factor in the blood is cleaved into several smaller polypeptides that remain associated. The acidic polypeptide on the aminoterminal side of the A3 domain of the light chain is released, however, and as this polypeptide mediates the association of factor VIII with von Willibrand factor, the activated factor VIII is released. While several proteases are capable of catalyzing these cleavages in vitro, only thrombin is active on factor VIII:von Willibrand factor complexes under physiological conditions (Eaton et al. 1986; Hill-Eubanks et al. 1989; Lollar et al. 1988; Pieters et al. 1989)</Comment>
    <Comment Source="Reactome">Factor VIII complexed to von Willibrand factor in the blood is cleaved into several smaller polypeptides that remain associated. The acidic polypeptide on the aminoterminal side of the A3 domain of the light chain is released, however, and as this polypeptide mediates the association of factor VIII with von Willibrand factor, the activated factor VIII is released. While several proteases are capable of catalyzing these cleavages in vitro, only thrombin is active on factor VIII:von Willibrand factor complexes under physiological conditions (Eaton et al. 1986; Hill-Eubanks et al. 1989; Lollar et al. 1988; Pieters et al. 1989)</Comment>
    <BiopaxRef>b26</BiopaxRef>
    <BiopaxRef>a34</BiopaxRef>
    <BiopaxRef>c95</BiopaxRef>
    <BiopaxRef>f70</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1849.0" Y="154.0" GraphRef="n1406" RelX="1.054054054054054" RelY="0.0" />
      <Point X="1913.0" Y="155.0" GraphRef="f51e7" RelX="-17.0" RelY="11.5" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_217" />
  </Interaction>
  <Interaction GraphId="e_1415">
    <Comment Source="Reactome">The activated forms of factors VIII and IX associate on a cell surface to form a complex that very efficiently catalyzes the activation of factor X, the so-called "intrinsic tenase complex". In vitro, negatively charged phospholipids can provide an appropriate surface. In the body, the surface is provided by the plasma membranes of activated platelets (Gilbert and Arena 1996).</Comment>
    <Comment Source="Reactome">The activated forms of factors VIII and IX associate on a cell surface to form a complex that very efficiently catalyzes the activation of factor X, the so-called "intrinsic tenase complex". In vitro, negatively charged phospholipids can provide an appropriate surface. In the body, the surface is provided by the plasma membranes of activated platelets (Gilbert and Arena 1996).</Comment>
    <BiopaxRef>cc1</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2374.0" Y="497.0" />
      <Point X="2715.0" Y="739.0" GraphRef="n1416" RelX="-0.3523809523809524" RelY="-1.1764705882352942" ArrowHead="Arrow" />
      <Anchor Position="0.0" Shape="None" GraphId="f9ac2" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_112" />
  </Interaction>
  <Interaction GraphId="e_1415_a_i0">
    <Comment Source="Reactome">The activated forms of factors VIII and IX associate on a cell surface to form a complex that very efficiently catalyzes the activation of factor X, the so-called "intrinsic tenase complex". In vitro, negatively charged phospholipids can provide an appropriate surface. In the body, the surface is provided by the plasma membranes of activated platelets (Gilbert and Arena 1996).</Comment>
    <Comment Source="Reactome">The activated forms of factors VIII and IX associate on a cell surface to form a complex that very efficiently catalyzes the activation of factor X, the so-called "intrinsic tenase complex". In vitro, negatively charged phospholipids can provide an appropriate surface. In the body, the surface is provided by the plasma membranes of activated platelets (Gilbert and Arena 1996).</Comment>
    <BiopaxRef>cc1</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2005.0" Y="285.0" GraphRef="n1413" RelX="0.9393939393939394" RelY="1.162162162162162" />
      <Point X="2374.0" Y="497.0" GraphRef="f9ac2" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_112" />
  </Interaction>
  <Interaction GraphId="e_1415_a_i1">
    <Comment Source="Reactome">The activated forms of factors VIII and IX associate on a cell surface to form a complex that very efficiently catalyzes the activation of factor X, the so-called "intrinsic tenase complex". In vitro, negatively charged phospholipids can provide an appropriate surface. In the body, the surface is provided by the plasma membranes of activated platelets (Gilbert and Arena 1996).</Comment>
    <Comment Source="Reactome">The activated forms of factors VIII and IX associate on a cell surface to form a complex that very efficiently catalyzes the activation of factor X, the so-called "intrinsic tenase complex". In vitro, negatively charged phospholipids can provide an appropriate surface. In the body, the surface is provided by the plasma membranes of activated platelets (Gilbert and Arena 1996).</Comment>
    <BiopaxRef>cc1</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2394.0" Y="462.0" GraphRef="n1376" RelX="-0.24242424242424243" RelY="1.2307692307692308" />
      <Point X="2374.0" Y="497.0" GraphRef="f9ac2" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_112" />
  </Interaction>
  <Interaction GraphId="e_1415_a_0">
    <Comment Source="Reactome">The activated forms of factors VIII and IX associate on a cell surface to form a complex that very efficiently catalyzes the activation of factor X, the so-called "intrinsic tenase complex". In vitro, negatively charged phospholipids can provide an appropriate surface. In the body, the surface is provided by the plasma membranes of activated platelets (Gilbert and Arena 1996).</Comment>
    <Comment Source="Reactome">The activated forms of factors VIII and IX associate on a cell surface to form a complex that very efficiently catalyzes the activation of factor X, the so-called "intrinsic tenase complex". In vitro, negatively charged phospholipids can provide an appropriate surface. In the body, the surface is provided by the plasma membranes of activated platelets (Gilbert and Arena 1996).</Comment>
    <BiopaxRef>cc1</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2631.0" Y="614.0" GraphRef="n1332" RelX="-0.01639344262295082" RelY="1.1935483870967742" />
      <Point X="2633.0" Y="660.0" GraphRef="f51e7" RelX="703.0" RelY="516.5" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_112" />
  </Interaction>
  <Interaction GraphId="e_1457">
    <Comment Source="Reactome">Factor IXa, in a complex with factor VIIIa on the surfaces of activated platelets (the "intrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor IXa, in a complex with factor VIIIa on the surfaces of activated platelets (the "intrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <BiopaxRef>beb</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2734.0" Y="422.0" />
      <Point X="2853.0" Y="422.0" />
      <Anchor Position="0.0" Shape="None" GraphId="db48d" />
      <Anchor Position="0.99" Shape="None" GraphId="eb2ab" />
      <Anchor Position="0.5" Shape="None" GraphId="f5c72" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1668" />
  </Interaction>
  <Interaction GraphId="e_1457_a_i0">
    <Comment Source="Reactome">Factor IXa, in a complex with factor VIIIa on the surfaces of activated platelets (the "intrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor IXa, in a complex with factor VIIIa on the surfaces of activated platelets (the "intrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <BiopaxRef>beb</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2714.0" Y="468.0" GraphRef="n1324" RelX="0.14814814814814814" RelY="-1.24" />
      <Point X="2734.0" Y="422.0" GraphRef="db48d" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1668" />
  </Interaction>
  <Interaction GraphId="e_1457_a_i1">
    <Comment Source="Reactome">Factor IXa, in a complex with factor VIIIa on the surfaces of activated platelets (the "intrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor IXa, in a complex with factor VIIIa on the surfaces of activated platelets (the "intrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <BiopaxRef>beb</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2675.0" Y="345.0" GraphRef="n1838" RelX="0.3442622950819672" RelY="1.1935483870967742" />
      <Point X="2734.0" Y="422.0" GraphRef="db48d" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1668" />
  </Interaction>
  <Interaction GraphId="e_1457_o0">
    <Comment Source="Reactome">Factor IXa, in a complex with factor VIIIa on the surfaces of activated platelets (the "intrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor IXa, in a complex with factor VIIIa on the surfaces of activated platelets (the "intrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <BiopaxRef>beb</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2853.0" Y="422.0" GraphRef="eb2ab" RelX="1.1900000000000546" RelY="0.0" />
      <Point X="2921.0" Y="336.0" GraphRef="n1325" RelX="-0.5357142857142857" RelY="1.1538461538461537" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1668" />
  </Interaction>
  <Interaction GraphId="e_1457_o1">
    <Comment Source="Reactome">Factor IXa, in a complex with factor VIIIa on the surfaces of activated platelets (the "intrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor IXa, in a complex with factor VIIIa on the surfaces of activated platelets (the "intrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <BiopaxRef>beb</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2853.0" Y="422.0" GraphRef="eb2ab" RelX="1.1900000000000546" RelY="0.0" />
      <Point X="2930.0" Y="478.0" GraphRef="n1326" RelX="-0.8372093023255814" RelY="-1.1132075471698113" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1668" />
  </Interaction>
  <Interaction GraphId="e_1457_c_0">
    <Comment Source="Reactome">Factor IXa, in a complex with factor VIIIa on the surfaces of activated platelets (the "intrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <Comment Source="Reactome">Factor IXa, in a complex with factor VIIIa on the surfaces of activated platelets (the "intrinsic tenase complex"), catalyzes the formation of activated factor X with high efficiency. The amino terminal part of the heavy chain of factor X, the factor X activation peptide, is released. (This peptide has no known function.)</Comment>
    <BiopaxRef>beb</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2735.0" Y="739.0" GraphRef="n1416" RelX="0.02857142857142857" RelY="-1.1764705882352942" />
      <Point X="2780.0" Y="422.0" GraphRef="f5c72" RelX="-13.5" RelY="0.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1668" />
  </Interaction>
  <Interaction GraphId="e_1458">
    <Comment Source="Reactome">Activated kallikrein binds to C1Inh (plasma protease C1 inhibitor) (Bock et al. 1986), forming a stable and enzymatically inactive complex. This reaction appears to be the major means by which kallikrein is inactivated (kallikrein can also be inactivated by binding to alpha2-macroglobulin) (Harpel et al. 1985; Ratnoff et al. 1969).</Comment>
    <Comment Source="Reactome">Activated kallikrein binds to C1Inh (plasma protease C1 inhibitor) (Bock et al. 1986), forming a stable and enzymatically inactive complex. This reaction appears to be the major means by which kallikrein is inactivated (kallikrein can also be inactivated by binding to alpha2-macroglobulin) (Harpel et al. 1985; Ratnoff et al. 1969).</Comment>
    <BiopaxRef>de8</BiopaxRef>
    <BiopaxRef>df4</BiopaxRef>
    <BiopaxRef>b0f</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="300.0" Y="470.0" />
      <Point X="301.0" Y="361.0" GraphRef="n1460" RelX="-0.010101010101010102" RelY="1.2222222222222223" ArrowHead="Arrow" />
      <Anchor Position="0.0" Shape="None" GraphId="ba5fd" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1486" />
  </Interaction>
  <Interaction GraphId="e_1458_a_i0">
    <Comment Source="Reactome">Activated kallikrein binds to C1Inh (plasma protease C1 inhibitor) (Bock et al. 1986), forming a stable and enzymatically inactive complex. This reaction appears to be the major means by which kallikrein is inactivated (kallikrein can also be inactivated by binding to alpha2-macroglobulin) (Harpel et al. 1985; Ratnoff et al. 1969).</Comment>
    <Comment Source="Reactome">Activated kallikrein binds to C1Inh (plasma protease C1 inhibitor) (Bock et al. 1986), forming a stable and enzymatically inactive complex. This reaction appears to be the major means by which kallikrein is inactivated (kallikrein can also be inactivated by binding to alpha2-macroglobulin) (Harpel et al. 1985; Ratnoff et al. 1969).</Comment>
    <BiopaxRef>de8</BiopaxRef>
    <BiopaxRef>df4</BiopaxRef>
    <BiopaxRef>b0f</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="343.0" Y="503.0" GraphRef="n1459" RelX="-0.6521739130434783" RelY="-1.2608695652173914" />
      <Point X="300.0" Y="470.0" GraphRef="ba5fd" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1486" />
  </Interaction>
  <Interaction GraphId="e_1458_a_i1">
    <Comment Source="Reactome">Activated kallikrein binds to C1Inh (plasma protease C1 inhibitor) (Bock et al. 1986), forming a stable and enzymatically inactive complex. This reaction appears to be the major means by which kallikrein is inactivated (kallikrein can also be inactivated by binding to alpha2-macroglobulin) (Harpel et al. 1985; Ratnoff et al. 1969).</Comment>
    <Comment Source="Reactome">Activated kallikrein binds to C1Inh (plasma protease C1 inhibitor) (Bock et al. 1986), forming a stable and enzymatically inactive complex. This reaction appears to be the major means by which kallikrein is inactivated (kallikrein can also be inactivated by binding to alpha2-macroglobulin) (Harpel et al. 1985; Ratnoff et al. 1969).</Comment>
    <BiopaxRef>de8</BiopaxRef>
    <BiopaxRef>df4</BiopaxRef>
    <BiopaxRef>b0f</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="272.0" Y="501.0" GraphRef="n1393" RelX="0.2698412698412698" RelY="-1.2608695652173914" />
      <Point X="300.0" Y="470.0" GraphRef="ba5fd" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1486" />
  </Interaction>
  <Interaction GraphId="e_1461">
    <Comment Source="Reactome">Activated kallikrein binds to alpha2-macroglobulin (Sottrup-Jensen et al. 1984), forming a stable and enzymatically inactive complex. Under normal conditions in vivo, this reaction appears to be responsible for the inactivation of about 1/6 of activated kallikrein (with C1Inh responsible for the inactivation of about 5/6) (Harpel et al. 1985).</Comment>
    <Comment Source="Reactome">Activated kallikrein binds to alpha2-macroglobulin (Sottrup-Jensen et al. 1984), forming a stable and enzymatically inactive complex. Under normal conditions in vivo, this reaction appears to be responsible for the inactivation of about 1/6 of activated kallikrein (with C1Inh responsible for the inactivation of about 5/6) (Harpel et al. 1985).</Comment>
    <BiopaxRef>df4</BiopaxRef>
    <BiopaxRef>ec3</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="217.0" Y="467.0" />
      <Point X="186.0" Y="407.0" GraphRef="n1463" RelX="0.06086956521739131" RelY="1.127659574468085" ArrowHead="Arrow" />
      <Anchor Position="0.0" Shape="None" GraphId="f10d9" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_25" />
  </Interaction>
  <Interaction GraphId="e_1461_a_i0">
    <Comment Source="Reactome">Activated kallikrein binds to alpha2-macroglobulin (Sottrup-Jensen et al. 1984), forming a stable and enzymatically inactive complex. Under normal conditions in vivo, this reaction appears to be responsible for the inactivation of about 1/6 of activated kallikrein (with C1Inh responsible for the inactivation of about 5/6) (Harpel et al. 1985).</Comment>
    <Comment Source="Reactome">Activated kallikrein binds to alpha2-macroglobulin (Sottrup-Jensen et al. 1984), forming a stable and enzymatically inactive complex. Under normal conditions in vivo, this reaction appears to be responsible for the inactivation of about 1/6 of activated kallikrein (with C1Inh responsible for the inactivation of about 5/6) (Harpel et al. 1985).</Comment>
    <BiopaxRef>df4</BiopaxRef>
    <BiopaxRef>ec3</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="176.0" Y="495.0" GraphRef="n1462" RelX="0.36134453781512604" RelY="-1.1714285714285715" />
      <Point X="217.0" Y="467.0" GraphRef="f10d9" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_25" />
  </Interaction>
  <Interaction GraphId="e_1461_a_i1">
    <Comment Source="Reactome">Activated kallikrein binds to alpha2-macroglobulin (Sottrup-Jensen et al. 1984), forming a stable and enzymatically inactive complex. Under normal conditions in vivo, this reaction appears to be responsible for the inactivation of about 1/6 of activated kallikrein (with C1Inh responsible for the inactivation of about 5/6) (Harpel et al. 1985).</Comment>
    <Comment Source="Reactome">Activated kallikrein binds to alpha2-macroglobulin (Sottrup-Jensen et al. 1984), forming a stable and enzymatically inactive complex. Under normal conditions in vivo, this reaction appears to be responsible for the inactivation of about 1/6 of activated kallikrein (with C1Inh responsible for the inactivation of about 5/6) (Harpel et al. 1985).</Comment>
    <BiopaxRef>df4</BiopaxRef>
    <BiopaxRef>ec3</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="251.0" Y="501.0" GraphRef="n1393" RelX="-0.3968253968253968" RelY="-1.2608695652173914" />
      <Point X="217.0" Y="467.0" GraphRef="f10d9" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_25" />
  </Interaction>
  <Interaction GraphId="e_1464">
    <Comment Source="Reactome">Activated factor XII (factor XIIa) binds to C1Inh (C1 inhibitor - Bock et al. 1986) to form a stable, inactive complex (Schneider et al. 1973). While several protease inhibitors can form stable complexes with XIIa in vitro, only C1Inh does so to a significant extent under normal conditions in vivo (Pixley et al. 1985).</Comment>
    <Comment Source="Reactome">Activated factor XII (factor XIIa) binds to C1Inh (C1 inhibitor - Bock et al. 1986) to form a stable, inactive complex (Schneider et al. 1973). While several protease inhibitors can form stable complexes with XIIa in vitro, only C1Inh does so to a significant extent under normal conditions in vivo (Pixley et al. 1985).</Comment>
    <BiopaxRef>de8</BiopaxRef>
    <BiopaxRef>ba6</BiopaxRef>
    <BiopaxRef>fb1</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="394.0" Y="466.0" />
      <Point X="392.0" Y="417.0" GraphRef="n1465" RelX="0.0" RelY="1.1818181818181819" ArrowHead="Arrow" />
      <Anchor Position="0.0" Shape="None" GraphId="e814e" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_825" />
  </Interaction>
  <Interaction GraphId="e_1464_a_i0">
    <Comment Source="Reactome">Activated factor XII (factor XIIa) binds to C1Inh (C1 inhibitor - Bock et al. 1986) to form a stable, inactive complex (Schneider et al. 1973). While several protease inhibitors can form stable complexes with XIIa in vitro, only C1Inh does so to a significant extent under normal conditions in vivo (Pixley et al. 1985).</Comment>
    <Comment Source="Reactome">Activated factor XII (factor XIIa) binds to C1Inh (C1 inhibitor - Bock et al. 1986) to form a stable, inactive complex (Schneider et al. 1973). While several protease inhibitors can form stable complexes with XIIa in vitro, only C1Inh does so to a significant extent under normal conditions in vivo (Pixley et al. 1985).</Comment>
    <BiopaxRef>de8</BiopaxRef>
    <BiopaxRef>ba6</BiopaxRef>
    <BiopaxRef>fb1</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="998.0" Y="477.0" GraphRef="n1397" RelX="-1.0895522388059702" RelY="-0.08333333333333333" />
      <Point X="394.0" Y="466.0" GraphRef="e814e" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_825" />
  </Interaction>
  <Interaction GraphId="e_1464_a_i1">
    <Comment Source="Reactome">Activated factor XII (factor XIIa) binds to C1Inh (C1 inhibitor - Bock et al. 1986) to form a stable, inactive complex (Schneider et al. 1973). While several protease inhibitors can form stable complexes with XIIa in vitro, only C1Inh does so to a significant extent under normal conditions in vivo (Pixley et al. 1985).</Comment>
    <Comment Source="Reactome">Activated factor XII (factor XIIa) binds to C1Inh (C1 inhibitor - Bock et al. 1986) to form a stable, inactive complex (Schneider et al. 1973). While several protease inhibitors can form stable complexes with XIIa in vitro, only C1Inh does so to a significant extent under normal conditions in vivo (Pixley et al. 1985).</Comment>
    <BiopaxRef>de8</BiopaxRef>
    <BiopaxRef>ba6</BiopaxRef>
    <BiopaxRef>fb1</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="366.0" Y="503.0" GraphRef="n1459" RelX="0.34782608695652173" RelY="-1.2608695652173914" />
      <Point X="394.0" Y="466.0" GraphRef="e814e" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_825" />
  </Interaction>
  <Interaction GraphId="e_1466">
    <Comment Source="Reactome">Membrane-bound factor Xa catalyzes the activation of small amounts of thrombin.  The amino terminal portion of prothrombin is released as an activation peptide, which can be cleaved further by activated thrombin.  Neither the full-length activation peptide nor its cleavage products have known functions.</Comment>
    <Comment Source="Reactome">Membrane-bound factor Xa catalyzes the activation of small amounts of thrombin.  The amino terminal portion of prothrombin is released as an activation peptide, which can be cleaved further by activated thrombin.  Neither the full-length activation peptide nor its cleavage products have known functions.</Comment>
    <BiopaxRef>ea8</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1761.0" Y="456.0" GraphRef="n1467" RelX="-0.5772357723577236" RelY="-1.1395348837209303" />
      <Point X="1691.0" Y="349.0" />
      <Anchor Position="0.99" Shape="None" GraphId="e95d1" />
      <Anchor Position="0.5" Shape="None" GraphId="f18a4" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1097" />
  </Interaction>
  <Interaction GraphId="e_1466_o0">
    <Comment Source="Reactome">Membrane-bound factor Xa catalyzes the activation of small amounts of thrombin.  The amino terminal portion of prothrombin is released as an activation peptide, which can be cleaved further by activated thrombin.  Neither the full-length activation peptide nor its cleavage products have known functions.</Comment>
    <Comment Source="Reactome">Membrane-bound factor Xa catalyzes the activation of small amounts of thrombin.  The amino terminal portion of prothrombin is released as an activation peptide, which can be cleaved further by activated thrombin.  Neither the full-length activation peptide nor its cleavage products have known functions.</Comment>
    <BiopaxRef>ea8</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1691.0" Y="349.0" GraphRef="e95d1" RelX="-0.7000000000000455" RelY="-1.0699999999999932" />
      <Point X="1778.0" Y="180.0" GraphRef="n1406" RelX="-0.22522522522522523" RelY="1.1304347826086956" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1097" />
  </Interaction>
  <Interaction GraphId="e_1466_o1">
    <Comment Source="Reactome">Membrane-bound factor Xa catalyzes the activation of small amounts of thrombin.  The amino terminal portion of prothrombin is released as an activation peptide, which can be cleaved further by activated thrombin.  Neither the full-length activation peptide nor its cleavage products have known functions.</Comment>
    <Comment Source="Reactome">Membrane-bound factor Xa catalyzes the activation of small amounts of thrombin.  The amino terminal portion of prothrombin is released as an activation peptide, which can be cleaved further by activated thrombin.  Neither the full-length activation peptide nor its cleavage products have known functions.</Comment>
    <BiopaxRef>ea8</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1691.0" Y="349.0" GraphRef="e95d1" RelX="-0.7000000000000455" RelY="-1.0699999999999932" />
      <Point X="1746.0" Y="325.0" GraphRef="n1468" RelX="-1.0714285714285714" RelY="0.543859649122807" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1097" />
  </Interaction>
  <Interaction GraphId="e_1466_c_0">
    <Comment Source="Reactome">Membrane-bound factor Xa catalyzes the activation of small amounts of thrombin.  The amino terminal portion of prothrombin is released as an activation peptide, which can be cleaved further by activated thrombin.  Neither the full-length activation peptide nor its cleavage products have known functions.</Comment>
    <Comment Source="Reactome">Membrane-bound factor Xa catalyzes the activation of small amounts of thrombin.  The amino terminal portion of prothrombin is released as an activation peptide, which can be cleaved further by activated thrombin.  Neither the full-length activation peptide nor its cleavage products have known functions.</Comment>
    <BiopaxRef>ea8</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1703.0" Y="745.0" GraphRef="n1469" RelX="-0.03333333333333333" RelY="-1.25" />
      <Point X="1692.0" Y="416.0" GraphRef="f18a4" RelX="-34.0" RelY="13.5" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1097" />
  </Interaction>
  <Interaction GraphId="e_1470">
    <Comment Source="Reactome">Activated thrombin (factor IIa) catalyzes the conversion of factor V to factor Va (activated factor V).  The activation peptide released in this reaction has no known function.</Comment>
    <Comment Source="Reactome">Activated thrombin (factor IIa) catalyzes the conversion of factor V to factor Va (activated factor V).  The activation peptide released in this reaction has no known function.</Comment>
    <BiopaxRef>ea8</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1484.0" Y="373.0" GraphRef="n1471" RelX="1.1111111111111112" RelY="0.9375" />
      <Point X="1501.0" Y="459.0" />
      <Anchor Position="0.99" Shape="None" GraphId="f4d1c" />
      <Anchor Position="0.5" Shape="None" GraphId="da5ed" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_708" />
  </Interaction>
  <Interaction GraphId="e_1470_o0">
    <Comment Source="Reactome">Activated thrombin (factor IIa) catalyzes the conversion of factor V to factor Va (activated factor V).  The activation peptide released in this reaction has no known function.</Comment>
    <Comment Source="Reactome">Activated thrombin (factor IIa) catalyzes the conversion of factor V to factor Va (activated factor V).  The activation peptide released in this reaction has no known function.</Comment>
    <BiopaxRef>ea8</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1501.0" Y="459.0" GraphRef="f4d1c" RelX="0.17000000000007276" RelY="0.8600000000000136" />
      <Point X="1476.0" Y="496.0" GraphRef="n1472" RelX="0.2962962962962963" RelY="-1.1176470588235294" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_708" />
  </Interaction>
  <Interaction GraphId="e_1470_o1">
    <Comment Source="Reactome">Activated thrombin (factor IIa) catalyzes the conversion of factor V to factor Va (activated factor V).  The activation peptide released in this reaction has no known function.</Comment>
    <Comment Source="Reactome">Activated thrombin (factor IIa) catalyzes the conversion of factor V to factor Va (activated factor V).  The activation peptide released in this reaction has no known function.</Comment>
    <BiopaxRef>ea8</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1501.0" Y="459.0" GraphRef="f4d1c" RelX="0.17000000000007276" RelY="0.8600000000000136" />
      <Point X="1541.0" Y="505.0" GraphRef="n1473" RelX="-0.5357142857142857" RelY="-1.1714285714285715" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_708" />
  </Interaction>
  <Interaction GraphId="e_1470_c_0">
    <Comment Source="Reactome">Activated thrombin (factor IIa) catalyzes the conversion of factor V to factor Va (activated factor V).  The activation peptide released in this reaction has no known function.</Comment>
    <Comment Source="Reactome">Activated thrombin (factor IIa) catalyzes the conversion of factor V to factor Va (activated factor V).  The activation peptide released in this reaction has no known function.</Comment>
    <BiopaxRef>ea8</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1761.0" Y="180.0" GraphRef="n1406" RelX="-0.5315315315315315" RelY="1.1304347826086956" />
      <Point X="1503.0" Y="387.0" GraphRef="da5ed" RelX="10.5" RelY="-29.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_708" />
  </Interaction>
  <Interaction GraphId="e_1474">
    <Comment Source="Reactome">Factors Va and Xa associate on a membrane surface to form a complex in which the activity of factor Xa on prothrombin is greatly increased (Mann et al. 1988).  The presence of negatively charged phospholipid in the membrane greatly facilitates this process, a feature that may contribute to its localization, as such phospholipids are normally on the cytosolic face of the plasma membrane (Devaux 1992), but could be exposed to the extracellular space following platelet activation or mechanical injury to endothelial cells.</Comment>
    <Comment Source="Reactome">Factors Va and Xa associate on a membrane surface to form a complex in which the activity of factor Xa on prothrombin is greatly increased (Mann et al. 1988).  The presence of negatively charged phospholipid in the membrane greatly facilitates this process, a feature that may contribute to its localization, as such phospholipids are normally on the cytosolic face of the plasma membrane (Devaux 1992), but could be exposed to the extracellular space following platelet activation or mechanical injury to endothelial cells.</Comment>
    <BiopaxRef>e58</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2214.0" Y="582.0" />
      <Point X="2227.0" Y="739.0" GraphRef="n1475" RelX="-0.05454545454545454" RelY="-1.162162162162162" ArrowHead="Arrow" />
      <Anchor Position="0.0" Shape="None" GraphId="fe1db" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_675" />
  </Interaction>
  <Interaction GraphId="e_1474_a_i0">
    <Comment Source="Reactome">Factors Va and Xa associate on a membrane surface to form a complex in which the activity of factor Xa on prothrombin is greatly increased (Mann et al. 1988).  The presence of negatively charged phospholipid in the membrane greatly facilitates this process, a feature that may contribute to its localization, as such phospholipids are normally on the cytosolic face of the plasma membrane (Devaux 1992), but could be exposed to the extracellular space following platelet activation or mechanical injury to endothelial cells.</Comment>
    <Comment Source="Reactome">Factors Va and Xa associate on a membrane surface to form a complex in which the activity of factor Xa on prothrombin is greatly increased (Mann et al. 1988).  The presence of negatively charged phospholipid in the membrane greatly facilitates this process, a feature that may contribute to its localization, as such phospholipids are normally on the cytosolic face of the plasma membrane (Devaux 1992), but could be exposed to the extracellular space following platelet activation or mechanical injury to endothelial cells.</Comment>
    <BiopaxRef>e58</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2905.0" Y="323.0" GraphRef="n1325" RelX="-1.1071428571428572" RelY="0.48717948717948717" />
      <Point X="2214.0" Y="582.0" GraphRef="fe1db" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_675" />
  </Interaction>
  <Interaction GraphId="e_1474_a_i1">
    <Comment Source="Reactome">Factors Va and Xa associate on a membrane surface to form a complex in which the activity of factor Xa on prothrombin is greatly increased (Mann et al. 1988).  The presence of negatively charged phospholipid in the membrane greatly facilitates this process, a feature that may contribute to its localization, as such phospholipids are normally on the cytosolic face of the plasma membrane (Devaux 1992), but could be exposed to the extracellular space following platelet activation or mechanical injury to endothelial cells.</Comment>
    <Comment Source="Reactome">Factors Va and Xa associate on a membrane surface to form a complex in which the activity of factor Xa on prothrombin is greatly increased (Mann et al. 1988).  The presence of negatively charged phospholipid in the membrane greatly facilitates this process, a feature that may contribute to its localization, as such phospholipids are normally on the cytosolic face of the plasma membrane (Devaux 1992), but could be exposed to the extracellular space following platelet activation or mechanical injury to endothelial cells.</Comment>
    <BiopaxRef>e58</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1587.0" Y="527.0" GraphRef="n1473" RelX="1.1071428571428572" RelY="0.08571428571428572" />
      <Point X="2214.0" Y="582.0" GraphRef="fe1db" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_675" />
  </Interaction>
  <Interaction GraphId="e_1476">
    <Comment Source="Reactome">The membrane-bound Va:Xa (prothrombinase) complex rapidly activates large amounts of thrombin.</Comment>
    <Comment Source="Reactome">The membrane-bound Va:Xa (prothrombinase) complex rapidly activates large amounts of thrombin.</Comment>
    <BiopaxRef>e58</BiopaxRef>
    <BiopaxRef>ea8</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1861.0" Y="479.0" GraphRef="n1467" RelX="1.048780487804878" RelY="-0.06976744186046512" />
      <Point X="1892.0" Y="407.0" />
      <Anchor Position="0.99" Shape="None" GraphId="e134b" />
      <Anchor Position="0.5" Shape="None" GraphId="f849d" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1446" />
  </Interaction>
  <Interaction GraphId="e_1476_o0">
    <Comment Source="Reactome">The membrane-bound Va:Xa (prothrombinase) complex rapidly activates large amounts of thrombin.</Comment>
    <Comment Source="Reactome">The membrane-bound Va:Xa (prothrombinase) complex rapidly activates large amounts of thrombin.</Comment>
    <BiopaxRef>e58</BiopaxRef>
    <BiopaxRef>ea8</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1892.0" Y="407.0" GraphRef="e134b" RelX="0.30999999999994543" RelY="-0.7199999999999704" />
      <Point X="1799.0" Y="180.0" GraphRef="n1406" RelX="0.15315315315315314" RelY="1.1304347826086956" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1446" />
  </Interaction>
  <Interaction GraphId="e_1476_o1">
    <Comment Source="Reactome">The membrane-bound Va:Xa (prothrombinase) complex rapidly activates large amounts of thrombin.</Comment>
    <Comment Source="Reactome">The membrane-bound Va:Xa (prothrombinase) complex rapidly activates large amounts of thrombin.</Comment>
    <BiopaxRef>e58</BiopaxRef>
    <BiopaxRef>ea8</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1892.0" Y="407.0" GraphRef="e134b" RelX="0.30999999999994543" RelY="-0.7199999999999704" />
      <Point X="1820.0" Y="341.0" GraphRef="n1468" RelX="0.6904761904761905" RelY="1.105263157894737" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1446" />
  </Interaction>
  <Interaction GraphId="e_1476_c_0">
    <Comment Source="Reactome">The membrane-bound Va:Xa (prothrombinase) complex rapidly activates large amounts of thrombin.</Comment>
    <Comment Source="Reactome">The membrane-bound Va:Xa (prothrombinase) complex rapidly activates large amounts of thrombin.</Comment>
    <BiopaxRef>e58</BiopaxRef>
    <BiopaxRef>ea8</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="2208.0" Y="739.0" GraphRef="n1475" RelX="-0.4" RelY="-1.162162162162162" />
      <Point X="1896.0" Y="479.0" GraphRef="f849d" RelX="19.5" RelY="36.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1446" />
  </Interaction>
  <Interaction GraphId="e_1517">
    <Comment Source="Reactome">The alpha and beta chains of fibrinogen hexamer are cleaved by thrombin to generate fibrin monomer.  The amino terminal regions of the cleaved alpha and beta chains are released (fibrinopeptides A and B respectively).</Comment>
    <Comment Source="Reactome">The alpha and beta chains of fibrinogen hexamer are cleaved by thrombin to generate fibrin monomer.  The amino terminal regions of the cleaved alpha and beta chains are released (fibrinopeptides A and B respectively).</Comment>
    <BiopaxRef>f1e</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="675.0" Y="263.0" GraphRef="n1518" RelX="-0.02702702702702703" RelY="-1.25" />
      <Point X="675.0" Y="215.0" />
      <Anchor Position="0.99" Shape="None" GraphId="b466b" />
      <Anchor Position="0.5" Shape="None" GraphId="b67f2" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_214" />
  </Interaction>
  <Interaction GraphId="e_1517_o0">
    <Comment Source="Reactome">The alpha and beta chains of fibrinogen hexamer are cleaved by thrombin to generate fibrin monomer.  The amino terminal regions of the cleaved alpha and beta chains are released (fibrinopeptides A and B respectively).</Comment>
    <Comment Source="Reactome">The alpha and beta chains of fibrinogen hexamer are cleaved by thrombin to generate fibrin monomer.  The amino terminal regions of the cleaved alpha and beta chains are released (fibrinopeptides A and B respectively).</Comment>
    <BiopaxRef>f1e</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="675.0" Y="215.0" GraphRef="b466b" RelX="0.0" RelY="-0.4800000000000182" />
      <Point X="736.0" Y="157.0" GraphRef="n1519" RelX="-0.24489795918367346" RelY="1.2608695652173914" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_214" />
  </Interaction>
  <Interaction GraphId="e_1517_o1">
    <Comment Source="Reactome">The alpha and beta chains of fibrinogen hexamer are cleaved by thrombin to generate fibrin monomer.  The amino terminal regions of the cleaved alpha and beta chains are released (fibrinopeptides A and B respectively).</Comment>
    <Comment Source="Reactome">The alpha and beta chains of fibrinogen hexamer are cleaved by thrombin to generate fibrin monomer.  The amino terminal regions of the cleaved alpha and beta chains are released (fibrinopeptides A and B respectively).</Comment>
    <BiopaxRef>f1e</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="675.0" Y="215.0" GraphRef="b466b" RelX="0.0" RelY="-0.4800000000000182" />
      <Point X="632.0" Y="159.0" GraphRef="n1520" RelX="0.16129032258064516" RelY="1.2608695652173914" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_214" />
  </Interaction>
  <Interaction GraphId="e_1517_o2">
    <Comment Source="Reactome">The alpha and beta chains of fibrinogen hexamer are cleaved by thrombin to generate fibrin monomer.  The amino terminal regions of the cleaved alpha and beta chains are released (fibrinopeptides A and B respectively).</Comment>
    <Comment Source="Reactome">The alpha and beta chains of fibrinogen hexamer are cleaved by thrombin to generate fibrin monomer.  The amino terminal regions of the cleaved alpha and beta chains are released (fibrinopeptides A and B respectively).</Comment>
    <BiopaxRef>f1e</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="675.0" Y="215.0" GraphRef="b466b" RelX="0.0" RelY="-0.4800000000000182" />
      <Point X="615.0" Y="216.0" GraphRef="n1521" RelX="1.0681818181818181" RelY="-0.058823529411764705" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_214" />
  </Interaction>
  <Interaction GraphId="e_1517_c_0">
    <Comment Source="Reactome">The alpha and beta chains of fibrinogen hexamer are cleaved by thrombin to generate fibrin monomer.  The amino terminal regions of the cleaved alpha and beta chains are released (fibrinopeptides A and B respectively).</Comment>
    <Comment Source="Reactome">The alpha and beta chains of fibrinogen hexamer are cleaved by thrombin to generate fibrin monomer.  The amino terminal regions of the cleaved alpha and beta chains are released (fibrinopeptides A and B respectively).</Comment>
    <BiopaxRef>f1e</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1732.0" Y="158.0" GraphRef="n1406" RelX="-1.054054054054054" RelY="0.17391304347826086" />
      <Point X="675.0" Y="241.0" GraphRef="b67f2" RelX="0.0" RelY="2.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_214" />
  </Interaction>
  <Interaction GraphId="e_1522">
    <Comment Source="Reactome">Fibrin monomers rapidly and spontaneously associate into large multimers, binding to one another via sites created by fibrinopeptide release (Laudano and Doolittelle 1980).  The process of multimerization, and the range of multimer structures that can form in vivo and in vitro, have been studied in detail (Doolittle 1984).  Here, multimer size has arbitrarily been set to three fibrin monomers.</Comment>
    <Comment Source="Reactome">Fibrin monomers rapidly and spontaneously associate into large multimers, binding to one another via sites created by fibrinopeptide release (Laudano and Doolittelle 1980).  The process of multimerization, and the range of multimer structures that can form in vivo and in vitro, have been studied in detail (Doolittle 1984).  Here, multimer size has arbitrarily been set to three fibrin monomers.</Comment>
    <BiopaxRef>ae9</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="521.0" Y="217.0" GraphRef="n1521" RelX="-1.0681818181818181" RelY="0.0" />
      <Point X="467.0" Y="217.0" GraphRef="n1523" RelX="1.0714285714285714" RelY="-0.08571428571428572" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1329" />
  </Interaction>
  <Interaction GraphId="e_1524">
    <Comment Source="Reactome">Activated thrombin cleaves the A chains of factor XIII tetramers in a reaction stimulated by the presence of fibrin multimers.  The amino terminal portions of the A chains are released as activation peptides, which have no known function.  The resulting factor XIII tetramer remains catalytically inactive.</Comment>
    <Comment Source="Reactome">Activated thrombin cleaves the A chains of factor XIII tetramers in a reaction stimulated by the presence of fibrin multimers.  The amino terminal portions of the A chains are released as activation peptides, which have no known function.  The resulting factor XIII tetramer remains catalytically inactive.</Comment>
    <BiopaxRef>c93</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="632.0" Y="336.0" GraphRef="n1525" RelX="1.105263157894737" RelY="-0.21212121212121213" />
      <Point X="708.0" Y="331.0" />
      <Anchor Position="0.99" Shape="None" GraphId="d540c" />
      <Anchor Position="0.5" Shape="None" GraphId="e72f5" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1536" />
  </Interaction>
  <Interaction GraphId="e_1524_o0">
    <Comment Source="Reactome">Activated thrombin cleaves the A chains of factor XIII tetramers in a reaction stimulated by the presence of fibrin multimers.  The amino terminal portions of the A chains are released as activation peptides, which have no known function.  The resulting factor XIII tetramer remains catalytically inactive.</Comment>
    <Comment Source="Reactome">Activated thrombin cleaves the A chains of factor XIII tetramers in a reaction stimulated by the presence of fibrin multimers.  The amino terminal portions of the A chains are released as activation peptides, which have no known function.  The resulting factor XIII tetramer remains catalytically inactive.</Comment>
    <BiopaxRef>c93</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="708.0" Y="331.0" GraphRef="d540c" RelX="0.7599999999999909" RelY="-0.05000000000001137" />
      <Point X="852.0" Y="202.0" GraphRef="n1527" RelX="-0.3944954128440367" RelY="1.1578947368421053" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1536" />
  </Interaction>
  <Interaction GraphId="e_1524_o1">
    <Comment Source="Reactome">Activated thrombin cleaves the A chains of factor XIII tetramers in a reaction stimulated by the presence of fibrin multimers.  The amino terminal portions of the A chains are released as activation peptides, which have no known function.  The resulting factor XIII tetramer remains catalytically inactive.</Comment>
    <Comment Source="Reactome">Activated thrombin cleaves the A chains of factor XIII tetramers in a reaction stimulated by the presence of fibrin multimers.  The amino terminal portions of the A chains are released as activation peptides, which have no known function.  The resulting factor XIII tetramer remains catalytically inactive.</Comment>
    <BiopaxRef>c93</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="708.0" Y="331.0" GraphRef="d540c" RelX="0.7599999999999909" RelY="-0.05000000000001137" />
      <Point X="744.0" Y="329.0" GraphRef="n1526" RelX="-1.0560747663551402" RelY="0.08333333333333333" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1536" />
  </Interaction>
  <Interaction GraphId="e_1524_c_0">
    <Comment Source="Reactome">Activated thrombin cleaves the A chains of factor XIII tetramers in a reaction stimulated by the presence of fibrin multimers.  The amino terminal portions of the A chains are released as activation peptides, which have no known function.  The resulting factor XIII tetramer remains catalytically inactive.</Comment>
    <Comment Source="Reactome">Activated thrombin cleaves the A chains of factor XIII tetramers in a reaction stimulated by the presence of fibrin multimers.  The amino terminal portions of the A chains are released as activation peptides, which have no known function.  The resulting factor XIII tetramer remains catalytically inactive.</Comment>
    <BiopaxRef>c93</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1732.0" Y="166.0" GraphRef="n1406" RelX="-1.054054054054054" RelY="0.5217391304347826" />
      <Point X="680.0" Y="333.0" GraphRef="e72f5" RelX="10.0" RelY="-0.5" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1536" />
  </Interaction>
  <Interaction GraphId="e_1524_a_0">
    <Comment Source="Reactome">Activated thrombin cleaves the A chains of factor XIII tetramers in a reaction stimulated by the presence of fibrin multimers.  The amino terminal portions of the A chains are released as activation peptides, which have no known function.  The resulting factor XIII tetramer remains catalytically inactive.</Comment>
    <Comment Source="Reactome">Activated thrombin cleaves the A chains of factor XIII tetramers in a reaction stimulated by the presence of fibrin multimers.  The amino terminal portions of the A chains are released as activation peptides, which have no known function.  The resulting factor XIII tetramer remains catalytically inactive.</Comment>
    <BiopaxRef>c93</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="461.0" Y="239.0" GraphRef="n1523" RelX="0.9285714285714286" RelY="1.1714285714285715" />
      <Point X="680.0" Y="333.0" GraphRef="e72f5" RelX="10.0" RelY="-0.5" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1536" />
  </Interaction>
  <Interaction GraphId="e_1568">
    <Comment Source="Reactome">Once the A chains of the Factor XIII tetramer have been cleaved by thrombin, the complex dissociates and the resulting A chain dimer binds Ca++ (one per peptide monomer) to form activated factor XIII (factor XIIIa).</Comment>
    <Comment Source="Reactome">Once the A chains of the Factor XIII tetramer have been cleaved by thrombin, the complex dissociates and the resulting A chain dimer binds Ca++ (one per peptide monomer) to form activated factor XIII (factor XIIIa).</Comment>
    <BiopaxRef>c93</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="940.0" Y="133.0" />
      <Point X="940.0" Y="79.0" />
      <Anchor Position="0.0" Shape="None" GraphId="b7db6" />
      <Anchor Position="0.99" Shape="None" GraphId="b5e65" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1314" />
  </Interaction>
  <Interaction GraphId="e_1568_a_i0">
    <Comment Source="Reactome">Once the A chains of the Factor XIII tetramer have been cleaved by thrombin, the complex dissociates and the resulting A chain dimer binds Ca++ (one per peptide monomer) to form activated factor XIII (factor XIIIa).</Comment>
    <Comment Source="Reactome">Once the A chains of the Factor XIII tetramer have been cleaved by thrombin, the complex dissociates and the resulting A chain dimer binds Ca++ (one per peptide monomer) to form activated factor XIII (factor XIIIa).</Comment>
    <BiopaxRef>c93</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="900.0" Y="158.0" GraphRef="n1527" RelX="0.48623853211009177" RelY="-1.1578947368421053" />
      <Point X="940.0" Y="133.0" GraphRef="b7db6" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1314" />
  </Interaction>
  <Interaction GraphId="e_1568_a_i1">
    <Comment Source="Reactome">Once the A chains of the Factor XIII tetramer have been cleaved by thrombin, the complex dissociates and the resulting A chain dimer binds Ca++ (one per peptide monomer) to form activated factor XIII (factor XIIIa).</Comment>
    <Comment Source="Reactome">Once the A chains of the Factor XIII tetramer have been cleaved by thrombin, the complex dissociates and the resulting A chain dimer binds Ca++ (one per peptide monomer) to form activated factor XIII (factor XIIIa).</Comment>
    <BiopaxRef>c93</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="982.0" Y="153.0" GraphRef="n1836" RelX="-0.9672131147540983" RelY="-1.1935483870967742" />
      <Point X="940.0" Y="133.0" GraphRef="b7db6" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1314" />
  </Interaction>
  <Interaction GraphId="e_1568_o0">
    <Comment Source="Reactome">Once the A chains of the Factor XIII tetramer have been cleaved by thrombin, the complex dissociates and the resulting A chain dimer binds Ca++ (one per peptide monomer) to form activated factor XIII (factor XIIIa).</Comment>
    <Comment Source="Reactome">Once the A chains of the Factor XIII tetramer have been cleaved by thrombin, the complex dissociates and the resulting A chain dimer binds Ca++ (one per peptide monomer) to form activated factor XIII (factor XIIIa).</Comment>
    <BiopaxRef>c93</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="940.0" Y="79.0" GraphRef="b5e65" RelX="0.0" RelY="-0.539999999999992" />
      <Point X="977.0" Y="49.0" GraphRef="n1569" RelX="-0.25" RelY="1.2608695652173914" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1314" />
  </Interaction>
  <Interaction GraphId="e_1568_o1">
    <Comment Source="Reactome">Once the A chains of the Factor XIII tetramer have been cleaved by thrombin, the complex dissociates and the resulting A chain dimer binds Ca++ (one per peptide monomer) to form activated factor XIII (factor XIIIa).</Comment>
    <Comment Source="Reactome">Once the A chains of the Factor XIII tetramer have been cleaved by thrombin, the complex dissociates and the resulting A chain dimer binds Ca++ (one per peptide monomer) to form activated factor XIII (factor XIIIa).</Comment>
    <BiopaxRef>c93</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="940.0" Y="79.0" GraphRef="b5e65" RelX="0.0" RelY="-0.539999999999992" />
      <Point X="911.0" Y="49.0" GraphRef="n1570" RelX="0.42424242424242425" RelY="1.1764705882352942" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1314" />
  </Interaction>
  <Interaction GraphId="e_1571">
    <Comment Source="Reactome">Fibrin multimers are stabilized by the formation of multiple covalent crosslinks between the side chains of specific lysine and glutamine residues in fibrinogen alpha and gamma chains, catalyzed by factor XIIIa.</Comment>
    <Comment Source="Reactome">Fibrin multimers are stabilized by the formation of multiple covalent crosslinks between the side chains of specific lysine and glutamine residues in fibrinogen alpha and gamma chains, catalyzed by factor XIIIa.</Comment>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="421.0" Y="198.0" GraphRef="n1523" RelX="-0.023809523809523808" RelY="-1.1714285714285715" />
      <Point X="423.0" Y="129.0" />
      <Anchor Position="0.99" Shape="None" GraphId="aebef" />
      <Anchor Position="0.5" Shape="None" GraphId="f50c8" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1852" />
  </Interaction>
  <Interaction GraphId="e_1571_o0">
    <Comment Source="Reactome">Fibrin multimers are stabilized by the formation of multiple covalent crosslinks between the side chains of specific lysine and glutamine residues in fibrinogen alpha and gamma chains, catalyzed by factor XIIIa.</Comment>
    <Comment Source="Reactome">Fibrin multimers are stabilized by the formation of multiple covalent crosslinks between the side chains of specific lysine and glutamine residues in fibrinogen alpha and gamma chains, catalyzed by factor XIIIa.</Comment>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="423.0" Y="129.0" GraphRef="aebef" RelX="0.01999999999998181" RelY="-0.6899999999999977" />
      <Point X="403.0" Y="116.0" GraphRef="n1572" RelX="0.6818181818181818" RelY="1.125" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1852" />
  </Interaction>
  <Interaction GraphId="e_1571_o1">
    <Comment Source="Reactome">Fibrin multimers are stabilized by the formation of multiple covalent crosslinks between the side chains of specific lysine and glutamine residues in fibrinogen alpha and gamma chains, catalyzed by factor XIIIa.</Comment>
    <Comment Source="Reactome">Fibrin multimers are stabilized by the formation of multiple covalent crosslinks between the side chains of specific lysine and glutamine residues in fibrinogen alpha and gamma chains, catalyzed by factor XIIIa.</Comment>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="423.0" Y="129.0" GraphRef="aebef" RelX="0.01999999999998181" RelY="-0.6899999999999977" />
      <Point X="443.0" Y="116.0" GraphRef="n1573" RelX="-1.1333333333333333" RelY="0.7419354838709677" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1852" />
  </Interaction>
  <Interaction GraphId="e_1571_c_0">
    <Comment Source="Reactome">Fibrin multimers are stabilized by the formation of multiple covalent crosslinks between the side chains of specific lysine and glutamine residues in fibrinogen alpha and gamma chains, catalyzed by factor XIIIa.</Comment>
    <Comment Source="Reactome">Fibrin multimers are stabilized by the formation of multiple covalent crosslinks between the side chains of specific lysine and glutamine residues in fibrinogen alpha and gamma chains, catalyzed by factor XIIIa.</Comment>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="861.0" Y="37.0" GraphRef="n1570" RelX="-1.0909090909090908" RelY="0.47058823529411764" />
      <Point X="421.0" Y="157.0" GraphRef="f50c8" RelX="-1.0" RelY="-6.5" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1852" />
  </Interaction>
  <Interaction GraphId="e_1614">
    <Comment Source="Reactome">Antithrombin III binds to membrane-associated heparin, e.g., on the surface of a normal endothelial cell.  This binding event increases the affinity of antithrombin III for thrombin approximately 1000-fold.</Comment>
    <Comment Source="Reactome">Antithrombin III binds to membrane-associated heparin, e.g., on the surface of a normal endothelial cell.  This binding event increases the affinity of antithrombin III for thrombin approximately 1000-fold.</Comment>
    <BiopaxRef>c2b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="314.0" Y="708.0" />
      <Point X="374.0" Y="740.0" GraphRef="n1617" RelX="-0.3626373626373626" RelY="-1.1578947368421053" ArrowHead="Arrow" />
      <Anchor Position="0.0" Shape="None" GraphId="dfb10" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_102" />
  </Interaction>
  <Interaction GraphId="e_1614_a_i0">
    <Comment Source="Reactome">Antithrombin III binds to membrane-associated heparin, e.g., on the surface of a normal endothelial cell.  This binding event increases the affinity of antithrombin III for thrombin approximately 1000-fold.</Comment>
    <Comment Source="Reactome">Antithrombin III binds to membrane-associated heparin, e.g., on the surface of a normal endothelial cell.  This binding event increases the affinity of antithrombin III for thrombin approximately 1000-fold.</Comment>
    <BiopaxRef>c2b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="301.0" Y="678.0" GraphRef="n1615" RelX="0.15384615384615385" RelY="1.1818181818181819" />
      <Point X="314.0" Y="708.0" GraphRef="dfb10" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_102" />
  </Interaction>
  <Interaction GraphId="e_1614_a_i1">
    <Comment Source="Reactome">Antithrombin III binds to membrane-associated heparin, e.g., on the surface of a normal endothelial cell.  This binding event increases the affinity of antithrombin III for thrombin approximately 1000-fold.</Comment>
    <Comment Source="Reactome">Antithrombin III binds to membrane-associated heparin, e.g., on the surface of a normal endothelial cell.  This binding event increases the affinity of antithrombin III for thrombin approximately 1000-fold.</Comment>
    <BiopaxRef>c2b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="300.0" Y="747.0" GraphRef="n1616" RelX="0.14814814814814814" RelY="-1.2307692307692308" />
      <Point X="314.0" Y="708.0" GraphRef="dfb10" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_102" />
  </Interaction>
  <Interaction GraphId="e_1618">
    <Comment Source="Reactome">Activated thrombin binds to the antithrombin III:heparin complex on the cell surface.</Comment>
    <Comment Source="Reactome">Activated thrombin binds to the antithrombin III:heparin complex on the cell surface.</Comment>
    <BiopaxRef>c2b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="399.0" Y="620.0" />
      <Point X="204.0" Y="740.0" GraphRef="n1619" RelX="0.14563106796116504" RelY="-1.1224489795918366" ArrowHead="Arrow" />
      <Anchor Position="0.0" Shape="None" GraphId="d8a42" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1822" />
  </Interaction>
  <Interaction GraphId="e_1618_a_i0">
    <Comment Source="Reactome">Activated thrombin binds to the antithrombin III:heparin complex on the cell surface.</Comment>
    <Comment Source="Reactome">Activated thrombin binds to the antithrombin III:heparin complex on the cell surface.</Comment>
    <BiopaxRef>c2b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="391.0" Y="740.0" GraphRef="n1617" RelX="0.01098901098901099" RelY="-1.1578947368421053" />
      <Point X="399.0" Y="620.0" GraphRef="d8a42" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1822" />
  </Interaction>
  <Interaction GraphId="e_1618_a_i1">
    <Comment Source="Reactome">Activated thrombin binds to the antithrombin III:heparin complex on the cell surface.</Comment>
    <Comment Source="Reactome">Activated thrombin binds to the antithrombin III:heparin complex on the cell surface.</Comment>
    <BiopaxRef>c2b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1732.0" Y="172.0" GraphRef="n1406" RelX="-1.054054054054054" RelY="0.782608695652174" />
      <Point X="399.0" Y="620.0" GraphRef="d8a42" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1822" />
  </Interaction>
  <Interaction GraphId="e_1620">
    <Comment Source="Reactome">Antithrombin III in the complex is cleaved by thrombin, thereupon undergoing a conformational change that stabilizes the thrombin:antithrombin III complex, trapping and inactivating the thrombin moiety.</Comment>
    <Comment Source="Reactome">Antithrombin III in the complex is cleaved by thrombin, thereupon undergoing a conformational change that stabilizes the thrombin:antithrombin III complex, trapping and inactivating the thrombin moiety.</Comment>
    <BiopaxRef>c2b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="162.0" Y="795.0" GraphRef="n1619" RelX="-0.6699029126213593" RelY="1.1224489795918366" />
      <Point X="115.0" Y="795.0" GraphRef="n1621" RelX="0.7692307692307693" RelY="1.096774193548387" ArrowHead="Arrow" />
      <Anchor Position="0.5" Shape="None" GraphId="a1b03" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1500" />
  </Interaction>
  <Interaction GraphId="e_1620_c_0">
    <Comment Source="Reactome">Antithrombin III in the complex is cleaved by thrombin, thereupon undergoing a conformational change that stabilizes the thrombin:antithrombin III complex, trapping and inactivating the thrombin moiety.</Comment>
    <Comment Source="Reactome">Antithrombin III in the complex is cleaved by thrombin, thereupon undergoing a conformational change that stabilizes the thrombin:antithrombin III complex, trapping and inactivating the thrombin moiety.</Comment>
    <BiopaxRef>c2b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="172.0" Y="795.0" GraphRef="n1619" RelX="-0.47572815533980584" RelY="1.1224489795918366" />
      <Point X="134.0" Y="806.0" GraphRef="a1b03" RelX="-4.5" RelY="11.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1500" />
  </Interaction>
  <Interaction GraphId="e_1622">
    <Comment Source="Reactome">The same conformational change that traps thrombin in its complex with cleaved antithrombin III also decreases the affinity of the latter for heparin, and the complex of cleaved antithrombin III and thrombin dissociates from the cell-bound heparin molecule.</Comment>
    <Comment Source="Reactome">The same conformational change that traps thrombin in its complex with cleaved antithrombin III also decreases the affinity of the latter for heparin, and the complex of cleaved antithrombin III and thrombin dissociates from the cell-bound heparin molecule.</Comment>
    <BiopaxRef>c2b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="67.0" Y="727.0" GraphRef="n1621" RelX="-0.15384615384615385" RelY="-1.096774193548387" />
      <Point X="62.0" Y="666.0" />
      <Anchor Position="0.99" Shape="None" GraphId="d99ad" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1283" />
  </Interaction>
  <Interaction GraphId="e_1622_o0">
    <Comment Source="Reactome">The same conformational change that traps thrombin in its complex with cleaved antithrombin III also decreases the affinity of the latter for heparin, and the complex of cleaved antithrombin III and thrombin dissociates from the cell-bound heparin molecule.</Comment>
    <Comment Source="Reactome">The same conformational change that traps thrombin in its complex with cleaved antithrombin III also decreases the affinity of the latter for heparin, and the complex of cleaved antithrombin III and thrombin dissociates from the cell-bound heparin molecule.</Comment>
    <BiopaxRef>c2b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="62.0" Y="666.0" GraphRef="d99ad" RelX="-0.04999999999999716" RelY="-0.6100000000000136" />
      <Point X="71.0" Y="619.0" GraphRef="n1623" RelX="-0.09090909090909091" RelY="1.1395348837209303" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1283" />
  </Interaction>
  <Interaction GraphId="e_1622_o1">
    <Comment Source="Reactome">The same conformational change that traps thrombin in its complex with cleaved antithrombin III also decreases the affinity of the latter for heparin, and the complex of cleaved antithrombin III and thrombin dissociates from the cell-bound heparin molecule.</Comment>
    <Comment Source="Reactome">The same conformational change that traps thrombin in its complex with cleaved antithrombin III also decreases the affinity of the latter for heparin, and the complex of cleaved antithrombin III and thrombin dissociates from the cell-bound heparin molecule.</Comment>
    <BiopaxRef>c2b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="62.0" Y="666.0" GraphRef="d99ad" RelX="-0.04999999999999716" RelY="-0.6100000000000136" />
      <Point X="266.0" Y="751.0" GraphRef="n1616" RelX="-1.1111111111111112" RelY="-0.9230769230769231" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1283" />
  </Interaction>
  <Interaction GraphId="e_1704">
    <Comment Source="Reactome">Activated thrombin (factor IIa) binds to thrombomodulin at the external face of the plasma membrane, forming a thrombin:thrombomodulin complex. In this complexed form, the activity of thrombin towards protein C is greatly increased, and as thrombomodulin is particularly abundant on the surfaces of endothelial cells, this association plays a major role in restricting clot formation.</Comment>
    <Comment Source="Reactome">Activated thrombin (factor IIa) binds to thrombomodulin at the external face of the plasma membrane, forming a thrombin:thrombomodulin complex. In this complexed form, the activity of thrombin towards protein C is greatly increased, and as thrombomodulin is particularly abundant on the surfaces of endothelial cells, this association plays a major role in restricting clot formation.</Comment>
    <BiopaxRef>da7</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1376.0" Y="703.0" />
      <Point X="1274.0" Y="738.0" GraphRef="n1706" RelX="0.6936936936936937" RelY="-1.1578947368421053" ArrowHead="Arrow" />
      <Anchor Position="0.0" Shape="None" GraphId="bdbf7" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1834" />
  </Interaction>
  <Interaction GraphId="e_1704_a_i0">
    <Comment Source="Reactome">Activated thrombin (factor IIa) binds to thrombomodulin at the external face of the plasma membrane, forming a thrombin:thrombomodulin complex. In this complexed form, the activity of thrombin towards protein C is greatly increased, and as thrombomodulin is particularly abundant on the surfaces of endothelial cells, this association plays a major role in restricting clot formation.</Comment>
    <Comment Source="Reactome">Activated thrombin (factor IIa) binds to thrombomodulin at the external face of the plasma membrane, forming a thrombin:thrombomodulin complex. In this complexed form, the activity of thrombin towards protein C is greatly increased, and as thrombomodulin is particularly abundant on the surfaces of endothelial cells, this association plays a major role in restricting clot formation.</Comment>
    <BiopaxRef>da7</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1389.0" Y="747.0" GraphRef="n1705" RelX="-0.07272727272727272" RelY="-1.2608695652173914" />
      <Point X="1376.0" Y="703.0" GraphRef="bdbf7" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1834" />
  </Interaction>
  <Interaction GraphId="e_1704_a_i1">
    <Comment Source="Reactome">Activated thrombin (factor IIa) binds to thrombomodulin at the external face of the plasma membrane, forming a thrombin:thrombomodulin complex. In this complexed form, the activity of thrombin towards protein C is greatly increased, and as thrombomodulin is particularly abundant on the surfaces of endothelial cells, this association plays a major role in restricting clot formation.</Comment>
    <Comment Source="Reactome">Activated thrombin (factor IIa) binds to thrombomodulin at the external face of the plasma membrane, forming a thrombin:thrombomodulin complex. In this complexed form, the activity of thrombin towards protein C is greatly increased, and as thrombomodulin is particularly abundant on the surfaces of endothelial cells, this association plays a major role in restricting clot formation.</Comment>
    <BiopaxRef>da7</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1743.0" Y="180.0" GraphRef="n1406" RelX="-0.8558558558558559" RelY="1.1304347826086956" />
      <Point X="1376.0" Y="703.0" GraphRef="bdbf7" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1834" />
  </Interaction>
  <Interaction GraphId="e_1707">
    <Comment Source="Reactome">Thrombin complexed with thrombomodulin at the endothelial cell surface cleaves the heavy chain of protein C, generating activated protein C and an activation peptide.  The activation peptide has no known function.</Comment>
    <Comment Source="Reactome">Thrombin complexed with thrombomodulin at the endothelial cell surface cleaves the heavy chain of protein C, generating activated protein C and an activation peptide.  The activation peptide has no known function.</Comment>
    <BiopaxRef>da7</BiopaxRef>
    <BiopaxRef>f3b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1188.0" Y="608.0" GraphRef="n1708" RelX="1.09375" RelY="-0.13043478260869565" />
      <Point X="1247.0" Y="608.0" />
      <Anchor Position="0.99" Shape="None" GraphId="f2d9e" />
      <Anchor Position="0.5" Shape="None" GraphId="e5cd2" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_374" />
  </Interaction>
  <Interaction GraphId="e_1707_o0">
    <Comment Source="Reactome">Thrombin complexed with thrombomodulin at the endothelial cell surface cleaves the heavy chain of protein C, generating activated protein C and an activation peptide.  The activation peptide has no known function.</Comment>
    <Comment Source="Reactome">Thrombin complexed with thrombomodulin at the endothelial cell surface cleaves the heavy chain of protein C, generating activated protein C and an activation peptide.  The activation peptide has no known function.</Comment>
    <BiopaxRef>da7</BiopaxRef>
    <BiopaxRef>f3b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1247.0" Y="608.0" GraphRef="f2d9e" RelX="0.5899999999999181" RelY="0.0" />
      <Point X="1271.0" Y="592.0" GraphRef="n1709" RelX="-0.5714285714285714" RelY="1.125" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_374" />
  </Interaction>
  <Interaction GraphId="e_1707_o1">
    <Comment Source="Reactome">Thrombin complexed with thrombomodulin at the endothelial cell surface cleaves the heavy chain of protein C, generating activated protein C and an activation peptide.  The activation peptide has no known function.</Comment>
    <Comment Source="Reactome">Thrombin complexed with thrombomodulin at the endothelial cell surface cleaves the heavy chain of protein C, generating activated protein C and an activation peptide.  The activation peptide has no known function.</Comment>
    <BiopaxRef>da7</BiopaxRef>
    <BiopaxRef>f3b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1247.0" Y="608.0" GraphRef="f2d9e" RelX="0.5899999999999181" RelY="0.0" />
      <Point X="1281.0" Y="629.0" GraphRef="n1710" RelX="-0.28" RelY="-1.2727272727272727" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_374" />
  </Interaction>
  <Interaction GraphId="e_1707_c_0">
    <Comment Source="Reactome">Thrombin complexed with thrombomodulin at the endothelial cell surface cleaves the heavy chain of protein C, generating activated protein C and an activation peptide.  The activation peptide has no known function.</Comment>
    <Comment Source="Reactome">Thrombin complexed with thrombomodulin at the endothelial cell surface cleaves the heavy chain of protein C, generating activated protein C and an activation peptide.  The activation peptide has no known function.</Comment>
    <BiopaxRef>da7</BiopaxRef>
    <BiopaxRef>f3b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1233.0" Y="738.0" GraphRef="n1706" RelX="-0.04504504504504504" RelY="-1.1578947368421053" />
      <Point X="1224.0" Y="607.0" GraphRef="e5cd2" RelX="6.5" RelY="-1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_374" />
  </Interaction>
  <Interaction GraphId="e_1707_a_0">
    <Comment Source="Reactome">Thrombin complexed with thrombomodulin at the endothelial cell surface cleaves the heavy chain of protein C, generating activated protein C and an activation peptide.  The activation peptide has no known function.</Comment>
    <Comment Source="Reactome">Thrombin complexed with thrombomodulin at the endothelial cell surface cleaves the heavy chain of protein C, generating activated protein C and an activation peptide.  The activation peptide has no known function.</Comment>
    <BiopaxRef>da7</BiopaxRef>
    <BiopaxRef>f3b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1220.0" Y="529.0" GraphRef="n1711" RelX="-0.009708737864077669" RelY="1.25" />
      <Point X="1224.0" Y="607.0" GraphRef="e5cd2" RelX="6.5" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_374" />
  </Interaction>
  <Interaction GraphId="e_1752">
    <Comment Source="Reactome">Activated protein C cleaves peptide bonds in activated factor V (factor Va), converting it to an inactive form (factor Vi).  The exact site(s) of cleavage are unknown.  Protein S, on the endothelial cell surface, positively regulates this reaction.  Although the mechanism of this regulation is unclear, the regulation is physiologically important, as people with reduced amounts of protein S, like people with reduced amounts of protein C, are susceptible to thromboembolism.</Comment>
    <Comment Source="Reactome">Activated protein C cleaves peptide bonds in activated factor V (factor Va), converting it to an inactive form (factor Vi).  The exact site(s) of cleavage are unknown.  Protein S, on the endothelial cell surface, positively regulates this reaction.  Although the mechanism of this regulation is unclear, the regulation is physiologically important, as people with reduced amounts of protein S, like people with reduced amounts of protein C, are susceptible to thromboembolism.</Comment>
    <BiopaxRef>da7</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1540.0" Y="546.0" GraphRef="n1473" RelX="-0.5714285714285714" RelY="1.1714285714285715" />
      <Point X="1465.0" Y="618.0" GraphRef="n1753" RelX="0.8888888888888888" RelY="-1.1395348837209303" ArrowHead="Arrow" />
      <Anchor Position="0.5" Shape="None" GraphId="a5236" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1071" />
  </Interaction>
  <Interaction GraphId="e_1752_c_0">
    <Comment Source="Reactome">Activated protein C cleaves peptide bonds in activated factor V (factor Va), converting it to an inactive form (factor Vi).  The exact site(s) of cleavage are unknown.  Protein S, on the endothelial cell surface, positively regulates this reaction.  Although the mechanism of this regulation is unclear, the regulation is physiologically important, as people with reduced amounts of protein S, like people with reduced amounts of protein C, are susceptible to thromboembolism.</Comment>
    <Comment Source="Reactome">Activated protein C cleaves peptide bonds in activated factor V (factor Va), converting it to an inactive form (factor Vi).  The exact site(s) of cleavage are unknown.  Protein S, on the endothelial cell surface, positively regulates this reaction.  Although the mechanism of this regulation is unclear, the regulation is physiologically important, as people with reduced amounts of protein S, like people with reduced amounts of protein C, are susceptible to thromboembolism.</Comment>
    <BiopaxRef>da7</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1593.0" Y="734.0" GraphRef="n1754" RelX="-0.30337078651685395" RelY="-1.1578947368421053" />
      <Point X="1498.0" Y="592.0" GraphRef="a5236" RelX="-4.5" RelY="10.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1071" />
  </Interaction>
  <Interaction GraphId="e_1752_a_0">
    <Comment Source="Reactome">Activated protein C cleaves peptide bonds in activated factor V (factor Va), converting it to an inactive form (factor Vi).  The exact site(s) of cleavage are unknown.  Protein S, on the endothelial cell surface, positively regulates this reaction.  Although the mechanism of this regulation is unclear, the regulation is physiologically important, as people with reduced amounts of protein S, like people with reduced amounts of protein C, are susceptible to thromboembolism.</Comment>
    <Comment Source="Reactome">Activated protein C cleaves peptide bonds in activated factor V (factor Va), converting it to an inactive form (factor Vi).  The exact site(s) of cleavage are unknown.  Protein S, on the endothelial cell surface, positively regulates this reaction.  Although the mechanism of this regulation is unclear, the regulation is physiologically important, as people with reduced amounts of protein S, like people with reduced amounts of protein C, are susceptible to thromboembolism.</Comment>
    <BiopaxRef>da7</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1507.0" Y="746.0" GraphRef="n1755" RelX="-0.046153846153846156" RelY="-1.2608695652173914" />
      <Point X="1498.0" Y="592.0" GraphRef="a5236" RelX="-4.5" RelY="10.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="REACT_1071" />
  </Interaction>
  <Label TextLabel="TF&#xA;F7 ">
    <Comment Source="Reactome">REACT_4908</Comment>
    <Graphics CenterX="100.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor X ">
    <Comment Source="Reactome">REACT_3749</Comment>
    <Graphics CenterX="210.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor Xa ">
    <Comment Source="Reactome">REACT_5349</Comment>
    <Graphics CenterX="320.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor VIIa ">
    <Comment Source="Reactome">REACT_2419</Comment>
    <Graphics CenterX="430.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="TF&#xA;F7a ">
    <Comment Source="Reactome">REACT_4532</Comment>
    <Graphics CenterX="540.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor VIIa ">
    <Comment Source="Reactome">REACT_3035</Comment>
    <Graphics CenterX="540.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor IXa ">
    <Comment Source="Reactome">REACT_3075</Comment>
    <Graphics CenterX="650.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="TFPI&#xA;TF&#xA;F7a&#xA;factor Xa ">
    <Comment Source="Reactome">REACT_2685</Comment>
    <Graphics CenterX="760.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="TF&#xA;F7a ">
    <Comment Source="Reactome">REACT_4532</Comment>
    <Graphics CenterX="760.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor VIIa ">
    <Comment Source="Reactome">REACT_3035</Comment>
    <Graphics CenterX="760.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor Xa ">
    <Comment Source="Reactome">REACT_3099</Comment>
    <Graphics CenterX="760.0" CenterY="1077.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="C1q binding protein tetramer ">
    <Comment Source="Reactome">REACT_2937</Comment>
    <Graphics CenterX="870.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="KNG&#xA;C1q binding protein tetramer ">
    <Comment Source="Reactome">REACT_4804</Comment>
    <Graphics CenterX="980.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="C1q binding protein tetramer ">
    <Comment Source="Reactome">REACT_2937</Comment>
    <Graphics CenterX="980.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="prekallikrein&#xA;kininogen&#xA;C1q binding protein tetramer ">
    <Comment Source="Reactome">REACT_3461</Comment>
    <Graphics CenterX="1090.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="KNG&#xA;C1q binding protein tetramer ">
    <Comment Source="Reactome">REACT_4804</Comment>
    <Graphics CenterX="1090.0" CenterY="957.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="C1q binding protein tetramer ">
    <Comment Source="Reactome">REACT_2937</Comment>
    <Graphics CenterX="1090.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="kallikrein&#xA;kininogen&#xA;C1q binding protein tetramer ">
    <Comment Source="Reactome">REACT_4714</Comment>
    <Graphics CenterX="1200.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="kallikrein ">
    <Comment Source="Reactome">REACT_5025</Comment>
    <Graphics CenterX="1200.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="KNG&#xA;C1q binding protein tetramer ">
    <Comment Source="Reactome">REACT_4804</Comment>
    <Graphics CenterX="1200.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="C1q binding protein tetramer ">
    <Comment Source="Reactome">REACT_2937</Comment>
    <Graphics CenterX="1200.0" CenterY="1037.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="prolylcarboxypeptidase dimer ">
    <Comment Source="Reactome">REACT_5699</Comment>
    <Graphics CenterX="1310.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="activated kininogen&#xA;C1q binding protein tetramer ">
    <Comment Source="Reactome">REACT_3121</Comment>
    <Graphics CenterX="1420.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="activated kininogen ">
    <Comment Source="Reactome">REACT_5305</Comment>
    <Graphics CenterX="1420.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="C1q binding protein tetramer ">
    <Comment Source="Reactome">REACT_2937</Comment>
    <Graphics CenterX="1420.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="Plasma kallikrein ">
    <Comment Source="Reactome">REACT_4124</Comment>
    <Graphics CenterX="1530.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor XIIa ">
    <Comment Source="Reactome">REACT_4236</Comment>
    <Graphics CenterX="1640.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor XI ">
    <Comment Source="Reactome">REACT_4915</Comment>
    <Graphics CenterX="1750.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor XI&#xA;GPIb-IX-V complex ">
    <Comment Source="Reactome">REACT_5726</Comment>
    <Graphics CenterX="1860.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor XI ">
    <Comment Source="Reactome">REACT_5214</Comment>
    <Graphics CenterX="1860.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="GPIb-IX-V complex ">
    <Comment Source="Reactome">REACT_3007</Comment>
    <Graphics CenterX="1860.0" CenterY="977.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="GPIb ">
    <Comment Source="Reactome">REACT_4769</Comment>
    <Graphics CenterX="1860.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor XIa&#xA;GPIb&#xA;GPIX&#xA;GPV complex ">
    <Comment Source="Reactome">REACT_4765</Comment>
    <Graphics CenterX="1970.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor XIa ">
    <Comment Source="Reactome">REACT_2333</Comment>
    <Graphics CenterX="1970.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="GPIb-IX-V complex ">
    <Comment Source="Reactome">REACT_3007</Comment>
    <Graphics CenterX="1970.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="GPIb ">
    <Comment Source="Reactome">REACT_4769</Comment>
    <Graphics CenterX="1970.0" CenterY="1017.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="Activated thrombin ">
    <Comment Source="Reactome">REACT_3298</Comment>
    <Graphics CenterX="2080.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor VIII ">
    <Comment Source="Reactome">REACT_4493</Comment>
    <Graphics CenterX="2190.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="von Willibrand factor multimer ">
    <Comment Source="Reactome">REACT_5706</Comment>
    <Graphics CenterX="2300.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor VIII&#xA;von Willebrand factor multimer ">
    <Comment Source="Reactome">REACT_3248</Comment>
    <Graphics CenterX="2410.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor VIII ">
    <Comment Source="Reactome">REACT_4493</Comment>
    <Graphics CenterX="2410.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor VIIIa ">
    <Comment Source="Reactome">REACT_4190</Comment>
    <Graphics CenterX="2520.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor VIIIa&#xA;factor IXa ">
    <Comment Source="Reactome">REACT_3217</Comment>
    <Graphics CenterX="2630.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor VIIIa ">
    <Comment Source="Reactome">REACT_4317</Comment>
    <Graphics CenterX="2630.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor IXa ">
    <Comment Source="Reactome">REACT_2936</Comment>
    <Graphics CenterX="2630.0" CenterY="1017.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="kallikrein&#xA;C1Inh ">
    <Comment Source="Reactome">REACT_5874</Comment>
    <Graphics CenterX="2740.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="Plasma kallikrein ">
    <Comment Source="Reactome">REACT_4124</Comment>
    <Graphics CenterX="2740.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="Alpha2-macroglobulin ">
    <Comment Source="Reactome">REACT_3449</Comment>
    <Graphics CenterX="2850.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="kallikrein&#xA;alpha2-macroglobulin ">
    <Comment Source="Reactome">REACT_4115</Comment>
    <Graphics CenterX="2960.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="Plasma kallikrein ">
    <Comment Source="Reactome">REACT_4124</Comment>
    <Graphics CenterX="2960.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="Alpha2-macroglobulin ">
    <Comment Source="Reactome">REACT_3449</Comment>
    <Graphics CenterX="2960.0" CenterY="997.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor XIIa&#xA;C1Inh ">
    <Comment Source="Reactome">REACT_2283</Comment>
    <Graphics CenterX="3070.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor XIIa ">
    <Comment Source="Reactome">REACT_4236</Comment>
    <Graphics CenterX="3070.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor Xa ">
    <Comment Source="Reactome">REACT_3099</Comment>
    <Graphics CenterX="3180.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor Va ">
    <Comment Source="Reactome">REACT_2497</Comment>
    <Graphics CenterX="3290.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="Va&#xA;Xa complex ">
    <Comment Source="Reactome">REACT_5441</Comment>
    <Graphics CenterX="3400.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor Xa ">
    <Comment Source="Reactome">REACT_3099</Comment>
    <Graphics CenterX="3400.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor Va ">
    <Comment Source="Reactome">REACT_4837</Comment>
    <Graphics CenterX="3400.0" CenterY="1017.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="Fibrinogen ">
    <Comment Source="Reactome">REACT_4095</Comment>
    <Graphics CenterX="3510.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="fibrin monomer ">
    <Comment Source="Reactome">REACT_5594</Comment>
    <Graphics CenterX="3620.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="fibrin multimer ">
    <Comment Source="Reactome">REACT_4444</Comment>
    <Graphics CenterX="3730.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="fibrin monomer ">
    <Comment Source="Reactome">REACT_5594</Comment>
    <Graphics CenterX="3730.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor XIII ">
    <Comment Source="Reactome">REACT_4285</Comment>
    <Graphics CenterX="3840.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor XIII cleaved tetramer ">
    <Comment Source="Reactome">REACT_2648</Comment>
    <Graphics CenterX="3950.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor XIIIa ">
    <Comment Source="Reactome">REACT_4387</Comment>
    <Graphics CenterX="4060.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="antithrombin III&#xA;heparin ">
    <Comment Source="Reactome">REACT_2653</Comment>
    <Graphics CenterX="4170.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="thrombin&#xA;antithrombin III&#xA;heparin ">
    <Comment Source="Reactome">REACT_2423</Comment>
    <Graphics CenterX="4280.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="activated thrombin ">
    <Comment Source="Reactome">REACT_5334</Comment>
    <Graphics CenterX="4280.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="thrombin&#xA;cleaved antithrombin III&#xA;heparin ">
    <Comment Source="Reactome">REACT_2621</Comment>
    <Graphics CenterX="4390.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="activated thrombin ">
    <Comment Source="Reactome">REACT_5334</Comment>
    <Graphics CenterX="4390.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="cleaved antithrombin III ">
    <Comment Source="Reactome">REACT_5877</Comment>
    <Graphics CenterX="4390.0" CenterY="1017.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="thrombin&#xA;cleaved antithrombin III ">
    <Comment Source="Reactome">REACT_4175</Comment>
    <Graphics CenterX="4500.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="Activated thrombin ">
    <Comment Source="Reactome">REACT_3298</Comment>
    <Graphics CenterX="4500.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="cleaved antithrombin III ">
    <Comment Source="Reactome">REACT_3619</Comment>
    <Graphics CenterX="4500.0" CenterY="1017.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="activated thrombin&#xA;thrombomodulin ">
    <Comment Source="Reactome">REACT_5904</Comment>
    <Graphics CenterX="4610.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="activated thrombin ">
    <Comment Source="Reactome">REACT_5334</Comment>
    <Graphics CenterX="4610.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="protein C ">
    <Comment Source="Reactome">REACT_4912</Comment>
    <Graphics CenterX="4720.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="activated protein C ">
    <Comment Source="Reactome">REACT_2599</Comment>
    <Graphics CenterX="4830.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="factor Vi ">
    <Comment Source="Reactome">REACT_4020</Comment>
    <Graphics CenterX="4940.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="activated protein C ">
    <Comment Source="Reactome">REACT_5044</Comment>
    <Graphics CenterX="5050.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="GPIb-IX-V complex ">
    <Comment Source="Reactome">REACT_3007</Comment>
    <Graphics CenterX="5160.0" CenterY="917.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="GPIb ">
    <Comment Source="Reactome">REACT_4769</Comment>
    <Graphics CenterX="5160.0" CenterY="937.0" Width="80.0" Height="20.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="cytoplasm" GraphId="comp_text_1316">
    <Graphics CenterX="2575.0" CenterY="867.5" Width="78.0" Height="33.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Shape GraphId="comp_1316">
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="1671.0" CenterY="823.0" Width="3300.0" Height="132.0" ZOrder="16384" FontSize="10" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Group GroupId="1407750.26866068013384425" Style="Complex" />
  <Group GroupId="1407390.3575707758019925" Style="Complex" />
  <Group GroupId="1406890.20354281619170667" Style="Complex" />
  <Group GroupId="1407510.0068594233077811095" Style="Complex" />
  <Group GroupId="1407340.2835253504744524" Style="Complex" />
  <Group GroupId="1407330.21393290239157847" Style="Complex" />
  <Group GroupId="1408960.5711435348782689" Style="Complex" />
  <Group GroupId="1408330.8390454022727077" Style="Complex" />
  <Group GroupId="1407340.9848290460901136" Style="Complex" />
  <Group GroupId="1407330.33778460995024207" Style="Complex" />
  <Group GroupId="1406490.22310516120981316" Style="Complex" />
  <Group GroupId="1583180.24682457041767225" Style="Complex" />
  <Group GroupId="1581720.4107935766207831" Style="Complex" />
  <Group GroupId="1583180.4249271272321663" Style="Complex" />
  <Group GroupId="1584040.8273408742960129" Style="Complex" />
  <Group GroupId="1581720.236107297834812" Style="Complex" />
  <Group GroupId="1583180.34489288549614994" Style="Complex" />
  <Group GroupId="1581970.8050872888752268" Style="Complex" />
  <Group GroupId="1582430.8599995046203145" Style="Complex" />
  <Group GroupId="1581720.3915810453391875" Style="Complex" />
  <Group GroupId="1583180.25192077050986084" Style="Complex" />
  <Group GroupId="1581760.75023621733358" Style="Complex" />
  <Group GroupId="1582570.46215373858212094" Style="Complex" />
  <Group GroupId="1584000.6385055572847841" Style="Complex" />
  <Group GroupId="1583180.6493625737658735" Style="Complex" />
  <Group GroupId="1581400.86723657000276" Style="Complex" />
  <Group GroupId="1583060.03234454559252553" Style="Complex" />
  <Group GroupId="1582340.06089759672804407" Style="Complex" />
  <Group GroupId="1581620.7576067018832149" Style="Complex" />
  <Group GroupId="1581430.5992630800508533" Style="Complex" />
  <Group GroupId="1146680.6997874521448195" Style="Complex" />
  <Group GroupId="1146670.6838511503788506" Style="Complex" />
  <Group GroupId="1581300.5703842487022937" Style="Complex" />
  <Group GroupId="1583900.6348549720288448" Style="Complex" />
  <Group GroupId="1146680.6365232844321559" Style="Complex" />
  <Group GroupId="1146670.04277691965236419" Style="Complex" />
  <Group GroupId="1567860.06592605786600314" Style="Complex" />
  <Group GroupId="1583500.3291229080131778" Style="Complex" />
  <Group GroupId="1581360.7615224343200825" Style="Complex" />
  <Group GroupId="1583630.3086352230503143" Style="Complex" />
  <Group GroupId="1583500.1396785018251797" Style="Complex" />
  <Group GroupId="1583070.07854737213047636" Style="Complex" />
  <Group GroupId="1583920.7657280645395035" Style="Complex" />
  <Group GroupId="1583740.715774201970569" Style="Complex" />
  <Group GroupId="1583670.9810203385058415" Style="Complex" />
  <Group GroupId="1584230.9589691155724928" Style="Complex" />
  <Group GroupId="1581400.5442506582005325" Style="Complex" />
  <Group GroupId="1582550.04777546856039361" Style="Complex" />
  <Group GroupId="1583340.03927490600508998" Style="Complex" />
  <Group GroupId="1581400.835786771930862" Style="Complex" />
  <Group GroupId="1582550.06040244502358183" Style="Complex" />
  <Group GroupId="1581410.9767476496480324" Style="Complex" />
  <Group GroupId="1583060.4284136010734807" Style="Complex" />
  <Group GroupId="1406490.5860404343430662" Style="Complex" />
  <Group GroupId="1406920.385987081563939" Style="Complex" />
  <Group GroupId="1406620.122797511230897" Style="Complex" />
  <Group GroupId="1406490.6051977607708366" Style="Complex" />
  <Group GroupId="1406610.03397430695579051" Style="Complex" />
  <Group GroupId="1146180.16323640758295732" Style="Complex" />
  <Group GroupId="1405860.8029475397924184" Style="Complex" />
  <Group GroupId="1399330.42210777163117874" Style="Complex" />
  <Group GroupId="1405860.6948354753994485" Style="Complex" />
  <Group GroupId="1406080.016012592627640654" Style="Complex" />
  <Group GroupId="1407890.5725579502588494" Style="Complex" />
  <Group GroupId="1408490.2042600944116444" Style="Complex" />
  <Group GroupId="1407990.44607989096756084" Style="Complex" />
  <Group GroupId="1408120.501370913251049" Style="Complex" />
  <Group GroupId="1408110.8273497280641423" Style="Complex" />
  <Group GroupId="1408710.3286139911579644" Style="Complex" />
  <Group GroupId="1408110.8008209055126884" Style="Complex" />
  <Group GroupId="1408220.037304361429414956" Style="Complex" />
  <Group GroupId="1408740.930415118792029" Style="Complex" />
  <Group GroupId="1567860.8941215948137226" Style="Complex" />
  <Group GroupId="1408210.5452695326602988" Style="Complex" />
  <Group GroupId="1410380.8684683498695691" Style="Complex" />
  <Group GroupId="1408110.5561401666924648" Style="Complex" />
  <Group GroupId="1410430.46307642254280024" Style="Complex" />
  <Group GroupId="1410500.1200796567509006" Style="Complex" />
  <Group GroupId="1410550.5389102513198324" Style="Complex" />
  <Group GroupId="1410240.20175381088475985" Style="Complex" />
  <Group GroupId="1146680.5267670834694168" Style="Complex" />
  <Group GroupId="1146670.2749259321699087" Style="Complex" />
  <InfoBox CenterX="0.0" CenterY="0.0" />
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d54">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3486420</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Characterization of a cDNA coding for human factor VII.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hagen FS, Gray CL, O'Hara P, Grant FJ, Saari GC, Woodbury RG, Hart CE, Insley M, Kisiel W, Kurachi K.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f7b">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3264725</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Thim L, Bjoern S, Christensen M, Nicolaisen EM, Lund-Hansen T, Pedersen AH, Hedner U.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bb6">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">836809</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Di Scipio RG, Hermodson MA, Yates SG, Davie EW.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c4a">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">6871167</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Complete amino acid sequence of the light chain of human blood coagulation factor X: evidence for identification of residue 63 as beta-hydroxyaspartic acid.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">McMullen BA, Fujikawa K, Kisiel W, Sasagawa T, Howald WN, Kwa EY, Weinstein B.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="da1">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">6587384</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Characterization of a cDNA coding for human factor X.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Leytus SP, Chung DW, Kisiel W, Kurachi K, Davie EW.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a14">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">921929</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Activation of human factor X (Stuart factor) by a protease from Russell's viper venom.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Di Scipio RG, Hermodson MA, Davie EW.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e58">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3052293</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cofactor proteins in the assembly and expression of blood clotting enzyme complexes.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mann KG, Jenny RJ, Krishnaswamy S.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e8a">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2994716</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nucleotide sequence of the gene for human factor IX (antihemophilic factor B).</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fe8">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">6688526</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The occurrence of beta-hydroxyaspartic acid in the vitamin K-dependent blood coagulation zymogens.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">McMullen BA, Fujikawa K, Kisiel W.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e5d">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">873923</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Primary structure of human prethrombin 2 and alpha-thrombin.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Butkowski RJ, Elion J, Downing MR, Mann KG.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d4a">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2825773</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nucleotide sequence of the gene for human prothrombin.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Degen SJ, Davie EW.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e0c">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">266717</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Amino acid sequence of human prothrombin fragments 1 and 2.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Walz DA, Hewett-Emmett D, Seegers WH.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ed6">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">88107560</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b3d">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">86313665</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ed5">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12393635</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Factor V: a combination of Dr Jekyll and Mr Hyde.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mann KG, Kalafatis M.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b23">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3026437</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Amino acid sequence of the a subunit of human factor XIII.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ichinose A, Hendrickson LE, Fujikawa K, Davie EW.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="add">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3021194</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Amino acid sequence of the b subunit of human factor XIII, a protein composed of ten repetitive segments.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ichinose A, McMullen BA, Fujikawa K, Davie EW.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c93">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2866798</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Regulation of formation of factor XIIIa by its fibrin substrates.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lewis SD, Janus TJ, Lorand L, Shafer JA.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c28">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">6298709</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cloning and expression of the cDNA for human antithrombin III.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bock SC, Wion KL, Vehar GA, Lawn RM.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a42">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2822087</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wen DZ, Dittman WA, Ye RD, Deaven LL, Majerus PW, Sadler JE.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="da7">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2538457</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The roles of protein C and thrombomodulin in the regulation of blood coagulation.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Esmon CT.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e35">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2405901</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Endoproteolytic processing of the dibasic cleavage site in the human protein C precursor in transfected mammalian cells: effects of sequence alterations on efficiency of cleavage.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Foster DC, Sprecher CA, Holly RD, Gambee JE, Walker KM, Kumar AA.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a11">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">6589623</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Characterization of a cDNA coding for human protein C.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Foster D, Davie EW.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f3b">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">468991</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kisiel W.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d16">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">420821</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Characterization of protein S, a gamma-carboxyglutamic acid containing protein from bovine and human plasma.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DiScipio RG, Davie EW.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ec8">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2704749</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wilcox JN, Smith KM, Schwartz SM, Gordon D.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a92">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3527261</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bach R, Gentry R, Nemerson Y.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d57">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">6980899</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Binding of human factor VII and VIIa to monocytes.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Broze GJ Jr.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cd2">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3275472</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tissue factor and hemostasis.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nemerson Y.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="df0">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8639673</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kinetics of human factor VII activation.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Butenas S, Mann KG.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ed3">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8598903</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Banner DW, D'Arcy A, Chène C, Winkler FK, Guha A, Konigsberg WH, Nemerson Y, Kirchhofer D.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="baa">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2248955</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Komiyama Y, Pedersen AH, Kisiel W.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d46">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8578528</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The tissue factor pathway: how it has become a "prima ballerina".</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rapaport SI, Rao LV.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ed4">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2040636</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lawson JH, Mann KG.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e5a">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2271516</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Regulation of coagulation by a multivalent Kunitz-type inhibitor.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Broze GJ Jr, Girard TJ, Novotny WF.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cd9">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8195709</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ghebrehiwet B, Lim BL, Peerschke EI, Willis AC, Reid KB.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a1e">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8710908</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Joseph K, Ghebrehiwet B, Peerschke EI, Reid KB, Kaplan AP.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dab">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11986212</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mahdi F, Madar ZS, Figueroa CD, Schmaier AH.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f42">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">500690</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kerbiriou DM, Griffin JH.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="aa7">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">9226169</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">High molecular weight kininogen peptides inhibit the formation of kallikrein on endothelial cell surfaces and subsequent urokinase-dependent plasmin formation.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lin Y, Harris RB, Yan W, McCrae KR, Zhang H, Colman RW.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f84">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12944405</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mahdi F, Shariat-Madar Z, Schmaier AH.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a08">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">9427705</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Motta G, Rojkjaer R, Hasan AA, Cines DB, Schmaier AH.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ae0">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3521732</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chung DW, Fujikawa K, McMullen BA, Davie EW.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eb9">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12123826</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Identification of prolylcarboxypeptidase as the cell matrix-associated prekallikrein activator.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Moreira CR, Schmaier AH, Mahdi F, da Motta G, Nader HB, Shariat-Madar Z.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b66">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">28321</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Odya CE, Marinkovic DV, Hammon KJ, Stewart TA, Erdös EG.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ffe">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11830581</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Shariat-Madar Z, Mahdi F, Schmaier AH.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e60">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14996700</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Recombinant prolylcarboxypeptidase activates plasma prekallikrein.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Shariat-Madar Z, Mahdi F, Schmaier AH.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a1a">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8344943</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C). Similarity to both serine carboxypeptidase and prolylendopeptidase families.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tan F, Morris PW, Skidgel RA, Erdös EG.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b5c">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">4054110</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The amino acid sequence of the light chain of human high-molecular-mass kininogen.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lottspeich F, Kellermann J, Henschen A, Foertsch B, Müller-Esterl W.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d07">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3484703</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Completion of the primary structure of human high-molecular-mass kininogen. The amino acid sequence of the entire heavy chain and evidence for its evolution by gene triplication.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kellermann J, Lottspeich F, Henschen A, Müller-Esterl W.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ca9">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">6604055</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Amino acid sequence of human beta-factor XIIa.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fujikawa K, McMullen BA.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cef">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1066663</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Griffin JH, Cochrane CG.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b18">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11204562</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Joseph K, Shibayama Y, Ghebrehiwet B, Kaplan AP.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f54">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3886654</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Amino acid sequence of the heavy chain of human alpha-factor XIIa (activated Hageman factor).</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">McMullen BA, Fujikawa K.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fb9">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">874082</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Meier HL, Pierce JV, Colman RW, Kaplan AP.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fec">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">7391081</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Silverberg M, Dunn JT, Garen L, Kaplan AP.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c7a">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14691562</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The physiologic basis of assembly and activation of the plasma kallikrein/kinin system.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schmaier AH.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cee">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3017409</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Binding of coagulation factor XI to washed human platelets.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Greengard JS, Heeb MJ, Ersdal E, Walsh PN, Griffin JH.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d24">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11696542</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Baglia FA, Badellino KO, Li CQ, Lopez JA, Walsh PN.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d64">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1730602</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Modderman PW, Admiraal LG, Sonnenberg A, von dem Borne AE.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c89">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12391017</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Localization of the adhesion receptor glycoprotein Ib-IX-V complex to lipid rafts is required for platelet adhesion and activation.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Shrimpton CN, Borthakur G, Larrucea S, Cruz MA, Dong JF, López JA.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b7a">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10781579</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Baglia FA, Walsh PN.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bee">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">893417</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bouma BN, Griffin JH.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d85">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">588558</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor).</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kurachi K, Davie EW.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b17">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1998667</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">McMullen BA, Fujikawa K, Davie EW.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c3f">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8338946</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gailani D, Broze GJ Jr.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f30">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2019570</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Naito K, Fujikawa K.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d32">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">9888880</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Thrombin activates factor XI on activated platelets in the absence of factor XII.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Oliver JA, Monroe DM, Roberts HR, Hoffman M.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e03">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11342438</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gailani D, Ho D, Sun MF, Cheng Q, Walsh PN.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d59">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">681330</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Osterud B, Bouma BN, Griffin JH.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b26">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3082357</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Eaton D, Rodriguez H, Vehar GA.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a34">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2505252</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hill-Eubanks DC, Parker CG, Lollar P.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="aea">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3524673</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Amino acid sequence of human von Willebrand factor.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Titani K, Kumar S, Takio K, Ericsson LH, Wade RD, Ashida K, Walsh KA, Chopek MW, Sadler JE, Fujikawa K.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b4d">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">6438527</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Structure of human factor VIII.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vehar GA, Keyt B, Eaton D, Rodriguez H, O'Brien DP, Rotblat F, Oppermann H, Keck R, Wood WI, Harkins RN, Tuddenham EG, Lawn RM, Capon DJ.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c95">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3134349</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Association of the factor VIII light chain with von Willebrand factor.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lollar P, Hill-Eubanks DC, Parker CG.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cf8">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">7756647</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vlot AJ, Koppelman SJ, van den Berg MH, Bouma BN, Sixma JJ.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f70">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2502206</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pieters J, Lindhout T, Hemker HC.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cc1">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8626656</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Activation of the factor VIIIa-factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl-L-serine.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gilbert GE, Arena AA.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="beb">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2110473</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kinetics of coagulation factor X activation by platelet-bound factor IXa.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rawala-Sheikh R, Ahmad SS, Ashby B, Walsh PN.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="de8">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3756141</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bock SC, Skriver K, Nielsen E, Thøgersen HC, Wiman B, Donaldson VH, Eddy RL, Marrinan J, Radziejewska E, Huber R.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="df4">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2579948</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin-kallikrein complexes.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Harpel PC, Lewin MF, Kaplan AP.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b0f">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">4178758</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ratnoff OD, Pensky J, Ogston D, Naff GB.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ec3">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">6203908</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Primary structure of human alpha 2-macroglobulin. V. The complete structure.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sottrup-Jensen L, Stepanik TM, Kristensen T, Wierzbicki DM, Jones CM, Lønblad PB, Magnusson S, Petersen TE.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ba6">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2578463</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The regulation of human factor XIIa by plasma proteinase inhibitors.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pixley RA, Schapira M, Colman RW.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fb1">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">4703226</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schreiber AD, Kaplan AP, Austen KF.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ea8">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14982929</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The factor V activation paradox.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Orfeo T, Brufatto N, Nesheim ME, Xu H, Butenas S, Mann KG.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f1e">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2742826</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">High-resolution NMR studies of fibrinogen-like peptides in solution: interaction of thrombin with residues 1-23 of the A alpha chain of human fibrinogen.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ni F, Konishi Y, Frazier RB, Scheraga HA, Lord ST.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ae9">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">7356959</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Laudano AP, Doolittle RF.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c2b">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12907439</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Heparin-induced substrate behavior of antithrombin Cambridge II.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mushunje A, Zhou A, Carrell RW, Huntington JA.</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>